



INVESTIGATING HISTONE DEACETYLASE 










Histone deacetylase inhibitors are analgesic in preclinical pain models but the 
contribution of specific histone deacetylases (HDACs) to pain states remains unclear. 
HDAC4 is a transcriptional co-repressor that has previously been linked to aberrant 
nociception and synaptic plasticity. The aim of this project was to investigate the role 
of HDAC4 in vivo using the Cre-loxP system to conditionally delete HDAC4 from 
primary sensory neurons and characterize transcriptional and behavioural outcomes 
in models of pain and peripheral nerve regeneration.  
To do this I established two novel HDAC4 conditional knockout strains that enabled 
investigation of HDAC4 in both sensory neuron development and in adult sensory 
processing. In both strains, loss of HDAC4 was associated with altered expression of 
the gene encoding the transient receptor potential cation channel member A1 (Trpa1) 
and the voltage-gated calcium channel subunit α2δ-1 (Cacna2d1) in naïve ganglia. 
Bioinformatics analysis indicated that HDAC4 may bind Cacna2d1 directly. 
Furthermore, across many injury paradigms I found that HDAC4 conditional 
knockouts expressed lower levels of calcitonin-related polypeptide alpha (Calca) and 
the gene encoding the high-affinity nerve growth factor receptor (Ntrk1). While 
peripheral expression of HDAC4 was not required for sensory neuron differentiation, 
peripheral nerve regeneration or for the development of mechanical hypersensitivity 
in neuropathic pain models, I found highly reproducible and significant attenuation of 
thermal hypersensitivity in models of chronic inflammation. This was associated with 
significantly reduced mRNA expression of the transient receptor potential cation 
channel member V1 (Trpv1) and reduced capsaicin sensitivity in vitro, possibly as a 
result of aberrant nerve growth factor signaling.  
HDAC inhibitors and other drugs that target chromatin modifying and transcriptional 
regulatory proteins are already being used clinically to treat cancer. Work to 
characterize the function of these molecules in diverse systems will provide a rational 
basis for the broader application of these therapies.  
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We have evolved to engage with the world in which we find ourselves. Our senses, 
refined over many millennia, are tuned to the frequencies of light and sound, the 
vibrations and textures and smells appropriate for our survival.  
Aristotle proposed that we have five senses: vision, hearing, taste, olfaction and 
touch. Today that list has expanded to incorporate nociception, itch, thermosensation 
and proprioception. All of these sensory systems rely on similar organizational 
properties. The neuronal patterns that underlie them encode modality, location, 
intensity and duration via relay systems. They employ specialized receptors to 
transform outside signals into electrical impulses, and it is the sum of all of these 
signals, in combination with motivational and emotional processing, that give rise to a 
percept. How the binding of the individual inputs occurs is still beyond the 
understanding of neuroscience, but for the past century scientists have made great 
advances characterizing the properties of the sensory receptors, their relays, and the 
ways in which they can be modulated. In this chapter I will give an overview of the 
development, physiology and anatomy of dorsal root ganglion sensory neurons, 
which are responsible for transducing touch, proprioception, thermosensation, itch 
and nociception. Later I will go on to discuss the molecular and cellular biology of 
these neurons, and the ways in which different molecular pathways are altered in 
pathological states such as inflammation and after nerve injury. Finally, I will touch on 
the novel field of epigenetics and discuss how epigenetic mechanisms may be 
involved in these processes, with a focus on the putative role of histone deacetylase 
four (HDAC4).   
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1.1 Development of the dorsal root ganglia 
All neuronal tissue derives from the ectoderm, the top layer of tissue formed early in 
embryonic development (Kandel et al., 2000). The ectoderm develops into the neural 
plate, a specialized structure which, in a series of steps, folds in on itself to form the 
neural tube. The cells continue to proliferate in an asymmetric way, forming the 
telencephalon, mesencephalon and the rhombencephalon, which are the embryonic 
origins of the brain, midbrain/pons and spinal cord, respectively. Sensory neuron and 
glial precursors migrate from the dorsal neural tube to form the neural crest 
(Marmigere and Ernfors, 2007). Subsequently the cell bodies cluster into ganglia, 
and their axons extend to their peripheral targets.  
1.1.1 Differentiation of sensory neurons 
Throughout the nervous system, development begins with over-proliferation of cells 
and synaptic connections, followed by apoptosis and pruning of excess neurons and 
synapses. This is also the case for sensory neurons of the dorsal root ganglia (DRG). 
Axon guidance proceeds via combinations of chemical and physical signals that 
promote pathfinding to end organs (Dickson, 2002). A limiting amount of growth 
factors are released from peripheral targets, and upon innervation, growth factors 
bind to their cognate receptors, causing phosphorylation and the initiation of 
downstream signaling pathways that inhibit programmed cell death via the B-cell 
lymphoma 2 protein (BCL2) and caspases (Levi-Montalcini and Cohen, 1956; Smith, 
2001). The sensitivity of the innervating cells to different growth factors, in concert 
with intrinsic factors that govern their responses to downstream signaling pathways, 
progressively specifies different subtypes of DRG neurons (Figure 1). 
On a population level, DRG neurons can be broken into two main subtypes: large 
light cells, and small dark cells (Lawson and Biscoe, 1979), which go on to specify 
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light touch/proprioceptive neurons and small, primarily nociceptive neurons, 
respectively. These two subtypes are distinct from the moment of neurogenesis 
(Frank and Sanes, 1991). Exit from the cell cycle requires the expression of 
neurogenin transcription factors (NGN1 and NGN2), and early specification of 
neuronal fate is governed by the transcription factors SOX10, KROX20, FOXS1, 
BRN3A and ISLET1 (for review see Marmigere and Ernfors, 2007). 
 
Figure 1 - Sensory neuron differentiation, adapted from Lallemend and Ernfors 2012 
The cell lineages described in the mouse are outlined in different colours, with the stage of 
development indicated on the right hand side of the figure, E = embryonic, P = postnatal. 
NCC = neural crest cells, the origin of all DRG sensory neurons. Three main lineages of 
myelinated sensory neurons have been described, the early Ret expressing (eRet), the 
TrkB/C and the early TrkA lineage. The unmyelinated neurons are broken into four 
populations: the late TrkA (lTrkA), late Ret expressing (lRet), TRPM8 expressing and tyrosine 
hydroxylase (TH) expressing subtypes. The embryonic origin of the TH neurons is unknown, 
which is why it appears unconnected to the others. Many questions remain regarding the 
cues for sensory neuron development, and question marks indicate lineages that remain to be 
clarified with fate-mapping studies. 
 
also regulates expression of ion channels involved in mech-
anoreceptor function [25]. It appears that Shox2 is initiat-
ed in some of the early Ret+/MafA+ neurons, where it
suppresses TrkC expression and is necessary for TrkB
expression in these neurons [24] (Figure 4), thereby defin-
ing Ret+/TrkB+ neurons in this branch of sensory neurons
(i.e. Ret+/TrkB+/MafA+/Shox2+ neurons). In Shox2!/!mice,
large numbers of the TrkB+ neurons fail to develop, the
TrkC population expands and a concomitant deficit of
projections to Meissner corpuscles (as well as to Merkel
cells) and a dramatic impairment in light-touch responses
are observed [24,26]. Thus, it is conceivable that, in the
eRet+/MafA+/TrkB+/Shox2+ population, the role of Shox2
upstream of TrkB could result in the inability of MafA to
repress this receptor and so these neurons express both Ret
and TrkB but not TrkC. The transcriptional mechanism for
segregating Ret+/MafA+ and Ret+/MafA+/TrkC+ neurons
has not been unraveled.
TrkB/C lineage
The large-size myelinated proprioceptive neurons (TrkC+/
Runx3+neurons) and some TrkB+neurons (TrkB+/Shox2+/!)
without Ret may arise from two early TrkC+populations, one
that expresses TrkB until approximately E12.5 and another
without TrkB (for simplicity, denominated TrkB/C lineage in
Figure 2, shaded green). Runx3 expression is initiated early
during development in these immature neurons [16,27] and
is necessary to consolidate a solitary TrkC phenotype by
rep essing the potential for T kB expression and maintain-
ing the expression of TrkC within the prospective proprio-
ceptive neurons (Figure 4) [16,27,28]. The early hybrid TrkB/
TrkC neurons fail to segregate (i.e. downregulate TrkB) in
Runx3!/! mice and ectopically expressed Runx3 in DRG
neurons suppresses TrkB in all mechanosensory neurons,
including also the eRet branch, which instead now coex-
presses TrkC [16]. Intron 7 of the TrkB gene contains a
silencer that depends not only on Runx protein complex, but
also on NT3 signaling for a repressor activity [29]. In addi-
tion to TrkB, Runx3 also represses Shox2, thereby extin-
guishing the transcriptional activator for TrkB in neurons
adopting a proprioceptive fate [24]. Maintained expression of
Shox2 is largely seen in neurons with extinguished Runx3
expression (which occurs independently of Shox2) and, in
these neurons, Shox2 represses TrkC and promotes TrkB
expression [24,26]. Thus, such cross-activation and repres-
sion activities may underlie the consolidation of the propri-
oceptive TrkC+ and the TrkB+ populations. These TrkB+/
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TRENDS in Neurosciences 
Figure 2. Dorsal root ganglion (DRG) neuron diversification during development. Schematic representation of the different main lineages (outlined by color shading) during
the course of sensory neuron differentiation in mouse. All sensory neurons arise from neural crest cells (NCCs). The far right column refers to development stages in
mouse, where E and P represent embryonic and postnatal stages, respec ively. Hence, within the myelinated populations, light-brown, green a d gray identify the early Ret
(eRet), tropomyosin-receptor kinase (Trk)B/TrkC and early TrkA (eTrkA) lineages, respectively. The unmyelinated populations are divided into four main categories: the late
TrkA (lTrkA), the late Ret (lRet), the TrpM8 and the TH lineages, identified by the red, orange, blue and yellow color codes, respectively. The ancestors of vesicular glutamate
transporter type 3 (VGLUT3+)/tyrosine hydroxylase (TH+) neurons are unknown; therefore, this type of neuron is not connected to any early immature neuronal population.
Factors with question marks remain to be clarified and plus and minus signs refer to expression in some but not all neurons in the indicated subtype of neurons.
Furthermore, the arrow within cells of the eTrkA lineage remains to be clarified for definite assignment.
Review Trends in Neurosciences June 2012, Vol. 35, No. 6
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1.1.2 Neurotrophic factor receptors specify neuronal subtypes of the 
DRG 
Several classes of neurotrophic factor receptors are expressed in the DRG, some of 
which are critical for development of sensory neuron subpopulations. These include 
the neurotrophic tyrosine kinase receptor (NTKR) family members, TrkA, TrkB and 
TrkC, and the receptor kinases Met and Ret.  TrkA is preferentially activated by nerve 
growth factor (NGF), TrkB responds to brain-derived neurotrophic factor (BDNF) and 
TrkC responds to neurotrophin-3 (NT3). Met is the receptor for hepatocyte growth 
factor (HGF) and Ret activation is coupled to glial-derived trophic factor (GDNF) 
family ligand (GFLs) signaling. The precise timing and expression of these receptors 
is critical for appropriate peripheral innervation, cell survival and to specify the 
molecular and physiological characteristics of the different sensory neuron types, for 
example by regulating the expression of channels that can transduce specific stimuli. 
Importantly, growth factors, particularly NGF, can elicit nociception in adulthood, and 
blocking them has emerged as an important novel strategy for pain relief in the clinic, 
although poorly misunderstood side-effects have slowed the wide-spread application 
of these therapies (FDA, 2012; Lane et al., 2010; Pezet and McMahon, 2006). 
Understanding the molecular cues that regulate growth factor signaling, and an in-
depth characterization of the cell populations that respond to NGF will be critical for 
this to be of use.  
The majority of anatomical studies to characterize distribution of Trk receptors have 
been performed in lumbar ganglia of the rat and mouse, which largely innervate 
cutaneous tissues. It must be noted, therefore, that these findings may not fully 
describe ganglia that innervate viscera or muscles (McMahon et al., 1994). Broadly 
speaking, TrkB and TrkC are the primary growth factor receptors expressed in large 
light neurons, though a small subset of peptidergic large neurons also express TrkA. 
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This population is characterized by fast conduction velocities, large myelinated fibres 
and transduces proprioceptive and light touch information from the periphery. Its 
diversification relies on RUNX3, a runt-domain transcription factor, alongside the 
MAF and SHOX transcription factors (Lallemend and Ernfors, 2012). 
Conversely, TrkA signaling is essential for the survival and development of small, 
unmyelinated sensory neurons, which transmit information about pain, itch and 
temperature (Snider, 1994). Two main classes of small neurons are formed through 
multiple stages of development, the calcitonin-gene related peptide (CGRP)-positive 
(peptidergic) population, and the isolectin B4 (IB4)-positive (non-peptidergic) 
population, although other sub-classes have also been identified. 
A different set of transcription factors is responsible for the development of these 
small cell populations. Expression of NGN1 first specifies differentiation of small 
neurons, after the first wave of neurogenesis occurs in the neural crest (Ma et al., 
1999). Neurons then begin to express the NGF receptor TrkA and the transcription 
factor RUNX1 (Ma et al., 1999). Upon target innervation half of the neurons will 
switch to become GDNF sensitive, progressively losing TrkA and CGRP expression 
and upregulating Ret, forming the non-peptidergic subpopulation (Luo et al., 2007; 
Molliver, 1997; Yoshikawa et al., 2007). The other half will continue to express TrkA 
and CGRP, a proportion of which will further differentiate to form an HGF-sensitive 
population (Gascon et al., 2010). Further specification of neurons continues in the 
early postnatal period, with non-peptidergic neurons preferentially expressing 
different Mas-related G-protein coupled (MRGPR) receptors (Liu et al., 2008; 
Molliver, 1997; Samad et al., 2010). 
The differential reliance on growth factors and transcription factors implies that these 
populations of neurons may have selective activation patterns, with implications for 
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the generation of pain (Snider and McMahon, 1998). In the following sections, I will 
discuss how these populations may encode sensory information.  
1.2 Sensory transduction  
In 1822 Magendie first ascribed sensory function to the dorsal roots of the spinal 
cord. Since then scientists have continued to refine and expand upon our 
understanding of the transduction of outside signals to form percepts.  
Early studies of sensory perception supported the idea of a “labeled line” encoding of 
sensory stimulation: a single fibre fired to encode a single stimulus. Evidence for this 
came from Blix, Von Frey and others in the second half of the nineteenth century, 
who demonstrated that different areas of the skin were sensitive to different types of 
stimulation. Von Frey proposed that labeled lines had distinct anatomical structures, 
which was true in the case of light touch and pressure, but could not be 
demonstrated for the different nociceptive stimuli. This was the primary argument of 
Weddell, Adrian, Nafe and others who instead proposed a “pattern theory” of sensory 
encoding, in which any stimulus was thought to activate any nerve, and the quality of 
the stimulus was determined by the pattern of activation. Evidence from nerve 
recordings refuted this, as it was discovered that nerves responded to very specific 
stimuli, although these experiments also demonstrated that there was not always a 
one-to-one relationship between nerve activation and perception. Today, a modified 
version of the Gate Theory of Melzack and Wall, called the population-coding 
hypothesis is argued to be the most accurate description to account for these varied 
data: specific sense information is encoded by labeled lines that engage in “cross-
talk” in the periphery. This is then translated into central activation patterns in the 
spinal cord that are recognized by higher cortical centres, giving rise to sensory 
perception (Ma, 2012). It must be noted that this theory does not fully account for all 
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aspects of sensation; visceral pain, for example, may be more accurately described 
by the pattern theory (Cervero and Laird, 1999).  
In order to detect the wide range of stimuli, cutaneous somatosensory receptors form 
a diverse array of nerve endings that are finely tuned to respond to particular 
modalities. Touch and proprioceptive information are primarily relayed via large, Aβ 
afferents innervating Merkel cells, Meissnerʼs corpuscles, Pacinian corpuscles and 
Raffini endings. Nociception and thermosensation are detected by thinly myelinated 
Aδ fibres and unmyelinated C fibres that terminate in the epidermis as free nerve 
endings. In addition, a class of “silent nociceptors” exists, that are normally 
unresponsive to mechanical stimulation unless they are first sensitized by 
inflammatory mediators (Lynn and Carpenter 1982, Meyer 1991).  
The modality specificity of each of these receptors relies on the selective expression 
of channels and receptors that transduce external stimuli into ionic currents and 
action potential generation. Over the past few decades, great strides have been 
made in identifying channels and receptors with selective activation properties 
(Basbaum et al., 2009), for example the transient receptor potential (TRP) ion 
channels that are required for sensing a variety of stimulants including heat, protons 
and toxins, and the MRGPR class of G-protein coupled receptors, some of which 
respond selectively to pruritogens like chloroquine, a malaria treatment that 
commonly evokes itch as a side-effect (Liu et al., 2009). In the following section I will 
discuss some of the key molecules and general principles of the molecular basis of 
sensory transduction. 
1.2.1 Molecular transducers of external stimuli 
Capsaicin, the ingredient in chili peppers that gives them their kick, was the basis of 
the discovery of the first somatosensory TRP channel to be identified, TRPV1 
24 
(Caterina, 1997). TRPV1 is a ligand-gated ion channel and upon binding of 
capsaicin, the channel opens and allows an influx of cations, leading to 
depolarization. Because capsaicin administration feels ʻhotʼ, it was postulated that 
TRPV1 may also be involved in heat sensing, and indeed it is: it can be activated by 
increases in temperature, with an activation threshold of ~43ºC (Basbaum et al., 
2009). Approximately thirty other members of the TRP family have been identified, a 
number of which have been shown to have some role in thermosensation through 
both heterologous expression and knockout studies, notably TRPM8, the menthol 
receptor, that is involved in cold sensing (Bautista et al., 2007; Colburn et al., 2007; 
Dhaka et al., 2007). The precise distribution of these receptors and their individual 
contributions to thermosensation is an area of active enquiry.  
Mechanosensation has proven much more difficult to study due to inherent technical 
challenges, including a dearth of in vivo assays to study different aspects of 
somatosensation in model animals, and a lack of molecular markers for assigning 
currents to particular cell types when measured by patch clamp in vitro (Basbaum et 
al., 2009). A number of candidate mammalian mechanotransducers have been 
proposed based on homology with mechanosensitive channels in model organisms, 
including the TRP channel TRPA1, the acid-sensing ion channels (ASICs), and the 
Piezo proteins (PIEZO1 and PIEZO2). To date, the evidence regarding TRPs and 
ASICs is conflicting, and neither family has been shown conclusively to have an 
essential role in mechanotransduction, though both have been implicated in 
hypersensitivity in pathological conditions (Delmas et al., 2011). In contrast, the 
Piezo proteins, and more recently the delayed-rectifier voltage-gated potassium 
channel Kv1.1, have been convincingly shown to be mechanosensitive and can 
confer mechanosensivity when heterologously expressed in cell lines (Coste et al., 
2010; Hao et al., 2013). PIEZO2 is expressed in the DRG, and siRNA against it can 
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inhibit rapidly adapting currents in response to mechanical stimulation, implying that it 
may play a role in non-nociceptive mechanosensation. Kv1.1, on the other hand, 
appears to be more important in regulating the firing rate of Aβ rapidly adapting 
mechanoreceptors and the firing threshold of C-high threshold mechanoreceptors, 
potentially implicating it in noxious mechanosensation. 
Other proteins have also been shown to influence touch sensitivity through a 
modulatory role in sensory neurons, for example members of the two-pore domain 
(KCNK) potassium channel subfamily and the integral membrane protein Stomatin 
which may alter excitability of sensory neurons rather than having a role in 
mechanosensation per se (Delmas et al., 2011). Mechanical allodynia, the perception 
of an innocuous stimulus as painful, and hyperalgesia, a heightened response to a 
painful stimulus are hallmarks of many chronic pain states, and understanding the 
molecular pathways that underlie them may provide new avenues for treatment 
(Wood and Eijkelkamp, 2012). The identification of cutaneous mechanotransducers 
is an area of ongoing research, and remains one of the key challenges in the field of 
somatosensation and pain. 
Chemosensation refers to the process by which sensory receptors respond to 
chemical irritants. These may arise from endogenous sources, such as histamine 
and bradykinin that are released from damaged tissues after injury, or from the 
external environment. Alongside their function as mechano- and thermosensitive 
channels, TRP channels have also been shown to play a critical role in 
chemosensation, particularly TRPA1, the receptor for the pungent ingredients in 
mustard and garlic, isothyocyanates and thiosulfinates (Bautista et al., 2006). TRPA1 
channels can respond to structurally diverse stimuli that are capable of crossing the 
membrane to covalently modify cysteine residues on the intracellular side of the 
channel. Because chemical irritants can result in sensitization of sensory neurons to 
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subsequent input, this positions TRPA1 as a potentially important molecule at the 
interface between acute and chronic nociception. 
1.2.2 Propagating the receptor potential 
The activation of mechano- thermo- and chemosensitive channels results in the influx 
of depolarizing cations, generating what is known as the receptor potential. The 
receptor potential activates voltage-sensitive channels in the membrane to further 
depolarize the terminal and cause an action potential to travel to the cell body. Many 
different voltage-gated sodium, potassium and calcium channels have been identified 
on sensory neuron terminals, some of which have been shown to be critical for 
modality-specific sensation, for example the voltage-gated sodium channel Nav1.7, is 
required for nociception but not for light touch and proprioception (Nassar et al., 
2004). Selective antagonists for this channel may have therapeutic potential in the 
treatment of chronic pain.  
Voltage-sensitive calcium channels play a key role in the release of neurotransmitters 
and neuropeptides from both central and peripheral terminals of DRG sensory 
neurons (Basbaum et al., 2009). They are heteromeric proteins, composed of the α1 
pore-forming subunit along with various combinations of α2δ, α2β and α2γ subunits 
that modulate their activity. The α2δ subunit, encoded by the Cacna2d1 gene, has 
been shown to be important in regulating the kinetics of channel activation and 
inactivation, as well as the current density. They are the primary targets of 
gabapentinoids used to treat epilepsy and neuropathic pain (Field et al., 2006).  
1.3 Response to injury 
Tissue injury results in changes to sensory neuron activity via direct stimulation of 
afferents as well as indirect mechanisms involving the release of mediators from non-
neuronal cells (McMahon, 2013). The modification and alternate transcriptional 
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regulation of sensory receptors and channels are critical for appropriate behavioural 
responses to allow for tissue healing. These mechanisms may also be engaged to 
produce persistent pain in the absence of overt tissue injury. Deeper understanding 
of these mechanisms may help to identify novel therapeutic targets for patients. Here 
I will discuss changes to sensory neuron function that emerge as a result of 
inflammation and nerve injury, respectively. 
1.3.1 Inflammation and peripheral sensitization 
Two thousand years ago, Celsus described the four classical signs of inflammation: 
rubor (redness), tumor (swelling), calor (heat) and dolor (pain). These signs result 
from the activation of many different cell types at the site of injury that release a wide 
variety of signaling factors, including bradykinin, ATP, neurotransmitters, 
neuropeptides, neurotrophins, and cytokines, collectively known as “inflammatory 
soup” (McMahon, 2013). Some of these factors can bind to receptors on nociceptors, 
and directly enhance the excitability of the nerve fibre. This process is called 
peripheral sensitisation, and it is characterized by a decrease in response threshold, 
an increased response to suprathreshold stimuli and spontaneous activity, 
corresponding to the experience of hyperalgesia. In the following sections, I will 
discuss some of the key molecules involved in peripheral sensitization, and the 
downstream signaling pathways they engage to produce this altered activity.  
1.3.2 Signaling pathways and transcriptional regulation 
Many overlapping mechanisms contribute to the phenomenon of peripheral 
sensitization, including post-translational modification of chemo- and thermosensitive 
receptors and voltage-gated channels, as well as more long-term changes in 
excitability resulting from transcriptional dysregulation (Figure 2). One of the best-
characterized mediators is the growth factor, NGF. Although required for sensory 
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neuron survival during development, in the adult, peripheral NGF administration is 
acutely nociceptive, and blocking NGF or its high-affinity receptor, TrkA, have been 
shown to be potently analgesic (Pezet and McMahon, 2006). Upon release, NGF 
binds to TrkA as a dimer, leading to auto-phosphorylation of the internal side of the 
receptor. The phosphorylation of the TrkA receptor can have direct effects on other 
receptors in the membrane, for example it can transactivate TRPV1, enhancing 
capsaicin sensitivity (Chuang et al., 2001). Alternatively, NGF may have more long-
term effects through the action of intracellular signalling cascades, or by retrograde 
transport to the cell soma (Pezet and McMahon, 2006).  
 
Figure 2 - Signaling cascades in peripheral sensitization 
Activation of nociceptors by inflammatory soup components such as bradykinin (BK), protons 
(H+), prostaglandin (PG) and NGF leads to the activation of downstream signaling pathways 
that enhance excitability by sensitizing textrodotoxin-resistant (TTX-R) voltage-gated sodium 
channels. Hypersensitivity to heat can be induced by direct sensitization of TRPV1 (VR1) by 
binding of H+ or anandamide (AEA), or through the action of NGF and BK binding their own 
receptors to induce phospholipase-C signaling (PLC) which stimulates PKC-epsilon, 
enhancing TRPV1 responses. PG binding to the PGE2 receptor also contributes to 
sensitization by coupling to Gs proteins that increase adenylyl cyclase (AC) and activate 
protein kinase A (PKA) phosphorylation of TTX-R channels. This can be opposed by 
cannabinoids (CBs) or opiates acting through Gi coupled GPCRs, contributing to peripherally-
mediated analgesia. Adapted from Julius and Basbaum, 2001. 
 
The cyclic AMP (cAMP)-dependent protein kinases PKA and PKCε as well as the 
MAP kinases (MAPK) have all been implicated as downstream effectors of NGF 
sensitization. Both PKA and PKCε sensitize neurons by altering the activity of 
or more of polymodal nociceptors that innervate the receptive field20.
At the cellular level, protons depolarize sensory neurons by directly
activating a non-selective cationic current38,39. In many DRG 
neurons, this response consists of a transient, rapidly inactivating
current that is carried predominantly by Na+ ions, followed by a 
sustained non-selective cationic current. Responses of a sustained
nature have been proposed to underlie persistent pain a sociated
with tissue acidosis37, but this may not occur in all physiological 
settings. For example, during cardiac ischaemia, DRG neurons that
innervate the epicardium show very large, but transient, response to
extracellular protons40. A number of proton-sensitive channels are
found on sensory neurons and thus an important goal has been to
determine which, if any, of these molecules contributes to proton
sensitivity of nociceptors in vivo. Two main candidates have emerged
— VR1 and a family of ASICs.
The similarity between native proton (pH 5)-evoked and 
capsaicin-evoked currents in dissociated DRG neurons41 is well
established, and low extracellular pH can augme t responses of 
cultured DRG neurons to capsaicin42. These observations suggested
that protons and vanilloid compounds interact with the same ion-
channel complex on the nociceptor (perhaps providing a cellular
rationale for the culinary appeal of ‘hot’ and sour soup). Analysis of
the cloned vanilloid receptor in heterologous expression systems has
substantiated these observations. Protons have two main effects on
VR1 function17. First, VR1 can be activated at room temperature
when the extracellular pH drops below 6, producing currents that
resemble the sustained component of proton-evoked responses
observed in sensory neurons. Second, protons potentiate responses
to capsaicin or heat, and do so over a concentration range (pH 6–8)
that matches the extent of local acidosis associated with various
forms of tissue injury. These changes in VR1 activity would be
expected to increase nociceptor excitability, even at normal body
temperature. Structure–function studies have now identified several
negatively charged residues within putative extracellular loops of
VR1 that are important for mediating these effects18,43, supporting
the idea that protons interact directly with the vanilloid receptor to
allosterically modulate channel function.
Although proton-evoked changes in VR1 thermal sensitivity
closely resemble those exhibited by nociceptors during inflamma-
tion, does VR1 actually contribute to pH sensitivity of nociceptors in
vivo? DRG neurons or sensory nerve fibres from VR1-deficient mice
do indeed show a marked reduction in sustained proton (pH 5)-
evoked membrane currents. But proton-evoked responses, particu-
larly those of a transient nature, are not eliminated completely in
VR1–/–mice and may be mediated by members of the ASIC channel
family.
Lazdunski and c lleagues44 described a family of two-transmem-
brane-domain proteins that are related to the putative mechan sen-
sory DEG/ENaC channels. These novel cation-channel subunits
were named ASICs because of their ability to be gated by reductions
in extracellular pH when expressed in heterologous systems (Fig. 2b).
Including splice variants, there are at least five ASIC subtypes (1a, 1b,
2a, 2b and 3) in rats, each having a unique profile of pH sensitivity,
activation a d desensitization rates, ionic permeability and tissu
distribution. Most subtypes are expressed in DRG, with ASIC1b and
ASIC3 (known also as ASIC-! and DRASIC, respectively) showing
exclusive or preferential expression within sensory ganglia. Can
ASIC channels account for any aspect of transient or sustained pro-
ton-evoked currents observed in DRG neurons? Heterologous
expression of most ASIC subunits produces currents consisting of a
single transient phase, or one having a sustained component that is
Na+-selective or observed only at non-physiological proton 
concentrations ("pH 5). However, co-expression of ASIC3 with
ASIC2b (a splice variant of MDEG, also called MDEG2) generates a
more native-like current containing a sustained component with
non-selective cation permeability30. McCleskey and colleagues40have
provided strong evidence that ASIC3/2b heteromeric channels,
rather than VR1, underlie the unusually large and mostly transient
proton-evoked currents observed in the relatively small subpopula-
tion (2–3%) of DRG afferents that innervate the heart. This makes
good physiological sense because occlusion of a cardiac artery 
produces modest acidosis (to just below pH 7), but this is sufficient to
activate cardiac nociceptors or ASIC3/2b.
By contrast, genetic studies indicate that MDEG (BNC1) gene
products (ASIC2a and 2b) do not contribute to acid sensitivity in
most non-cardiac nociceptors32. Thus, BNC1–/– mice showed no
obvious decrement in pH 5-evoked responses among large- or 
small-diameter DRG neurons. Moreover, acid produced normal 
sustained discharges in cutaneous C fibres from these animals. Gene
knockouts of other members of this family will be needed to clarify
the contribution of ASICs to proton detection and nociceptor 
sensitization at various physiological sites.
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Figure 4When nociceptors are exposed to
products of injury and inflammation, their
excitability is altered by a variety of intracellular
signalling pathways. The figure highlights the
vanilloid receptor (VR1) and tetrodotoxin-resistant
(TTX-R) voltage-gated sodium channels (Nav1.8
and 1.9) as downstream targets of modulation.
Responses of VR1 to heat can be potentiated by
direct interaction of the channel with extracellular
protons (H+) or lipid metabolites, such as
anandamide (AEA). VR1 activity can also be
heightened by agents such as NGF or bradykinin,
which bind to their own cell-surface receptors (TrkA
and BK, respectively) to stimulate phospholipase C
(PLC-# or PLC-!) signalling pathways. This, in
turn, leads to hydrolysis of plasma membrane lipids
and the subsequent stimulation of protein kinase C
isoforms, such as PKC-$. Both of these actions
have been proposed to potentiate VR1 function.
Prostaglandins (PGE2) and other inflammatory products that activate adenylyl cyclase (AC) through Gs-coupled receptors also enhance nociceptor excitability. This occurs, in part, by
a cyclic AMP-dependent protein kinase (PKA)-dependent phosphorylation of Nav1.8 and/or Nav1.9. By activating Gi-coupled receptors, opiates and cannabinoids can counteract
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tetrodotoxin-resistant voltage-gated sodium currents (Gold et al., 1998; Khasar et al., 
1999) and may also contribute to TRPV1 sensitization via direct phosphorylation 
(Srinivasan et al., 2008) (Figure 2). Both the p38 MAPK and the extracellular signal-
related kinase (ERK) are phosphorylated by nociceptive stimulation, and blocking 
them has been shown to be analgesic (Dai et al., 2002; Ji et al., 2002; Obata et al., 
2004). p38 activation has been shown to depend on NGF, and is required for NGF-
induced thermal hypersensitivity and TRPV1 protein upregulation (Ji et al., 2002).  
Sensitization of TRPs and voltage-gated sodium channels leads increased channel 
opening and influx of calcium ions, which act on downstream signalling pathways to 
induce transcriptional changes. One transcription factor that has been implicated in 
peripheral sensitization is the cAMP response element binding protein (CREB) 
(Nakanishi et al., 2010). CREB regulates the expression of many neuropeptides, 
including CGRP, which is rapidly induced by inflammation (Nahin and Byers, 1994). 
Other signalling pathways, such as the janus kinase/signal transducer and activator 
of transcription (JAK/STAT) pathway, as well as the cJun N-terminal kinase (JNK) 
and nuclear factor kappa-light-chain-enhancer of activated B cells (NFΚB) family 
members have also been implicated in inflammation-associated hypersensitivity (Han 
et al., 2001; Igwe, 2005; Inoue et al., 2006; Tamura et al., 2005), and may contribute 
to altered transcriptional regulation. For example, Igwe demonstrated that inhibition 
of the p65 subunit of NFΚB could block the expression of cyclooxygenase two 
(COX2), the major target of non-steroidal anti-inflammatory drugs (NSAIDs) and a 
known pain mediator (Igwe, 2005).  
 
Though a number of studies have demonstrated transcriptional changes of individual 
targets in inflammatory pain models, including upregulation of the genes encoding 
CGRP and BDNF (Lindsay and Harmar, 1989; Michael et al., 1997), there are 
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surprisingly few studies that have characterized the transcriptional profile of primary 
sensory neurons using high-throughput techniques (Chang et al., 2010; Yang et al., 
2007). Instead, more focus has been placed on describing changes in the spinal 
cord, as the site of central sensitization, and on immune cells (Donate et al., 2013; 
Geranton et al., 2007; Ren et al., 2005; Rodriguez Parkitna et al., 2006; Victoratos et 
al., 1997; Yukhananov and Kissin, 2008). The study by Yang et al only found one 
target, the chemokine Ccl2, that has since replicated across many different pain 
models (LaCroix-Fralish et al., 2011). Using cut-off criteria of unadjusted p value 
<0.05 and fold change >1.5 over naïve, the more recent study by Chang et al 
identified 235 differentially regulated oligo probes, of which 140 had been annotated, 
and represented individual genes. Overall there was a trend for upregulation of 
genes associated with neuronal growth and survival, and downregulation of 
inflammation-associated genes. Two recent studies have indicated that drugs that 
are capable of altering chromatin architecture, and may thus impact transcription, can 
be analgesic in inflammatory pain models (Bai et al., 2010; Zhang et al., 2011). 
Further work on chromatin remodeling may give rise to new insights about the 
underlying mechanisms of peripheral sensitization, as will be discussed in the section 
on epigenetics below.  
1.3.3 Nerve injury 
After traumatic injury to a peripheral nerve, the affected cell bodies undergo drastic 
changes to gene and protein expression, and display altered morphology: cell bodies 
appear swollen, Nissl bodies dissolve and the nucleus is displaced. The distal nerve 
undergoes the process of Wallerian degeneration, while the proximal end forms a 
growth cone and begins the process of regeneration and remyelination. The capacity 
to regenerate is unique to the peripheral nervous system, owing in part to the 
permissive milieu created by the injury site (Makwana and Raivich, 2005). Functional 
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recovery depends both on the severity and location of the injury. Unrepaired 
lacerating injuries (neurotmesis) have the worst outcomes due to misrouting of 
regenerating fibres, whereas injuries that do not disrupt the nerve sheath 
(axonotmesis) are more likely to regenerate appropriately along their original path.  
There are three main signals that are thought to underlie the phenotypic changes to 
the primary sensory neuron cell bodies and their subsequent regenerative capacity: 1 
– rapid influxes of calcium which result from electrical stimulation of the nerve upon 
injury; 2 – retrograde transport of factors, such as cytokines, from the injury site; and, 
3 – loss of tonic neurotrophic factor signaling (Patodia and Raivich, 2012).  All of 
these signals may result in transcriptional changes, as outlined in the previous 
section.  
Unlike the inflammation field, the DRG transcriptome has been extensively 
characterized following nerve injury (Bonilla et al., 2002; Costigan et al., 2002; 
Hammer et al., 2010; Levin et al., 2008; Valder et al., 2003; Vega-Avelaira et al., 
2009; Wang et al., 2002; Xiao et al., 2002), and it is clear that transcriptional 
mechanisms are important for various aspects of the response to injury, for example 
by enhancing the production of cytoskeletal proteins to achieve regeneration 
(recently reviewed by (Patodia and Raivich, 2012)). Some work has been done to try 
to identify commonly occurring transcriptional events, for example the ʻmeta-analysisʼ 
published by LaCroix-Fralish et al (LaCroix-Fralish et al., 2011) which looked for 
commonly dysregulated transcripts in twenty microarray datasets from multiple 
tissues and pain models. This group identified 79 genes that were altered in at least 
four studies. Interestingly, this list was enriched for genes associated with immune 
function and synaptic transmission, indicating that these processes may be involved 
across a wide variety of pain states (LaCroix-Fralish et al., 2011).  
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Figure 3 - Commonly dysregulated transcripts in pain are associated with immune 
function and synaptic transmission, among others. Adapted from LaCroix-Fralish et 
al., 2011 
 
Many transcription factors have been implicated in mediating these changes, 
including cJUN and CREB, but the extent to which these transcription factors engage 
epigenetic modification of chromatin to exert their effects is only beginning to be 
explored. For example, one recent study looked at the activity of the RE-1 site 
transcription factor (REST) following nerve injury, and found that two genes with RE-
1 binding sites, Scn9a and Oprm1, bound to REST after injury and were 
downregulated, which was associated with reduced histone H3 acetylation around 
the RE-1 motifs (Uchida et al., 2010). In the following section, I will introduce the field 
of epigenetics, and discuss how a deeper understanding of the molecules involved in 
modulating chromatin, for example through histone deacetylation, may provide new 
avenues for the treatment of diseases associated with long-term transcriptional 
dysregulation. 
1.4 Epigenetics 
Transcriptional regulation is critical for appropriate cellular responses to external 
stimulation. With the increasing availability of high-throughput transcriptional profiling 











the massive scale and influence of transcriptional change in disease states has been 
recognized, leading to further investigations into the mechanisms that underlie and 
maintain these changes. Epigenetic mechanisms, such as covalent DNA- and 
histone post-translational modifications, may provide the missing link as they are 
dynamic, responding readily to external cues; instructive for transcription; and 
potentially long-lasting (Allis et al., 2007). Exploring these mechanisms may lead to 
novel approaches to treating disease (Arrowsmith et al., 2012; Crow et al., 2013). 
Epigenetics is a field with a convoluted history, due in part to the simultaneous use of 
the word to describe two different things. In the nineteen-fifties, the word epigenetics 
was defined by Waddington as the study of “causal mechanisms” through which “the 
genes of the genotype bring about phenotypic events”; Nanney used it to explain his 
observation that cells of the same genotype could have different phenotypes that 
persisted for many generations (Haig, 2004). Today, epigenetics refers to the study 
of alterations to gene function that cannot be explained by DNA sequence (Allis et 
al., 2007). There are several molecular mechanisms that contribute to epigenetic 
gene regulation including ATP-dependent chromatin remodeling, covalent 
modifications of DNA and histone proteins and exchange of histone variants. 
Historically, research in this area has focused on dividing cells and mitotic/meiotic 
heritability, but in recent years there has been much interest in studying epigenetic 
processes within the post-mitotic environment of the nervous system (Day and 
Sweatt, 2011; Maze et al., 2013). Particular attention has been paid to the role of 
histone post-translational modifications and I will discuss this in greater detail below. 
In the nucleus DNA is tightly associated with histones to form chromatin, the 
substrate for epigenetic processes to regulate gene expression. The repeating unit of 
chromatin is the nucleosome, which is composed of 147 base pairs of superhelical 
DNA wrapped around a core of eight histone proteins (two copies each of H2A, H2B 
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H3 and H4). To date, more than 350 chromatin modifying proteins have been 
identified which are capable of changing the physical interactions between DNA and 
histones or can result in gene regulation by recruiting transcriptional machinery 
(Kouzarides, 2007). Chromatin modifying proteins are commonly broken down into 
writers (that add modifications), readers (that respond to modifications and translate 
them into different actions) and erasers (that take away modifications). These three 
divisions can be further sub-divided by the specific modification (e.g. lysine 
acetylation vs. lysine methylation) that they write, read or erase (Figure 4).  
 
Figure 4 - Schematic representation of chromatin structure and key epigenetic 
processes involved in gene expression 
DNA is packaged into chromatin by wrapping around histones, forming a repeating subunit 
called a nucleosome. Histones are subject to post-translational modifications (PTMs) that 
alter their association with DNA, for example acetylation of terminal lysine residues reduces 
chromatin compaction, which can enhance accessibility to RNA polymerase. There is no one-
to-one relationship between histone marks and transcriptional status, which suggets that gene 
expression is mediated by a combination of PTMs. Chromatin modifying protein families are 
illustrated on the right. ʻWritersʼ deposit marks onto histones, whereas ʻerasersʼ remove them. 
Marks are recognized by ʻreadersʼ that contain specific protein-binding domains, e.g. plant 
homeodomains (PHDs) or bromodomains. Figure adapted from Arrowsmith et al., 2012.  
Although the genome is studded with histone modifications or ʻmarksʼ, many of them 
appear to be poorly predictive of transcriptional status on their own, leading to the 
idea of the ʻhistone codeʼ or ʻlanguageʼ. By this schema it is thought that the 




























An evolutionarily conserved, 
~110-amino-acid motif 
composed of four left-handed, 
antiparallel α-helices.
regulatory mechanism25. Arginine methylation of his-
tones can promote or antagonize the interaction of 
nuclear factors with other nearby histone marks, thereby 
increasing the complexity of the histone code26,27.
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The readers, writers and erasers of epigenetic marks can 
contribute to or drive disease via two primary mecha-
nisms. First, aberrant activity due to mutation or altered 
expression of epigenetic factors can alter subsequent 
cellular gene expression patterns that lead to or even 
drive and maintain disease states. Second, because the 
readers, writers and erasers are general factors that work 
in concert with many other cellular proteins, especially 
tissue-specific and environmentally responsive DNA-
binding transcription factors, they can mediate altered 
gene expression patterns driven by upstream signals10. 
Importantly, the latter case offers the opportunity to 
target disease pathways whose primary drivers (for 
example, certain transcription factors or external stimuli) 
may not be druggable.
Cancer. Epigenetic mechanisms have long been known to 
be involved in cancer, beginning with the observation that 
levels of DNA methylation were dramatically altered in 
most cancers. Although cancer is fundamentally a genetic 
disease that is driven by irreversible genomic mutations 
that subsequently activate oncogenes or inactivate tumour 
suppressor genes, there is increasing evidence that many 
epigenetic regulatory proteins are among those dysregu-
lated in cancer, and that histone marks are globally and 
locally altered within cancer epigenomes28.
This knowledge stimulated the development of inhib-
itors of DNA methyltransferases and HDACs that are 
clinically effective in several cancers, attesting to the value 
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of a particular gene (Fischle et al., 2003; Lee et al., 2010). Although we are a long 
way away from understanding what these marks do on a genome-wide basis, the use 
of drugs to inactivate various classes of chromatin modifying proteins and the study 
of individual targets has been informative, implicating these marks and the enzymes 
responsible for them in diverse biological processes, from differentiation and 
proliferation to neurodegeneration and pain (Szyf, 2009).  
In our lab, we became interested in epigenetic mechanisms after a post-doctoral 
fellow (Dr. Franziska Denk) discovered that intrathecal treatment with histone 
deacetylase inhibitors could be analgesic in two rat models of painful peripheral 
neuropathy (Denk et al., 2013). Although this behavioural effect was very 
reproducible, the potential mechanisms underlying this were far from obvious, as the 
role of histone deacetylases in primary sensory and second-order interneurons was 
completely unknown. My project has its origins in exploring histone deacetylases but 
we quickly focused on a specific member of the histone deacetylase family, HDAC4, 
as evidence from the literature suggested it may have a role in mediating sensory 
behaviour (Rajan et al., 2009; Williams et al., 2010). In the following sections I will 
discuss this in greater detail.  
1.5 HDAC4 
Lysine acetylation is a reversible process, mediated by the opposing actions of lysine 
acetyltransferases (HATs or KATs) and lysine deacetylases (HDACs or KDACs) to 
transfer an acetyl moiety from acetyl-coenzyme A to the epsilon-amino group of a 
lysine residue. Although this modification was discovered on histones in the 1960s, 
its functional implications only began to be appreciated from the nineteen-nineties 
when Allisʼs lab provided direct evidence that histone acetylation was connected to 
the control of gene expression (Brownell et al., 1996). Although originally thought to 
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be restricted to histones, it is now appreciated that acetylation affects many different 
proteins, with wide-ranging implications for cell function (Glozak et al., 2005).  
The first lysine deacetylases were identified in 1996 (Rundlett et al., 1996). Following 
this, many other proteins were discovered that also had deacetylase activity, and 
they were classed according to sequence homology to the yeast deacetylases Rpd3, 
Hda1 and Sir2 (Figure 5). In the mouse, HDACs are divided into four classes: class I, 
which are homologous to Rpd3 contains HDAC1, -2, 3, and -8; class II, related to 
Hda1 contains HDAC4, -5, -6, -7, -9 and -10, but is further subdivided into classes IIa 
and IIb based on phylogenetic analysis; class III, or Sirtuins, which are NAD+ 
dependent rather than zinc-dependent enzymes; and class IV, which contains 
HDAC11 (Haberland et al., 2009).  
 
Figure 5 – Classification of the HDAC family 
HDACs are grouped based on sequence homology to yeast proteins. Class I HDACs (a) are 
similar to yeast Rpd3 whereas class II HDACs (b) show homology to yeast Hda1. Binding 
motifs to MEF2 are represented in green and other motifs and phosphorylable serines are 
represented in blue. (DAC, deacetylase domain). Figure adapted from Yang and Seto, 2008. 
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One of a family of acidic 
proteins that are conserved 
from yeast and plants to 
humans and are highly 
abundant. They are ~30 kDa 
in size and often recognize 
target proteins with the 
sequence motif RXXpS/TXP or 
RXXXpS/TXP, where X is any 
residue and pS/T denotes 
phosphoSer or phosphoThr.
ZnF-UBP 
A ubiquitin-binding zinc finger 
that is present in HDAC6 and 
several ubiquitin-specific 
proteases. 
human HDAC6 (REF. 26) is almost identical in macaques 
(GenBank accession number XP_001101619) and 
highly conserved in horses (GenBank accession number 
XP_001493915), but is only partial in mice, implying that 
this domain is specific to higher mammals.
The other class IIb member, HDAC10, has an 
N-terminal half that is highly similar to the first deacety-
lase domain of HDAC6, whereas the C-terminal half is 
Leu rich (FIG. 1b). Although there are no invertebrate ortho-
logues, a distant relative exists in zebrafish (Supplementary 
information S2c (figure)), which indicates that HDAC10 
might have a vertebrate-specific role. However, little is 
known about its actual biological function.
HDAC11 as a highly conserved deacetylase. The class IV 
member HDAC11 shows sequence similarity to class I and 
II HDACs32 (FIG. 1c). It is highly conserved from C. elegans 
and D. melanogaster to humans (Supplementary infor-
mation S1 (figure)), and there are also related proteins 
in bacteria16 and plants (Arabidopsis thaliana HDA2). 
HDAC11 is sometimes referred to as a class I member, 
but phylogenetic analysis indicates that this deacetylase 
and its homologues belong to a separate class16. Little is 
known about its function or regulation, but its evolution-
ary conservation implies that it has a fundamental role in 
diverse organisms. 
Structures of Zn2+-dependent deacetylase domains. Crystal 
structures have been solved for the catalytic domains of 
class I member HDAC8 (REFS 25,33), class II member 
HDAC7 (Protein Data Bank ID 2NVR) and two bacte-
rial deacetylases34,35. These four structures are extremely 
similar and comprise a single A/B domain composed of 
an eight-stranded B-sheet that is sandwiched between 
>12 A-helices (also see Supplementary information S3 
(figure)). The catalytic centre contains a zinc ion that is 
chelated by side chains of His and Asp residues. These 
structures indicate that the deacetylase domains from 
Figure 1 | Domain organization of classical HDACs from yeast and humans. The histone deacetylases (HDACs) are 
grouped into different classes according to sequence similarity to yeast prototypes. In mammals, class I (Rpd3-lik ) 
members include HDAC1, -2, -3 and -8 (a); class II members are HDAC4, -5, -6, -7, -9 and -10 (b), which are related to yeast 
Hda1. Class IV consists of HDAC11 (c). Class II is further divided into two subclasses: IIa (HDAC4, -5, -7 and -9) and IIb 
(HDAC6 and -10). The total number of amino acid residues in each deacetylase is shown on the right. Many of the 
deacetylases have isoforms that result from alternative splicing; for simplicity, the number of amino acids refers to the 
longest isoform. The deacetylase (DAC) domain is depicted as an orange cylinder, and the percentage amino acid 
s quenc  identity/similarity to that of Rpd3 (for class I) r Hda1 (class II/IV) is shown. The sequence identity/similarity of 
Hda1 and HDAC11 to Rpd3 is given in brackets. The C-terminal domains (grey) of Hda1 and Clr3 are homologous 
(identity/similarity: 26/57%). Thick black lines represent similar N-terminal domains and C-terminal tails of class IIa HDACs. 
Myocyte enhancer factor-2 (MEF2)-binding motifs are depicted as short green cylinders, whereas 14-3-3 binding motifs 
are shown as short blue cylinders labelled with ‘S’ (for Ser). Clr3, cryptic locus regulator-3; Hda1, histone deacetylase-1;  
H. sapiens, Homo sapiens; Rpd3, reduced potassium dependency-3; S. cerevisiae, Saccharomyces cerevisiae; SE14, Ser-Glu-
containing tetradecapeptide repeats; S. pombe, Schizosaccharomyces pombe; ZnF, ubiquitin-binding zinc finger.
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Class I HDACs are ubiquitous nuclear enzymes with high deacetylase activity. They 
are recruited to gene promoters as part of the mSin3a and coREST complexes, and 
deacetylate target genes, altering chromatin structure to promote transcriptional 
repression. In contrast, class IIa HDACs (comprising HDACs -4, -5, -7 and -9) have a 
much more tissue-specific expression pattern (Grozinger et al., 1999). They are 
characterized by their long N-terminal domains, which contain multiple 
phosphorylation sites and intrinsic nuclear import and export signals that allow for 
dynamic nucleo-cytoplasmic trafficking. Shuttling between the cellular compartments 
is controlled by a wide variety of stimuli, implicating these molecules as potentially 
important signal transducers (Yang and Seto, 2008). 
Human HDAC4 was first cloned in 1999 by Grozinger and colleagues, who described 
that it formed a complex with the class I histone deacetylase, HDAC3 (Grozinger et 
al., 1999). As mentioned previously, unlike class I HDACs, HDAC4 showed tissue-
restricted expression patterns, with high levels of expression in neural tissues 
including the brain and skeletal muscle, hinting at a potential role in tissue 
differentiation. The first paper to describe HDAC4 function was published soon after 
and reported that HDAC4 could bind to and repress myocyte enhancer factor 2 
(MEF2), a transcription factor involved in muscle development and neuronal survival 
(Heidenreich and Linseman, 2004; Miska et al., 1999). This group were also the first 
to demonstrate calcium-dependent HDAC4 nucleo-cytoplasmic shuttling, a 
mechanism that has since emerged as integral to class IIa HDAC function.  
1.5.1 Molecular mechanisms of HDAC4 
Since the first report of MEF2 binding, a conserved role for HDAC4 in transcriptional 
repression and transcription factor binding has emerged from reports in many 
different cell types and conditions (Li et al., 2012; Paroni et al., 2008; Salma and 
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McDermott, 2012; Sando Iii et al., 2012; Yang et al., 2011). In one dramatic example, 
global HDAC4 knockout revealed a role for HDAC4 in bone formation via runt-related 
transcription factor 2 (RUNX2) (Vega et al., 2004). In the absence of HDAC4, 
RUNX2-dependent transcription was activated too early in bone pregenitors: 
chondrocytes failed to differentiate, and ossified too soon, which was lethal in the 
early post-natal stage. Overexpression and knockdown studies have also revealed 
extensive transcriptional repercussions of HDAC4 manipulation (Kehat et al., 2011; Li 
et al., 2012; Sando Iii et al., 2012) although deletion of HDAC4 from the 
calcium/calmodulin-dependent protein kinase IIa (CaMKIIa) population of cortical 
neurons did not alter transcription in conditional knockouts (Kim et al., 2012), 
implying that other mechanisms of HDAC4 are likely to play a role in the learning and 
memory deficit observed in these mutant mice. Mechanisms other than 
transcriptional repression via deacetylation have also been reported, including a role 
as an E3 sumo-ligase (Zhao et al., 2005), and in histone methylation (Hohl et al., 
2013) (Table 1). 
Table 1 - HDAC4 interacting proteins 
Protein Cellular compartment Function References 
MEF2 nucleus 
Represses transcription of MEF2 
target genes; in muscle this is partly 
through MEF2 sumoylation. May also 
occur through HDAC3/SMRT/NCoR 
deacetylation. Implications for 
myoblast differentiation, cell survival 
in neurons 
Miska et al., 
1999; Miska et al. 
2001; Paroni et 
al. 2008; Zhao et 
al., 2005; Salma 
and McDermott, 
2012; Li et al., 
2012; Sando III et 
al., 2012  
CREB nucleus Transcriptional repression; associated with cell death 
Bolger and Yao, 




Co-recruited to promoters following 
DNA damage, results in 
transcriptional repression 
Berns et al., 
2004; Basile, 
Montovani and 
Imbriano 2006  
PPARγ nucleus 
Translocates to the nucleus after 
H2O2 stimulation, represses PPARγ 
transcription and makes neurons 
more vulnerable to oxidative stress 
Yang et al., 2011 
FOXO1/3 nucleus 
Deacetylates FOXO transcription 
factors, enhancing transcription in 
the liver in response to glucagon 
signaling 
Mihaylova et al., 
2011 
RUNX2 nucleus Transcriptional repression; required for bone formation Vega et al., 2004 
HIF1 
alpha cytoplasm 
Deacetylates HIF1alpha, enhancing 
its stability, protein expression and 
transcriptional activity. Improves 
retinal ganglion cell survival in 
development and disease.  
Qian et al., 2006; 
Geng et al., 
2011; Seo et al., 
2009; Chen and 
Cepko, 2009 
STAT1 cytoplasm 
Activates and represses STAT1 via 
acetylation and sumoylation, 
respectively. Affects inflammatory 
transcriptional activation. 
Sun et al., 2009; 
Yuan et al., 2005; 
Stronach et al., 
2011 
LXRa/ß cytoplasm 
Sumoylates LXRs, negatively 
regulates inflammatory responses in 
macrophages 
Lee et al., 2009; 
Ghisletti et al., 
2007; Stempelj et 
al., 2007 
MEKK2 cytoplasm 
Promotes deacetylation of MEKK2 
after muscle denervation and 
contributes to muscle atrophy via 
AP1 induction 
Choi et al., 2012 
DNAJB8 cytoplasm 
DNAJB8 promotes oxidized HDAC4 
reduction by Trx1, leading to nuclear 
import and rescue from cardiac 
hypertrophy  
Ago et al., 2008 
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The transcriptional repressor function of HDAC4 is independent of its deacetylase 
domain (Miska et al., 1999; Vega et al., 2004). Indeed, the deacetylase domain of 
HDAC4 is mysterious: on its own, HDAC4 has no endogenous deacetylase activity 
due to a conserved tyrosine to histidine substitution found in all class IIa enzymes 
(Lahm et al., 2007), and it is thought that most of the deacetylation activity ascribed 
to HDAC4 results from its partnership with HDAC3 (Fischle et al., 2002). However, 
HDAC3 is normally restricted to the nucleus, and studies have reported HDAC4-
associated deaceylation activity in the cytoplasm (Choi et al., 2012; Qian et al., 2006; 
Seo et al., 2009; Stronach et al., 2011). Whether HDAC4 complexes with as-yet-
unidentified binding partners to mediate this remains to be seen. Interestingly, global 
deletion of the HDAC4 deacetylase domain results in reduced thermosensitivity in 
knockout mice, in the absence of other gross morphological differences (Rajan et al., 
2009). Although it is unclear which cell types are responsible for this phenotype, it is 
tempting to speculate that this may reflect a role for HDAC4 in DRG sensory 
neurons. Of note, a study in the nematode indicated that knockout of the HDAC4 
homologue, hda4, led to reduced responses to a thermal gradient, something that 
normally elicits movement of the worms toward a preferred temperature (Wang et al., 
2011), indicating that HDAC4 may have a conserved role in thermosensation. 
 
The best characterized activity of HDAC4 is its dynamic nucleo-cytoplasmic shuttling, 
which relies on reversible phosphorylation and links the protein to several 
biochemical signaling pathways (Yang and Seto, 2008). Nuclear export of HDAC4 
occurs in response to activation of calcium/calmodulin-dependent protein kinase 
(CaMK), which phosphorylates HDAC4 and allows it to associate with the chaperone 
14-3-3 proteins (Grozinger and Schreiber, 2000; McKinsey et al., 2000). A recent 
report has also indicated that nuclear export of HDAC4 can be modulated directly by 
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nuclear calcium signaling (Schlumm et al., 2013), further strengthening the 
association of HDAC4 activity with calcium fluxes. Dephosphorylation by the protein 
phosphatase PP2A leads to nuclear accumulation of HDAC4 (Li et al., 2012; Paroni 
et al., 2008) and subsequent transcriptional repression. Nuclear localization has also 
been demonstrated following oxidation of HDAC4 and caspase-mediated cleavage 
events (Ago et al., 2008; Liu et al., 2004), implicating HDAC4 in apoptosis and 
oxidative stress signaling (Figure 6). 
 
Figure 6 – Nucleo-cytoplasmic shuttling of HDAC4 
 Phosphorylation of HDAC4 leads to nuclear export and cytoplasmic retention by binding of 
the 14-3-3 proteins. The cytoplasmic form of HDAC4 may have protein deacetylase activity, 
though whether it also acts as an E3 SUMO-ligase in the cytoplasm is unclear. 
Dephosphorylation leads to HDAC4 nuclear accumulation, and reduction of sulfide bonds by 
Trx1 favours its retention. The identity of the oxidase responsible for HDAC4 oxidation is 
unknown. In the nucleus HDAC4 has E3 SUMO-ligase activity on the listed substrates, and 
also has deacetylase activity on RUNX2, p53 and histones, likely through complexing with 
HDAC3. Figure adapted from Yao and Yang 2011 (Yao and Yang, 2011).  
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events (Ago et al., 2008; Liu et al., 2004), implicating HDAC4 in apoptosis and 
oxidative stress signaling (Figure 5). 
 
Figure 5 – Nucleo-cytoplasmic shuttling of HDAC4  
 
Phosphorylation of HDAC4 leads to nuclear export and cytoplasmic retention by binding of 
the 14-3-3 proteins. The cytoplasmic form of HDAC4 may have protein deacetylase activity, 
though whether it also acts as an E3 SUMO-ligase in the cytoplasm is unclear. 
Dephosphorylation leads to HDAC4 nuclear accumulation, and reduction of sulfide bonds by 
Trx1 favours its r tention. The i tity of the oxidase r sponsible for HDAC4 oxidati n is 
unk ow . In the nucleus HDAC   E3 SUMO-ligase activity on the list d ubstrates, and 
also has deacetylase activity on X2, p53 and histones, likely through complexing with 
HDAC3. Figure adapted from Yao and Yang 2011 (Yao and Yang, 2011).  
 
1.5.2 HDAC4 in neurons 
In cortical neurons, nuclear shuttling of HDAC4 has been shown to occur in both 
physiological and pathological conditions, with repercussions for cell survival and 
synaptic plasticity (Bolger and Yao, 2005; Li et al., 2012; Salma and McDermott, 























































Figure 1: A model on the regulation of nucleo-cytoplasmic shuttling and the functions of HDAC4. HDAC4 dynamically shuttles between
nucleus and cytoplasm, depending on its phosphorylation status. Phosphorylated HDAC4 binds to 14-3-3 and remains in the cytoplasm.
The cytoplasmic form of HDAC4might possess protein deacetylase activity. Whether cytoplasmic HDAC4 possesses SUMOE3 ligase activity
remains unclear. Dephosphorylated HDAC4 is impor ed into the nucleus, where reduction of HDAC4 by Trx1 favors nuclear retention.
Oxidases that catalyze the reverse reaction remain to be identified. Nuclear HDAC4 possesses deacetylase as well as SUMO E3 ligase activities
on substrates indicated in the figure.
Table 2: Subcellular localization and functions of nonhistone substrates of HDAC4 and HDAC7.
Histone deacetylases Substrates Localization of substrates Functions Comments
HDAC4 p53 Nucleus








Regulation of muscle contraction
in cardiac mechanical stretch
HIF1α Cytoplasm
Cytopla mic r tention to
maintain neuronal survival
DNAJB8 Cytoplasm
Suppression of cytotoxic protein
aggregation





1.5.2 HDAC4 in neurons 
In cortical neurons, nuclear shuttling of HDAC4 has been shown to occur in both 
physiological and pathological conditions, with repercussions for cell survival and 
synaptic plasticity (Bolger and Yao, 2005; Li et al., 2012; Salma and McDermott, 
2012; Sando Iii et al., 2012; Yang et al., 2011). Interestingly, three separate studies 
have shown HDAC4 shuttling in response to neuronal activity (Chawla et al., 2003; 
Sando Iii et al., 2012; Schlumm et al., 2013). The earliest of these, by Chawla et al, 
showed that spontaneous electrical activity was sufficient to cause nuclear export of 
HDAC4, which was dependent on CaMK. Sando et al showed that blocking 
glutamate receptors led to HDAC4 nuclear accumulation and subsequent 
downregulation of multiple genes associated with synaptic plasticity. Similarly, 
Schlumm et al indicated that blocking nuclear calcium using a targeted expression of 
CamBP4 led to accumulation of HDAC4 in the nucleus, which was relieved by bursts 
of action potentials. This poises HDAC4 as an activity-dependent signal transducer in 
neurons. Due to its transcriptional effects in the nucleus, this could have great 
implications for sensory neurons, for example, by de-repressing pro-inflammatory 
gene expression following injury. Indeed, HDAC4 has already been linked to the 
expression of genes that are involved in pain and regeneration, including Ptgs2 that 
encodes COX2 and activating transcription factor 3 (Atf3), a transcription factor that 
enhances sensory neuron regeneration after injury (Schlumm et al., 2013; Wang et 
al., 2008b). Interestingly, the role in COX2 transcription was linked to HDAC4 nuclear 
import following application of the epidermal growth factor (EGF). That HDAC4 is 
responsive to growth factor signaling, and has been linked to the transcription of 
pain-related genes may imply a role in sensory neuron transcriptional regulation. It 
will be of great interest to determine whether this may be the case. 
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Another interesting story that has emerged about HDAC4 regards its role in neuronal 
survival. The evidence here is conflicting, with some studies indicating that 
knockdown of HDAC4 can improve survival under toxic conditions (Bolger and Yao, 
2005; Salma and McDermott, 2012; Yang et al., 2011) whereas others report that 
knockdown causes neuronal death, attributed to the loss of neuroprotective functions 
in the cytoplasm (Chen and Cepko, 2009; Li et al., 2012; Majdzadeh et al., 2008; 
Sando Iii et al., 2012). Evidence from knockout mice fail to support either hypothesis, 
as they do not display gross abnormalities in brain architecture, or neuronal viability 
(Kim et al., 2012; Price et al., 2012; Rajan et al., 2009), although this could be due to 
developmental compensation. One explanation that may account for this is that 
HDAC4 is maintained in a dynamic equilibrium between the cytoplasm and the 
nucleus, and it is the ratio of HDAC4 in each subcellular compartment that 
determines whether knockdown will be neuroprotective or pro-apoptotic. For 
example, when cells have only nuclear HDAC4, knockdown is beneficial because it 
reduces the nuclear:cytoplasmic ratio; when there is HDAC4 in both the nucleus and 
the cytoplasm, knockdown kills cells by reducing the overall levels of HDAC4. This is 
supported by over-expression studies that show a protective role of cytoplasmic-
restricted HDAC4 (Chen and Cepko, 2009; Li et al., 2012; Liu et al., 2004) and a 
negative effect of nuclear-restricted HDAC4 over-expression (Bolger and Yao, 2005; 
Liu et al., 2004; Sando Iii et al., 2012).  
Toxic agents, such as chemotherapeutic drugs and nucleoside analogue anti-
retrovirals (NARTIs) can cause neuropathic pain in patients (Ferrier et al., 2013; 
Margolis et al., 2013). Due to its effect on cell survival, HDAC4 could play a role in 
mediating nociceptive responses to these stimuli.  
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1.6 Summary and aims 
Transcriptional regulation is essential for appropriate development, and responses to 
injury. HDAC4 is a transcriptional corepressor which is required for physiological 
thermosensation, however the mechanisms underlying this remain unclear. In other 
tissues, HDAC4 has been shown to interact with proteins necessary for sensory 
neuron differentiation, for example the RUNX family transcription factors, as well as 
CREB that regulates injury responses. Whether HDAC4 regulates these proteins in 
sensory neurons to contribute to thermosensation is unknown. In addition, the 
capacity for HDAC4 to shuttle in and out of the nucleus in a calcium-dependent 
manner positions it as a molecular cue. One could postulate that the movement of 
HDAC4 after injury could have crucial implications for the transcriptional status of 
affected neurons, or may have an effect on cell survival following toxic insult. 
To address these questions, I generated two novel strains of HDAC4 conditional 
knockout mice, and characterized their transcriptional and behavioural profiles across 
a variety of injury models. In the first data chapter I will describe the validation of the 
two conditional knockout strains, and the transcriptional and anatomical 
repercussions of HDAC4 deletion. In the second data chapter I will describe studies 
in which we explored whether HDAC4 is involved in peripheral nerve regeneration. 
The final data chapter will cover the role of HDAC4 in mediating nociception across a 
variety of pain models.  In addition, Appendix I contains a bioinformatics analysis of 
HDAC4 expression and function.  
HDAC inhibitors and other drugs that target chromatin modifying and transcriptional 
regulatory proteins are already being used clinically to treat cancer. Work to 
characterize the function of these molecules in diverse systems will provide a rational 
basis for broader application of these therapies.  
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2  Methods 
2.1 Animals 
All work performed conformed to United Kingdom Home Office legislation (Scientific 
Procedures Act 1986). All behaviour, surgery, and immunohistochemistry was 
performed on animals or tissue taken from 2-6 month old animals. When animals of 
both sexes were used, care was taken to ensure approximately equal numbers of 
males and females were used in each group (Table 2).  








Naive - RNA for affy Nav1.8 4/4 0/0 4/4 
Naive - immunohistochemistry Nav1.8 3/3 0/0 3/3 
Carrageenan - behaviour Nav1.8 6/6 0/0 6/6 
CFA - behaviour Nav1.8 6/6 0/0 6/6 
PSL - behaviour Nav1.8 8/8 0/0 8/8 
PSL - RNA for array cards Nav1.8 4/4 0/0 4/4 
PSL - immunohistochemistry Nav1.8 4/4 0/0 4/4 
D4T - behaviour Nav1.8 9/10 0/0 9/10 
D4T - immunohistochemistry Nav1.8 4/4 0/0 4/4 
Crush 1 Nav1.8 2/4 5/3 7/7 
Crush 2 Nav1.8 7/5 2/3 9/8 
24h axotomy - 
immunohistochemistry Nav1.8 3/3 0/0 3/3 
Baseline sensitivity/acute 
nociception Adv 3/4 7/3 10/7 
24h Axotomy  - RNA  Adv 4/4 0/0 4/4 
CFA Adv 5/1 7/5 12/6 
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2.1.1 Genotyping 
Ear-derived DNA was analyzed by polymerase chain reaction (PCR) to identify 
HDAC4fl/fl  and HDAC4 cKO mice. Ear clips were incubated between 3-12 hours at 
55°C in lysis buffer (50 mM KCl, 25 mM MgCl2, 10 mM Tris Base pH 8.5, 0.45% 
Tergitol, 0.45% Tween-20 and 0.1 mg/mL proteinase K in ddH2O), then at 95°C for 
20 minutes to inactivate proteinase K. 5 µL of this suspension was used for 
subsequent PCR reactions. All products were run on 2% agarose gels in 1X TAE 
stained with 0.5 mg/mL ethidium bromide. 
Table 3 - Genotyping primers 
 Forward (5ʼ – 3ʼ)  Reverse (5ʼ – 3ʼ) 




Nav1.8-Cre TGTAGATGGACTGCAGAGGATGGA  AAATGTTGCTGGATAGTTTTTACTGCC 
Wildtype Nav1.8 TGTAGATGGACTGCAGAGGATGGA TTACCCGGTGTGTGCTGTAGAAAG 
Advillin CreERT2  CCCTGTTCACTGTGAGTAGG GCGATCCCTGAACATGTCCATC 
Wildtype Advillin CCCTGTTCACTGTGAGTAGG AGTATCTGGTAGGTGCTTCCAG 
 
To identify the HDAC4fl/fl allele, reactions were performed in a final volume of 25 µL 
using the GoTaq® DNA Polymerase kit from Promega according to manufacturerʼs 
instructions. Amplifications were performed as follows: heating at 94°C for 2 min, 35 
cycles of 96°C for 15 s 58°C for 30 s and 72°C for 60 s, followed by a final extension 
at 72°C for 10 min. This yielded a wildtype band at 480 bp, and a floxed band at 620 
bp.  The HDAC4cKO (recombined) allele was identified following the same protocol, 
47 
and resulted in a wildtype band at 1278 bp, a floxed band at 1343 bp and a 
recombined band at 290 bp.  
To identify the Nav1.8-Cre allele, reactions were performed in a final volume of 25 µL 
using the GoTaq® DNA Polymerase kit from Promega according to manufacturerʼs 
instructions. Amplifications were performed as follows: heating at 94°C for 2 min, 30 
cycles of 94°C for 30 s, 60°C for 30 s and 72°C for 60 s, followed by a final extension 
at 72°C for 10 min. This yielded a Cre-positive band at 420 bp. The wildtype Nav1.8 
allele was identified following the same protocol, in a separate reaction and resulted 
in a 460 bp band. 
To identify the Advillin-CreERT2 allele, reactions were performed in a final volume of 
25 µL using the GoTaq® Flexi DNA Polymerase kit from Promega according to 
manufacturerʼs instructions, with a final concentration of 2.5 mM MgCl2. 
Amplifications were performed as follows: heating at 96°C for 3 min, 30 cycles of 
96°C for 30 s, 63°C for 30 s and 72°C for 60 s, followed by a final extension at 72°C 
for 10 min. This yielded a Cre-positive band at 180 bp. The wildtype Advillin allele 
was identified following the same protocol, in a separate reaction and resulted in a 
480 bp band. 
2.1.2 Tamoxifen Dosing 
Tamoxifen (Sigma T5648) was prepared according to the protocol of Metzger and 
Chambon (Metzger and Chambon, 2001). Briefly, 10 mg tamoxifen were dissolved in 
100 µL 100% ethanol, made up to 10 mg/mL in autoclaved sunflower oil, and placed 
on a shaker at room temperature for 2-3 hours. The drug was aliquoted and stored at 
-20°C prior to dosing. 8-10 week old mice received 2 mg tamoxifen/day i.p. over a 
five day period.  
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2.1.3 Inflammatory pain models 
Acute inflammation was induced via intraplantar injection of lambda carrageenan 
(Sigma C3889). Carrageenan was made up to 2% in sterile saline, and 20 µL were 
injected into the right hindpaw.  
To model chronic inflammatory pain, an intraplantar injection of 20 µL of Complete 
Freundʼs Adjuvant (CFA) (Sigma F5881) was made into the right hindpaw of affected 
animals.  
2.1.4 Neuropathic pain models 
To model neuropathic pain, the partial sciatic nerve ligation model (Seltzer et al., 
1990) and the d4T model (Renn et al., 2011) were used. To ligate the sciatic nerve, 
animals were placed under isoflurane anaesthesia, the thigh area was shaved and 
the skin opened using a sterile scalpel (Swann-Morton). The thigh muscle was blunt 
dissected using surgical scissors (Fine Science Tools) and the sciatic nerve was 
located and held steady using curved forceps. A Vicryl suture was tied around 
approximately 60% of the nerve, then the nerve and muscle layers were gently 
repositioned and the skin was closed using sterile wound clips. Wound clips were 
removed ten days after surgery.   
2′,3′-Didehydro-3′-deoxythymidine (stavudine; d4T) was received as a gift from Dr. 
Wenlong Huang and Dr. Andrew Rice from Imperial College London. It was 
reconstituted in 0.9% saline to 2.5 mg/mL and administered as a single 10 mg/kg 
intravenous (i.v.) dose by tail vein injection.  
2.1.5 Sciatic crush model of peripheral nerve regeneration 
Animals were placed under isoflurane anaesthesia, the thigh area was shaved and 
the skin opened using a sterile scalpel (Swann-Morton). The thigh muscle was blunt 
dissected using surgical scissors (Fine Science Tools) and the sciatic nerve was 
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exposed and crushed with fine forceps coated in lamp black to mark the crush site. 
The lesion site was kept a constant 37 mm from the tip of the third digit and the 
wound was closed with wound clips. 
2.2 Behaviour 
All behaviour testing was performed by an experimenter blind to genotype. On each 
day, animals were randomized into test boxes using the list randomizer function of 
http://www.random.org.  Baselines were determined over three days.  
2.2.1 Rotarod 
The rotarod test was used to determine locomotor coordination. The rotarod (Ugo-
Basile) was calibrated to accelerate from 4-38 RPM with a cut-off time of 295 
seconds.  Animals were allowed to habituate to the base speed for 20 seconds prior 
to the acceleration phase, and latency to fall was recorded. Three measurements 
were recorded on each test day, with at least 10 minutes between trials.  
2.2.2 Von Frey Test 
50% mechanical thresholds were determined using calibrated Von Frey filaments 
following the up-down method of Dixon (Dixon, 1965) and Chaplan (Chaplan et al., 
1994).  Animals were habituated to the testing environment for 60 minutes prior to 
testing.  Filaments were applied to the plantar surface of the hindpaw for three 
seconds, and a bimodal (yes/no) response was recorded.   
2.2.3 Hargreaves Test 
Heat withdrawal thresholds were assessed using the Hargreaves apparatus (Ugo 
Basile), set to an infrared intensity of 40 and cut-off time of 32.5 seconds. Animals 
were habituated for at least 30 minutes prior to testing, and care was taken to ensure 
the glass base was kept clean, and that animals were not in deep sleep when 
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measurements were taken as this has been shown to greatly influence withdrawal 
latencies (Callahan et al., 2008). At least three measurements of withdrawal latency 
were taken per paw on each test day.  
2.2.4 Tail flick 
The tail flick response was measured at 49°C or 52°C to determine spinal reflex 
responses to innocuous warm and noxious heat stimuli respectively following the 
protocol of Ben Bassat (Ben Bassat et al., 1959). Briefly, mice were restrained, the 
tail immersed into a water bath and latency to respond recorded. Three 
measurements were recorded on the test day, with at least 5 minutes between trials.  
2.2.5 Hot Plate 
Two protocols were used to assess thermal sensitivity on the hot plate (IITC). In the 
first, animals were allowed to habituate for five minutes on a hot plate set to 40°C, 
and a temperature ramp of 2.5°C/minute was initiated. The temperature of the first 
response (flick, lick or jump) was recorded. In the second protocol, animals were 
habituated to the hot plate at room temperature for five minutes then returned to their 
home cage. Once all the animals had been habituated, animals were placed on the 
hot plate at either 52.5°C or 55°C and the latency to first response (flick, lick or jump) 
was recorded.  
2.2.6 Randall-Selitto Test 
The Randall-Selitto test was used to assess mechanical pain thresholds. Under light 
restraint, increasing pressure was applied to the hindpaw of each animal using a Ugo 
Basile Algesiometer. The pressure at which a withdrawal response was elicited was 
recorded, with a cut-off of 150 g. Scores represent the mean withdrawal threshold of 
both paws.  
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2.2.7 Sciatic Functional Index 
The sciatic functional index is an integrated sensory motor function test designed to 
quantify re-innervation following sciatic nerve injury. Prior to surgery, animals were 
trained to run across a wooden plank toward a darkened home cage. Their hindpaws 
were inked and at least three paw prints per paw were measured on each day of 
testing. Measurements were: toe spread, first to fifth toes; intermediate toe spread, 
second to fourth toes; and print length end of the third toe to the bottom of the hind 
pad. These measurements were then used to calculate the sciatic functional index 
(Bain et al., 1989; Inserra et al., 1998). 
2.2.8 Pinprick Assay 
To assess sensory recovery following sciatic nerve crush, the pinprick test was used 
(Ma et al., 2011). Under light restraint, sixteen areas of the denervated paw were 
stimulated with a pin, and responses were scored on a three-point scale (0 – no 
response, 1 – light/inconsistent response, 2 – strong, consistent withdrawal 
response). Individual digit and composite scores were generated and compared 
using one-way repeated-measures analysis of variance (ANOVA) tests. 
2.3 Molecular Biology 
2.3.1 DRG dissections 
Animals were killed by cervical dislocation, or by fatal overdose of sodium 
pentobarbital prior to transcardial perfusion with phosphate buffered saline (PBS).  
Dorsal laminectomy of the spinal cord was performed in situ. To identify L3-L5 DRGs, 
the sciatic nerve was traced up to the spinal cord, and the three ganglia attached 
were dissected, snap frozen in liquid nitrogen and stored at -80°C prior to RNA or 
protein extraction. For dissociated DRG culture experiments, cultures were washed 
twice with warm PBS prior to lysis. 
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2.3.2 RNA extraction 
RNA extraction was performed with a two-step protocol consisting of phenol-
chloroform extraction followed by clean-up and elution on Qiagen RNAeasy MinElute 
columns. Care was taken to avoid batch effects by processing samples in matched 
groups.  Snap frozen tissues were transferred into 500 µL Trizol reagent (Invitrogen) 
in a fresh tube, and homogenized on ice in three 10 second bursts. Samples were 
lysed at room temperature for 10 minutes, then were transferred to Phase Lock Gel 
Heavy tubes (5 Prime), and 100 µL chloroform was added. Samples were shaken for 
15 seconds and allowed to rest at room temperature for three minutes prior to 
centrifugation at 11300 RPM for 15 minutes at 4°C. The aqueous phase was 
transferred to an RNAse-free eppendorf tube, an equal volume of fresh 70% ethanol 
was added, and this was loaded onto columns for clean-up following the 
manufacturerʼs protocol. RNA concentration was measured using a Nanodrop 
Spectrophotometer (Thermo-Fisher Scientific) and 500 ng total RNA were used for 
subsequent first-strand cDNA synthesis reactions with SuperScript III according to 
manufacturerʼs protocol (Invitrogen).  
2.3.3 Real-time quantitative PCR (RT-qPCR) 
RT-qPCR was performed using the LightCycler FastStart DNA MasterPLUS SYBR 
Green I kit (Roche) according to manufacturerʼs protocol on a Roche LightCycler 480 
machine. All primers used were exon-exon spanning and were tested both for 
efficiency using a standard curve and for specificity by melt curve analysis and gel 
electrophoresis of PCR products.  All primers had an efficiency of 2.0 ± 0.2.  Results 
were determined from plates where no template controls were used to ensure 
reagents were contamination free.  Triplicate Ct values were averaged and results 
were analysed using the ΔΔCt method (Livak and Schmittgen, 2001). 
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Table 4 - RT-qPCR primers 
  Forward (5ʼ – 3ʼ)  Reverse (5ʼ – 3ʼ) 
Atf3 GTCACCAAGTCTGAGGCGGCC TGACTCTTTCTGCAGGCACTCTGT 
Camk2a GCTGCCAAGATTATCAACACC CACGCTCCAGCTTCTGGT 
cJun GGGACACAGCTTTCACCCTA GAAAAGTAGCCCCCAACCTC 
Hdac4 exon 1-2 TGAACTTAAGGCACTGACGC AGGATTCAGCAGCTCCACAG 
Hdac4 exon 6-7 CCAGCGATCCCCGCTACTGG AGGCTGACACCCCACTCTGGG 
Hdac4 exon 12-13 GCACCTCAGCAAGATAATCTC GCTTCTTCCTCCTCACTCTC 
Hdac5 TGTCACCGCCAGATGTTTTG TGAGCAGAGCCGAGACACAG 
Hdac7 CTGCTTTCAGGATAGTGGTG ATTTGGCAGAAACATGGTGGTAGC 
Hdac9 GCGAGACACAGATGCTCAGAC TGGGTTTTCCTTCCATTGCT 
Hsp27 TGTATTTCCGGGTGAAGCAC CAGTGAAGACCAAGGAAGGC 
Ntrk1 ATATCTAGCCAGCCTGCACTTTGT GCTCATGCCAAAGTCTCCA 
Snap25 GCTCCTCCACTCTTGCTACC CAGCAAGTCAGTGGTGCTTC 
Sprr1a TGAGGAGGTACAGTGCAG GG CAGAGAACCTGCTCTTCTCTG AGT 
Sst TTCTCTGTCTGGTTGGGCTC CAGACTCCGTCAGTTTCTGC 
Trpv1 AACCAGGGCAAAGTTCTTCC CATCATCAACGAGGACCCAG 
Vglut1 GTGCAATGACCAAGCACAAG TAGTGCACCAGGGAGGCTAT 
β-2-microglobulin GCCTGTATGCTATCCAGAAAACCC TGTGAGGCGGGTGGAACTGTG 
Ywhaz AGTCGTACAAAGACAGCACGCTAA AGGCAGACAAAGGTTGGAAGG 
 
 
2.3.4 TaqMan Low-Density RT-qPCR Array Cards 
Custom TaqMan low-density RT-qPCR array cards were ordered from Life 
Technologies. On the day of the experiments, cDNA samples were diluted to 2 ng/µL 
in a final volume of 100 µL 1X PCR mastermix containing SYBR green in DNAse-free 
H2O. Samples were mixed by pipetting and loaded into wells, then cards were spun 
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at 1200 RPM for 2 minutes, sealed and run on an ABI 7900HT RT-qPCR machine 
(Applied Biosystems). Raw CT values were exported, and relative quantification was 
performed in Microsoft Excel using the ∆∆CT method.  Multi-array express viewer 
(MeV) software was used to create data visualization tools.  
2.3.5 Microarray  
RNA was processed by UCL Genomics using an Ambion Whole transcript 
Expression Kit (Invitrogen) and hybridized to Affymetrix Mouse Gene Arrays (Mouse 
Gene 2.0ST) on a GeneChip Fluidics Station 450. Chips were scanned on an 
Affymetrix GeneChip Scanner. Quality control and analysis were carried out using the 
following bioconductor packages in R: oligo (Carvalho and Irizarry, 2010) for 
preprocessing, RMA normalization (Irizarry et al., 2003), and various quality controls 
(including MA plots, box plots, and principal component analysis) and limma (Smyth, 
2005) for statistical analysis. 
2.3.6 Protein extraction 
Protein was extracted in lysis buffer (0.2% SDS in ddH20 with 1X protease inhibitor 
cocktail (Roche)) by shaking at room temperature for two hours with a Vortex at 
speed 4. Protein concentration was assessed by determining the absorbance at 280 
nm on a Nanodrop Spectrophotometer (Thermo-Fisher Scientific). Protein lysates 
were stored at -80°C prior to reduction for 5 minutes at 100°C in 1X Laemmli buffer, 
after which they were stored at -20°C. 
2.3.7 Western Blotting 
20 µg of protein were run on NuPAGE® Novex® 10% Bis-Tris Gels (Invitrogen) then 
transferred onto 0.45-μM polyvinylidene fluoride membranes (Millipore). Membranes 
were blocked in 5% milk and incubated overnight at 4°C with an HDAC4 (H92, Santa 
Cruz) primary antibody at 1:500 dilution. After 3 washes in Tris-buffered saline and 
55 
0.1% Tween-20, a secondary antibody was used for 1 hour (1:5000, horseradish 
peroxidase–conjugated anti-rabbit; GE Healthcare). The signal was detected using 
an ECL prime kit (GE Healthcare) and visualized using a UVP GelDoc-It Imaging 
system (Ultraviolet products). 
2.4 Tissue culture 
2.4.1 Dissociated dorsal root ganglion culture 
Following cervical dislocation and dorsal laminectomy, DRGs were dissected into 
F12 media (Gibco). Ganglia were digested for one hour at 37°C in a final 
concentration of 0.125% collagenase (Sigma) and 0.1 mg/mL DNAse I (Sigma), 
washed in 3 mL warm F12 and triturated in 2 mL F12 supplemented with 0.3% 
bovine serum albumin (Sigma), 1X N2 supplement (Gibco), and 1X 
penicillin/streptomycin (Sigma). The cell pellet was resuspended in supplemented 
F12 and plated onto coverslips pre-coated with poly-L-lysine (Invitrogen) and 0.01 
mg/mL laminin (Sigma).  
2.5 Fluorescence microscopy 
2.5.1 Sample Preparation 
Adult animals were transcardially perfused with freshly prepared 4% PFA in 0.1 M PB 
(pH 7.4-7.7) prior to dissection. Tissue was post-fixed at 4°C for 3 hours in 4% PFA 
in 0.1 M PB, followed by 24 hours at 4°C in 20% sucrose solution in 0.1 M PB. 
Samples were blocked in OCT medium (Tissue-Tek) and frozen in liquid nitrogen 
then stored at -80°C. Frozen sections were cut at 10 µM on a cryostat. Slides were 
dried for at least one hour and stored at -20°C until further processing. Slides were 
blocked for 30-60 minutes in 10% normal goat or donkey serum, incubated overnight 
at room temperature with primary antibodies, incubated for two hours in secondary 
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antibodies and mounted with Vectashield (Vector Labs).  Antibodies used include 
anti-mouse NF200 (1:400, Millipore; MAB5266), anti-sheep CGRP (1:800, BioMol; 
CA1137), lectin-IB4 (1:50, Sigma-Aldrich), anti-rabbit TrkA (1:500, Biosensis; R152-
200), anti-rabbit PGP9.5 (1:1000, Ultraclone), anti-rabbit Alexa 488 (1:1000, 
Invitrogen), anti-mouse Alexa 546 (1:1000, Invitrogen), anti-sheep Cy3 (1:400, 
Stratech; 713-166-147), anti-lectin AMCA (1:400; Vector Laboratories). 
2.5.2 Immunocytochemistry 
Cultured primary sensory neurons were washed three times with warm PBS, fixed 
with 4% PFA for twenty minutes at room temperature, washed three times in PBS 
and stored at 4C in PBS + 0.1% sodium azide until further processing, or blocked in 
10% normal goat or donkey serum in PBS + 0.2% Triton X + 0.1% sodium azide for 
thirty minutes, incubated with 1:1000 anti-mouse β-3-tubulin (Promega) for one hour, 
washed and incubated in 1:1000 Alexa-Fluor 488 (Invitrogen) and 1:10000 DAPI (Life 
Technologies) for a further hour. 
2.5.3 Microscopy and Image Analysis 
For each experiment, a minimum of three sections, from three animals per group 
were used for analysis. To avoid bias, images were taken and processed in a blinded 
manner: animals were assigned randomized numbers at the time of dissection that 
were not revealed until analysis had been completed. Images of DRG tissue sections 
were taken using a Zeiss Axioplan 2 fluorescence microscope (Zeiss). Counting and 
cell size measurements were done using Image J and Axiovision software, 
respectively.  
To assess neurite outgrowth in dissociated DRG cultures, neurons were imaged and 
analysed using the InCell Analyser 1000 and Developer Toolbox 1.0 software (GE 
Healthcare Life Sciences). The number of β-3-tubulin positive cells and the total 
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length of neurites per image were quantified in order to obtain a measurement of 
neurite length per neuron. Three wells from three independent experiments were 
averaged to determine the mean treatment effect.  
Intraepidermal nerve fibre density was determined following the criteria of Lauria et 
al. (Lauria et al., 2005). Nerve fibres were counted at 40X magnification on a 
minimum of three sections per animal. The length of each section was measured in 
Image J, and the intraepidermal nerve fibre density was calculated as the average 
number of fibres counted/average section length. 
2.5.4 Calcium Imaging 
DRG neurons were used for Ca2+ imaging experiments after 18–24 h in culture. Cells 
were incubated in buffer (HBSS with 10 mM glucose, 10 mM HEPES, pH  7.4) with 
Fura-2-AM (2 μM) and probenecid (1 mM) for 60 min at 37°C, then coverslips were 
washed and mounted for imaging. Capsaicin was made up to 100 nM in buffer and 
applied to cells by continuous perfusion. Individual cell fluorescence was measured 
at 340 and 380 nm excitation, and 510 nm emission using a microscope-based 
imaging system (PTI, Ford, UK). At the end of each experiment, cells were 
challenged with KCl (50 mM) to provide a maximal Ca2+ signal against which to 
normalize responses. Neurons were identified morphologically and were excluded 
from analysis if they did not respond to KCl. 
2.6 Statistical analysis and experimental design  
In keeping with the 3Rs of animal testing (reduction, refinement and replacement), a 
large battery of behavioural tests was initially run in smaller groups to allow for the 
identification of any large effects (Cohen, 1988). Results that looked interesting were 
validated in a separate cohort of animals to decrease the chance of a false positive 
result.  
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Statistical analysis was performed with IBM SPSS v 21. Single behavioural 
measures, immunohistochemical counts and RT-qPCR data were analyzed using 
Welchʼs unpaired t-tests. Behavioural data with repeated measures were analyzed 
with repeated measures analysis of variance (RM ANOVA) tests with day and paw 
as within-subjects variables and genotype as the between-subjects factor. Data is 
presented as mean ± standard error (SEM).   
For PCR array card studies, effects of injury were confirmed using multivariate 
ANOVAs with injury and genotype as independent variables and genes as dependent 
variables. To identify putative HDAC4 target genes, Welch's t-tests were used to 
compare similarly affected samples (e.g. cultured wt neurons vs cultured cKO 
neurons), followed by post-hoc false-discovery rate correction using the Benjamini-
Hochberg test implemented in MS Excel. Genes that were not expressed in more 
than 2 samples/group were excluded from analysis. In cases where no genes passed 
false discovery criteria, genes were ranked by unadjusted p-value and manually 
inspected to investigate possible trends in the data.  
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3 Generation and characterization of HDAC4 mutant mice 
3.1 Introduction 
The creation of knock-in mouse strains is now commonly used to determine gene 
function in vivo. A number of technical advances, including recombinant DNA 
technology, embryonic stem cell biology and an understanding of the principles of 
homologous recombination allowed gene targeting to be applied to mice since the 
late 1980s (Capecchi, 1989). The procedure is done in two stages: first, DNA 
constructs are designed and inserted into embryonic stem cells (ES cells) (illustrated 
in Figure 7). By engineering DNA constructs that are homologous to a region of 
interest of the mouse chromosome and have positive and negative selection 
markers, only clones that have undergone correct targeting will grow under different 
conditions. The classical example is the use of the neomycin resistance gene (neor) 
and the HSV-tk cassette as the basis of positive-negative selection. The neor 
cassette is placed between the two homology arms so that upon recombination it will 
replace the targeted gene, allowing the clones to grow in neomycin. The HSV-tk 
cassette is placed downstream of the 3ʼ homology arm. If a random integration has 
occurred, the clones will contain the HSV-tk cassette and will be sensitive to 
gancyclovir, an antiviral drug. Once positive clones have been identified, the ES cells 
will be injected into the blastocoel cavity of a 4.5 day embryo and then surgically 
implanted into pseudopregnant females. Commonly, the ES cells will come from a 
mouse strain with a different coat colour from that of the pseudopregnant female, so 
screening for mutations can be done on coat colour; those that are chimeric will be 
chosen for further breeding. If the mutation has made it into the germ cells, the 
progeny of a cross between a chimeric mouse and a wildtype mouse will be brown, 
and will have a 50% chance of carrying the mutated allele. This will be assessed 
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using PCR and heterozygous offspring will be mated to create homozygous mutant 
mice.  
 
Figure 7 – General workflow to generate germline chimeras from gene-targeted 
embryonic stem cells, adapted from (Capecchi, 2005) 
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This strategy was used to produce global HDAC4 knockouts (HDAC4-/-), first 
described by Vega et al. (Vega et al., 2004). Null HDAC4 mutants were found to 
have impairments in chondrocyte hypertrophy, an essential stage of bone 
development. Without this, ossification occurred far earlier than it should have, 
limiting mobility and leading to early postnatal lethality. The phenotypic abnormalities 
were seen as early as embryonic day 18 (E18) in HDAC4-/-, and though the animals 
provided important information regarding the function of HDAC4, an alternative 
deletion strategy was required to determine the proteinʼs function in adult tissues. 
So-called ʻconditionalʼ deletion relies on tissue-specific promoters to cause selective 
mutation. One of the most commonly used methods of introducing conditional 
deletion is with the Cre-loxP system (Chu et al., 2008). Cre recombinase is a 
bacterial enzyme that recognizes particular DNA sequences (loxP sites). When it is 
expressed, it will snip out the area between two loxP sites and re-ligate the DNA. To 
create deletions in a cell population of interest, Cre recombinase is driven from a 
promoter that is selective for that population.  When transgenic animals that express 
Cre are bred with animals carrying two copies of a gene with flanking loxP sites 
(floxed animals), heterozygous conditional knockout mice will be created. These will 
need to be backcrossed a further generation to produce homozygous conditional 
knockouts.  
HDAC4 floxed mice were first described in 2007, by Eric Olsonʼs group (Potthoff et 
al., 2007). In these animals, loxP sites were inserted into the introns on either side of 
exon 6, a region that contains the MEF binding domain which is required for HDAC4 
to interact with RUNX2 and the MEF family transcription factors (Miska et al., 1999; 
Vega et al., 2004). Insertion of the loxP sites did not disrupt HDAC4 function and 
floxed animals were indistinguishable from wild-type littermates. Crossing HDAC4fl/fl 
mice with an animal carrying a globally expressed Cre resulted in global HDAC4 
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knockout.  At the molecular level, HDAC4 protein could not be detected but an 
alternative transcript was clearly produced. Functionally, the mice phenocopied the 
global mutants, indicating that neither the alternative transcript, nor other class IIa 
HDACs could compensate for the loss of HDAC4. 
One mouse line that has been developed to allow for conditional knockout in primary 
sensory neurons uses the promoter of the voltage gated sodium channel, Nav1.8 
(encoded by the gene Scn9a), to drive Cre expression (Nassar et al., 2004). Nav1.8 
is a member of the voltage gated sodium channel superfamily, and its expression is 
mainly limited to small, nociceptive sensory neurons, although recent evidence 
suggests that it is also expressed in a proportion of proprioceptive neurons as well 
(Shields et al., 2012). A targeted ablation study has indicated that this population is 
critical for cold, noxious mechanical and inflammatory pain sensation (Abrahamsen 
et al., 2008). In the Nav1.8-Cre line, Cre recombinase has been knocked into the 
Nav1.8 gene locus, downstream of the promoter. Heterozygotes display normal 
expression and function of the sodium channel, and consequently normal sensory 
and pain behaviours, whereas homozygotes phenocopy Nav1.8 knockout mice.  
Because Nav1.8 is expressed during development, it is possible that knockout of 
HDAC4 at this time would affect development of the sensory neurons, particularly as 
known targets of HDAC4 are important in sensory neuron differentiation (Kobayashi 
et al., 2012; Yoshikawa et al., 2007). This is something we sought to investigate with 
these animals.  
To avoid the complication of interpreting whether a behavioural phenotype is primary 
or secondary to developmental defects, an inducible knockout strategy can be 
employed (Wilson et al., 2008). One way to do this is to fuse Cre to a mutated form of 
the estrogen receptor (ERT2) that is insensitive to its endogenous ligand but is still 
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sensitive to tamoxifen, a competitive inhibitor of the estrogen receptor (Wang et al., 
2008b). Under normal conditions, Cre is retained in the cytoplasm, chaperoned by 
heat-shock proteins. Upon tamoxifen administration, the drug binds the estrogen 
receptor and causes a conformational change that releases Cre from the chaperone 
proteins. Cre translocates to the nucleus and deletes floxed regions of the genome.   
This can be combined with tissue-specific promoters that drive Cre to achieve 
inducible, tissue-specific knockout. Only very recently has this become available for 
sensory neuron targeting (Lau et al., 2011).  Lau et al. made use of the bacterial 
artificial chromosome (BAC) transgenic approach to create animals that would 
express CreERT2 in all sensory neurons. BACs are used because they have a 
number of technical advantages over traditional methods. They can carry large 
amounts of information, up to several hundred kilobases of DNA, which means for 
any target gene they are likely to contain all of the required cis-regulatory elements 
for gene expression. This lends the strategy a high probability of success (Rong et 
al., 2010). 
To target all sensory neurons, Cre is driven by the Advillin promoter.  Advillin is an 
actin-binding protein of the gelsolin/villin family, which is expressed almost 
exclusively in peripheral sensory neurons (Gordon et al., 2009; Ontoria et al., 2009; 
Pan et al., 2010).  Lau et al. fully characterized the transgenic mice, showing that 
introduction of the transgene does not affect pain or sensory behaviour, and also that 
tamoxifen dosing itself does not alter pain behaviour (Lau et al., 2011). With this in 
place, it is possible to use these mice to determine the effect of HDAC4 knockout in 
all adult sensory neurons.  
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HDAC4 is a transcriptional repressor, and has been shown to be involved in 
regulating genes that are important for sensory neuron differentiation and function. 
Interestingly, knockout mice that lack the deacetylase domain of HDAC4 reportedly 
have impaired thermosensation. The reason behind this is unclear, but it is tempting 
to speculate that this may be due to aberrant sensory neuron development. In 
addition, the capacity for HDAC4 to shuttle in and out of the nucleus in a calcium-
dependent manner positions it as a molecular cue. The movement of HDAC4 after 
injury could have crucial implications for the transcriptional status of affected 
neurons.  
3.2 Aims 
The aims of this chapter are threefold:  
• Validate HDAC4 knockout from both Nav1.8 and Advillin positive populations 
of sensory neurons 
• Investigate whether knockout of HDAC4 has consequences for sensory 
neuron development 
• Characterize naïve sensory neuron transcription in the absence of HDAC4 
and determine transcriptional effects of knockout in various injury models 
3.3 Methods 
All methods were performed as described in Chapter 2.  
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3.4 Results  
3.4.1 Generation of HDAC4Nav1.8 conditional knockouts 
3.4.1.1 Breeding Scheme 
Since the late 1990s it has been appreciated that different inbred strains of mice 
have varying sensitivity to nociceptive tests (Paroni et al., 2008).  Because of this it 
has become clear that in order to understand effects of particular mutations, the 
background strain of the mutant mice must be considered, otherwise a nociceptive 
phenotype could be misattributed. The HDAC4fl/fl strain was initially bred onto a 
mixed SVz/129/Bl6 background, and at the time that we received them they had 
been backcrossed onto a C57/Bl6 (C57) background for two generations. We 
backcrossed them for two more generations. At N4, the animals should be >90% 
congenic, as according to Mendelʼs laws the amount of the donor strain is reduced by 
50% with each generation (Figure 8). The Nav1.8 line were backcrossed for many 
generations in Professor John Woodʼs lab (personal communication, Sam Gossage), 
meaning that the final cross between the N4 HDAC4fl/fl and the Nav1.8s would yield 
N5 congenicity. At N5, approximately 97% of the genome should be derived from 
C57s. Due to time constraints, this was deemed an acceptable level of congenicity 
for our studies.  
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Figure 8 - By Mendel's laws, the original strain loses 50% of its genomic content with 
each cross to a pure inbred strain 
 
A breeding plan was put in place to ensure that adequate numbers of experimental 
mice would be produced as early as possible. The breeding strategy for the 
experimental cohort ensured that all animals born would be used for the studies, as 
all were of one of the two desired genotypes, either HDAC4fl/fl or HDAC4fl/fl;Nav1.8-
Cre (HDAC4 cKO). This meant that the first experimental cohort was ready to be 
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Figure 9 - Breeding Scheme, HDAC4Nav1.8 cKO 
HDACfl/fl founders had been maintained on a mixed C57Bl/6 x CBA/1 (F1) background and 
required backcrossing. In each generation, animals were born in roughly Mendelian ratios. 
Note that in F5 Cre genotyping was only performed for HDAC4fl/fl animals, so the numbers of 
HDAC4fl/+ and HDAC4Nav1.8 were not assessed (N/A). Following this scheme, behavioural 






























Date of cross: 7/2/2011 
Date of birth: 28/2/2011 
Date of cross: 11/4/2011 
Date of birth: 2/5/2011 
Date of cross: 12/6/2011 
Date of birth: 3/7/2011 
Date of cross: 14/8/2011 
Date of birth: 4/9/2011 
Date of cross: 
16/10/2011 
Date of birth: 6/11/2011 
Date of cross: 
18/12/2011 
Date of birth: 8/1/2012 
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3.4.1.2 Genotyping and validation of HDAC4 knockout  
To identify animals for breeding and experimental cohorts, PCR-based genotyping 
was used, following established protocols (Figure 10A and B). Each generation, 
animals were born in Mendelian ratios (Figure 9). 
 
Figure 10 – Genotyping scheme and representative results 
A – Schematic of primer locations for HDAC4 and Nav1.8 Cre genotyping, respectively. B – 
Representative genotyping results from an F6 litter, with a wildtype negative control in lane 5.  
 
Though both the HDAC4fl/fl strain and the Nav1.8-Cre strain had been used 
independently, it was important to validate that recombination had occurred and 
caused successful knockout of HDAC4. This was first investigated at the genomic 
level, using DNA from DRG samples. The primers that were reported in the literature 
to detect the recombined allele did not work in my hands, so I endeavoured to design 
new primers that would be complementary to the intronic regions surrounding the 
deleted exon 6.  The first sets of primers I tried failed to show a difference between 
the animals that were Cre positive and those that did not have Cre. Could it be that 
Cre was not able to access the loxP sites around HDAC4? Digging deeper, I double-
checked the sequences of the primers, and that of the HDAC4 targeting construct. In 
the years since the mice had been first characterized, the gene had been re-
annotated and a new exon had been described, making the targeted ʻexon 6ʼ called 
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ʻexon 7ʼ on Ensembl. I designed a new set of primers and demonstrated the 
presence of the recombined allele (representative results Figure 16A).  
The next steps were to confirm that the knockout had been successful at both the 
mRNA and protein levels. Cre expression in HDAC4fl/fl animals led to significant 
reduction of HDAC4 mRNA (Figure 11, n=3, p<0.05).  Because it was reported that 
an alternative transcript was created in the HDAC4 cKOs, multiple sets of exon-
spanning primers were designed to determine whether this could be detected using 
RT-qPCR.  Primers spanning the targeted exon (exon 6-7) showed a statistically 
significant reduction in HDAC4 mRNA (fold change (FC)=0.43, n=3, p=0.04, Welchʼs 
t-test), and this was significantly less than the expression of exon 1-2 (p<0.01, 
studentʼs t-test), but not significantly different from the expression of exon 11-12 
(p=0.4, studentʼs t-test), likely due to the high variability of exon 11-12 levels between 
individual samples. The expression of the other exons was also reduced in Cre 
positive animals compared to littermate controls (FC=0.57, =0.58, p=0.02, =0.07, 
Welchʼs t-test). This data indicates that an alternative transcript is likely to be present 
at lower levels than the endogenous transcript, possibly because it is less stable or 
subject to more degradation. 
HDAC4 has a high structural homology with the three other Class IIa HDACs: 
HDAC5, HDAC7 and HDAC9. Because of this, there is a possibility that in the 
absence of HDAC4 there could be compensation for its function by one of these 
proteins. However, RT-qPCR analysis of the level of mRNA for each of these genes 
did not demonstrate a significant difference from HDAC4fl/fl controls (Figure 11). I 
interpret this to mean that compensation for HDAC4 loss was unlikely to have 
occurred in targeted cells.  
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A reduction in protein abundance was also observed using Western blotting, 
although this did not achieve statistical significance (FC=0.39, n=4-5, p=0.06). The 
residual expression of HDAC mRNA and protein is expected since there are many 
cells in the DRG that do not express Cre – both neurons not expressing Nav1.8 and 
many non-neuronal cells. The combined genomic, transcriptional and protein 
evidence confirms that HDAC4 has been successfully deleted in this novel strain of 
conditional knockouts.  
 
Figure 11 – Cre driven from the Nav1.8 promoter successfully causes deletion of floxed 
HDAC4 in the DRG 
A – Hdac4 mRNA levels were measured using RT-qPCR. Both exons 1-2 and exons 6-7 
were significantly less expressed in HDAC4 cKOs (p<0.05, n=3, Welchʼs t-test). B – Class IIa 
HDAC expression was measured by RT-qPCR. No significant differences were observed. C – 
Representative Western blot for HDAC4 with alpha-tubulin (a-tub) loading control D – 
Densitometric analysis indicates that HDAC4 cKO have reduced levels of HDAC4 protein but 


























































3.4.2 Functional effects of HDAC4 knockout in Nav1.8-positive sensory 
neurons 
3.4.2.1 Determining the effect of HDAC4 on sensory neuron development 
Previous work on HDAC4 has implicated it in regulating the expression of the Runt 
family of transcription factors, which are critical for sensory neuron differentiation. For 
example, forced Runx1 overexpression using the Tau promoter leads to a marked 
reduction of TrkA positive cells, and CGRP expression (Samad et al., 2010). Since 
the Cre used to generate these mutants is expressed during embryonic development, 
I sought to determine whether HDAC4 could play a role in sensory neuron 
differentiation by characterizing cell size distributions, and the proportion of cells 
expressing TrkA and the subtype markers CGRP, IB4 and neurofilament 200 
(NF200) in adult L4 sensory ganglia using immunohistochemistry.  
 
Figure 12 – There is no difference in the proportion of TrkA positive neurons or cell 
size in HDAC4Nav1.8 cKOs compared to littermate controls 
A – Whole L4 ganglia from HDAC4Nav1.8 cKO and HDAC4fl/fl animals were stained for TrkA. 
Scale bar represents 100 µM. B – Quantification of immunofluorescence. Similar proportions 
of DRG cell profiles were found to be TrkA positive (40.3%, 36.5%). C – Similar cell size 







































No difference in the proportion of TrkA positive cells was observed.  Similarly, when 
we performed a size distribution of DRG profiles, we did not see a loss of small 
neurons. Furthermore, there were no differences in the proportion of cells expressing 
any of the three markers in HDAC4 cKOs (Table 5, Figure 13). From this analysis we 
could not find evidence for a role of HDAC4 in sensory neuron differentiation.  
Table 5 - Quantification of subpopulation markers 
Counting was done on 3-5 sections from at least 3 animals per genotype. No difference was 
observed in the proportion of profiles expressing the different population markers, suggesting 
that HDAC4 is dispensable for sensory neuron diversification (images next page) 
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Figure 13 - HDAC4 is not required for sensory neuron differentiation 
Images show representative naïve L4 DRG from HDAC4fl/fl animals on the left and 
HDAC4Nav1.8 cKOs on the right; scale bar represents 100 µM. CGRP, IB4 and NF200 
immunoreactivity can be used to classify the major subgroups of the DRG, namely the 
peptidergic unmyelinated/thinly myelinated neurons, the nonpeptidergic unmyelinated 
neurons, and the large myelinated neurons. Both HDAC4fl/fl and HDAC4Nav1.8 cKOs showed 
equal proportions of these markers, indicating that HDAC4 does not play a role in sensory 





HDAC4fl/fl HDAC4Nav1.8 cKO 
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3.4.2.2 Transcriptional regulation in naïve animals 
To determine the effect of HDAC4 on transcriptional regulation, I performed an 
affymetrix array on adult DRG samples from experimentally naïve HDAC4fl/fl and 
HDAC4 cKO animals. Analysis of this data proved that HDAC4 has little role in 
regulating transcription in naive sensory neurons. A principle component analysis 
(PCA) showed a high degree of overlap between the samples. The LIMMA algorithm 
was used to discover alternatively regulated transcripts. No genes passed this test 
(data not shown).  
Similarly, medium-throughput analysis of mRNA levels using custom-designed Taq-
Man low-density array cards yielded only four differentially regulated genes (from a 
pool of 48 genes on a ʻpain cardʼ) at a statistical significance cut-off unadjusted 
p<0.05: Ptgs2, Trpa1, and the voltage-gated sodium channel genes Scn11a and 
Scn10a that encode for Nav1.9 and Nav1.8, respectively. The expression changes 
were small (<2 fold) and did not pass false-discovery testing using the Benjamini-
Hochberg test (Figure 14), which may explain why they were not seen in the 
microarray. It is curious that the expression of these genes is lower than that 
observed in controls, as HDAC4 is thought to have a negative effect on transcription, 
so in its absence one would expect upregulation of target genes. This may imply that 
HDAC4 works to repress a negative transcriptional regulator, for example 
REST/NRSF. Interestingly, both Trpa1 and Scn10a expression are regulated by 
REST knockdown (Uchida et al., 2010). Furthermore, HDAC4 has previously been 
linked to Ptgs2 expression (Wang et al., 2008a). It may be interesting to follow up this 
finding using a protein expression assay, like an ELISA. 
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Figure 14 – HDAC4 has a limited effect on gene expression in naïve sensory neurons 
Four genes were differentially expressed in naïve HDAC4Nav1.8 cKO samples at a statistical 
cut-off of unadjusted p!0.05: Ptgs2 (FC=0.51, p=0.05); Scn10a (FC=0.76, p=0.05); Trpa1 
(FC=0.84, p=0.04) and Scn11a (FC=0.77, p=0.04). Although none of these survived false 
discovery testing, this may imply a role for HDAC4 in regulating the transcription of these 
genes.  
 
3.4.2.3 Transcriptional regulation in a nerve injury model 
Although robust transcriptional alterations were not observed in naïve DRG samples, 
I wondered whether the loss of HDAC4 would have implications for the transcriptional 
response to injury. Acute DRG dissociation and incubation in a high concentration of 
NGF (50 ng/mL) was used as an in vitro injury model. Putative HDAC4 targets were 
identified by comparing HDAC4fl/fl cultures with HDAC4Nav1.8 cKO cultures.  Using a 
cut-off value of unadjusted p<0.01, six genes were found to be differentially 
regulated: somatostatin (Sst), Ngf, the gene encoding TrkA (Ntrk1), calcitonin-related 
polypeptide alpha (Calca) that encodes for CGRP, Trpv1 and the nerve growth factor 
inducible peptide Vgf  (Figure 15). Of note, only Ntrk1 passed false-discovery testing. 
To validate this analysis, a multivariate ANOVA was performed to compare gene 
expression after culturing with that of naïve adult DRGs, with injury and genotype as 
independent variables and genes as dependent variables. All genes discovered 
using unadjusted p-value criteria were also found to have significant interaction of  





















Figure 15 - Loss of HDAC4 results in altered transcriptional regulation following acute 
dissociation of DRG neurons 
The heat map shows normalized individual expression values for six differentially regulated 
genes, with blue meaning lower expression and yellow meaning higher expression. Genes 
are arranged by hierarchical clustering, with those that were upregulated in the HDAC4 cKOs 
at the top, and downregulated genes below. 
Interestingly, the majority of these genes are related to NGF signaling. Ngf itself was 
upregulated in the knockout, whereas its receptor, Ntrk1, and downstream target, 
Vgf, were both downregulated. TRPV1 activity is also known to be regulated by NGF 
(Ji et al., 2002), and has been shown to have implications for CGRP release (Meng 
et al., 2009; Nakanishi et al., 2010). This suggests that HDAC4Nav1.8 cKOs may show 
reduced behavioural hypersensitivity, which will be discussed in Chapter 5. 
Table 6 - Multivariate analysis confirms that HDAC4 is required for transcriptional 
regulation of NGF-associated genes 
Genes are listed in the order that they appear in the heatmap in Figure 15. Analyses were 
performed against datasets from naïve adult DRG, with the factors injury (naïve vs cultured) 
and genotype (wildtype vs. HDAC4Nav1.8 cKO). All genes discovered using t-tests were found 
to have significant genotype*injury interaction effects at p<0.02. 
 
Main effect of injury Main effect of genotype Interaction 
genotype*injury 
p F(1,12) p F(1,12) p F(1,12) 
Sst <0.0001 26.32 0.001 21.37 0.019 7.26 
Ngf <0.0001 108.56 n.s - 0.006 11.22 
Ntrk1 0.001 20.92 <0.0001 27.48 0.002 15.13 
Calca n.s. - 0.001 17.12 0.013 8.61 
Trpv1 n.s. - 0.017 7.64 0.002 15.92 
Vgf <0.0001 109.03 0.002 16.08 <0.0001 25.15 
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3.4.3 Advillin CreERT2 conditional knockout 
The Advillin CreERT2 line was being developed and characterized early on in my 
PhD, and was made available for our use in mid-2012.  A similar breeding strategy 
was adopted for the generation of HDAC4 Advillin CreERT2 cKOs (HDAC4Adv cKO). 
By the time the Advillin CreERT2 animals had been transferred to our animal house, I 
had already backcrossed HDAC4fl/fl twice to N4 C57 and could immediately cross the 
HDAC4fl/fl animals with the Cre line. Our first experimental cohort was ready to be 
dosed with tamoxifen in April 2013.  
3.4.3.1 Genotyping and knockout validation 
PCR based genotyping was used to inform breeding pair selection, following 
established protocols. Because BAC-derived genes can integrate at multiple sites in 
the chromosome, they may not follow Mendelian inheritance. However, if the 
transgene has integrated into one chromosome, there should be approximately 50% 
inheritance (Haruyama et al., 2009). We received four founders from Professor John 
Woodʼs lab, of which two successful litters were derived. One of these yielded 50% 
transgene expression, and this line was continued to produce HDAC4 cKOs. Cre 
positive animals were never crossed with one another to reduce the possibility of 
differing copy numbers between experimental animals.  
Similarly to the HDAC4Nav1.8 cKO line, it was necessary to validate the knockout of 
HDAC4 in this novel strain of conditional mutants. To do this, we analysed events at 
the DNA, RNA and protein level one week after the end of tamoxifen dosing. Using 
the same protocols and primers described above (see chapter 3.4.1.2), we 
successfully detected the recombined HDAC4 allele in DRG samples of Cre positive 
animals (Figure 16).  
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Figure 16 - Validation of HDAC4Adv conditional deletion 
HDAC4 conditional deletion was validated using PCR, RT-qPCR and Western blotting seven 
days after treatment with tamoxifen. A – PCR-based genotyping revealed the presence of the 
recombined (deleted) allele in Advillin-CreERT2 positive animals treated with tamoxifen. B – 
Western blot showing the loss of HDAC4 from Advillin-CreERT2 animals. The identity of the 
lower band is unknown. C – RT-qPCR revealed significant reduction in Hdac4 mRNA in 
Advilin-CreERT2 animals (FC=0.6, =0.42, p<0.05) D – Quantification of the Western blot in B. 
Significant knockdown of HDAC4 protein was observed in tamoxifen-treated Advillin-CreERT2 
animals (27.3% of controls, p<0.05). The remaining protein is possibly due to non-neuronal 
expression of HDAC4. 
To determine whether reduced HDAC4 expression could be detected at the mRNA 
level, RT-qPCR against exons 1-2 and the targeted exon 6-7 was used.  Results from 
RT-qPCR showed that, indeed, there was a significant reduction in the level of 
HDAC4 mRNA expression in Cre positive animals (Figure 16).  Although both exons 
showed significantly reduced expression (n=3-4, p=0.021 exon 1-2, p=0.023 exon 6-
7, Welchʼs t-test), the fold change between genotypes was greater for the targeted 
exon 6 (0.42 vs 0.60), possibly due to an alternate transcript that is maintained in the 
conditional knockout.  
Protein levels of HDAC4 were assessed using western blotting. Cre positive animals 
had significantly less HDAC4 protein than Cre negative littermate controls (27.2% of 
control, n=3-4, p=0.047, Welchʼs t-test). 
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This evidence indicates that there has been successful targeting, tamoxifen 
administration and recombination of HDAC4 in the DRG, and that these animals can 
be used for further functional analysis.  
3.4.4 Functional effects of HDAC4 deletion in adult sensory neurons 
3.4.4.1 Transcriptional regulation in naïve animals 
It was important to determine whether upregulation of other HDACs may compensate 
for the loss of HDAC4. RT-qPCR was used to look for the expression of HDAC5, 
HDAC7 and HDAC9, the other Class IIa HDACs. Interestingly, one week after 
tamoxifen administration, upregulation of both HDAC5 (1.7 fold, n=3, p=0.078) and 
HDAC9 was observed (1.4 fold, n=3, p=0.037), but HDAC7 expression was not 
affected (1.1 fold, n=3, p=0.5) (Figure 17). 
 
Figure 17 - Class IIa HDACs are upregulated following HDAC4 deletion 
One week after tamoxifen treatment, RNA was extracted from HDAC4fl/fl and HDAC4Adv cKO 
DRGs. A trend toward upregulation of other class IIa HDAC family members was observed in 
cKO samples, with Hdac9 expression showing a statistically significant increase (FC=1.4, 
p=0.04). This suggests that class IIa HDAC expression is tightly regulated in adult sensory 
neurons, and may imply functional compensation for HDAC4 loss.  
I further characterized the transcriptional differences between HDAC4Adv cKOs and 
littermates using TaqMan PCR array cards as described previously. Interestingly, 
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Cacna2d1, Trpa1, the gene encoding the vaso-active intestinal protein (Vip), the mu-
opioid receptor gene (Oprm1) and purinoreceptor 3 (P2rx3), were all differentially 
regulated in HDAC4Adv cKOs at a statistical cut-off of unadjusted p<0.05 (Figure 18). 
However, it must be noted that none of these passed false-discovery criteria using 
the Benjamini-Hochberg test. 
 
Figure 18 - Knockout of HDAC4 from adult DRG results in altered gene expression 
Genes are arranged by unadjusted p-value. ***=p<0.01, **=p<0.02, *=p<0.05, n=4, Welchʼs t-
test. N.B. No genes passed false-discovery testing. Cacna2d1, Oprm1, P2rx3 and Vip were 
upregulated in HDAC4Adv cKOs (FC=1.55, 1.75, 1.3, 2.84) and Trpa1 was downregulated 
(FC=0.69).  
 
3.4.4.2 Transcriptional regulation is altered in HDAC4Adv cKOs after sciatic 
nerve transection 
Having previously discovered that HDAC4Nav1.8 cKO responded differently to an in 
vitro nerve injury model, we sought to determine whether HDAC4Adv cKOs would also 
exhibit transcriptional dysregulation in response to nerve injury. The sciatic nerve 
transection model was used, and 24 hours after in vivo axotomy, L3 and L4 lumbar 
ganglia were harvested for RNA extraction and subsequent RT-qPCR analysis using 

























Comparison of wildtype (HDAC4fl/fl) and HDAC4Adv cKO ipsilateral gene expression 
revealed seven genes that were differentially expressed at an unadjusted p<0.05: 
Ngf, Gad2, Scn10a, Calca, Cacna2d1, Trpa1 and Vip1 (n=4, Welchʼs t-test) (Figure 
19). Multivariate analysis of this data with the factors injury (sciatic nerve transection 
ipsi vs. contra) and genotype (wildtype vs. HDAC4Adv cKO) confirmed significant main 
effects of injury for Scn10a (F(1,12)=6.45, p=0.026), Cacna2d1 (F(1,12)=22.71, 
p<0.0001), Gad2 (F(1,12)=284.77, p<0.0001), and Ngf (F(1,12)=56.23, p<0.0001). 
Significant main effects of genotype were observed for Scn10a (F(1,12)=9.47, p=0.01), 
Cacna2d1 (F(1,12)=21.57, p=0.001), Trpa1 (F(1,12)=20.09, p=0.001), Gad2 (F(1,12)= 
15.96, p=0.002), and Vip (F(1,12)=11.30, p=0.006) and near significant genotype x 
injury interaction effects were observed for Calca (F(1,12)=4.50, p=0.055) and Ngf 
(F(1,12)=3.88, p=0.07).  
 
Figure 19 – After peripheral nerve injury multiple genes trend toward differential 
expression between HDAC4Adv cKOs and littermates  
Columns represent fold changes over uninjured wildtype controls (wt contra). Genes that 
were differentially regulated between injured wt and HDAC4Adv cKO samples at unadjusted 
p<0.05 are shown. After correcting for multiple comparisons, no genes were statistically 
significant. Of note, Calca and Ngf expression trend in the same direction as changes 











































After sciatic nerve transection Scn10a, Calca and Trpa1 were expressed at lower 
levels in HDAC4Adv cKOs compared to littermates, whereas Ngf, Gad2, Cacna2d1 
and Vip were expressed at higher levels. The overexpression of Ngf and 
downregulation of Calca were similar to what had been observed previously in the 
HDAC4Nav1.8 cKOs (Figure 15), indicating that these might be conserved HDAC4 
targets.  
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3.4.5 Is there a consistent effect of HDAC4 deletion on sensory neuron 
transcription? Comparing transcription data from HDAC4Nav1.8 and 
HDAC4Adv cKOs 
HDAC4 has been shown to be critical for the regulation of a number of genes related 
to synaptic plasticity (Sando Iii et al., 2012), a key mechanism that underlies chronic 
pain. Conditional deletion of HDAC4 was associated with altered transcription in both 
strains of mice after injury. We hypothesized that true HDAC4 target genes would 
show consistent differences in both strains of conditional mutants. To investigate this 
we compared TaqMan low-density array card RT-qPCR data from four different 
models of injury: an in vitro inflammation model (dissociation + 50 ng/mL NGF), 
partial sciatic nerve ligation, sciatic nerve transection (SNT) and the Complete 
Freundʼs adjuvant (CFA) model of chronic inflammation (Table 7).  
Table 7 - List of studies used for transcription 'meta-analysis' 
 
3.4.5.1 Effect of HDAC4 deletion on uninjured sensory neuron transcription 
To compare results from the different experiments, analysis was performed on 
normalized cycle time (CT) values (delta CT (dCT) = CTgene of interest – CTreference gene). 
Similar to previous results from the affymetrix array, comparison of naïve or uninjured 
samples (from studies 2 and 3) revealed no significant differences in gene 
expression between cKOs and littermate controls (n=8, p>0.05, Welchʼs t-test).  
KO strain! Injury model! Tissue! Time point!
Study 1! HDAC4Nav1.8! dissociation (axotomy) + 




3 hours after 
plating!
Study 2! HDAC4Nav1.8! partial sciatic nerve 
ligation; naive control !
L3-L5 DRG! D28 after injury!




24 hours after 
injury!







However, ranking the top ten gene expression changes by p-value in both datasets 
revealed that Cacna2d1 was upregulated in both HDAC4Nav1.8 cKOs and HDAC4Adv 
cKOs (FC=1.32, 1.55; p=0.13, 0.01) and Trpa1 was downregulated (FC=0.84, 0.69; 
p=0.04, 0.02) (Table 8, Figure 20), suggesting that HDAC4 is required to maintain 
transcript levels for these genes.  
Table 8 - Top ranked gene expression changes, naïve and SNT contra 
 
 
Figure 20 - Cacna2d1 and Trpa1 trend toward differential expression in both strains of 
HDAC4 cKOs. 
Charts were generated from PCR array card data. FC and unadjusted p-values are as listed 
in Table 8. Interestingly, larger fold changes were observed in HDAC4Adv cKOs, which is 
consistent with the deletion of HDAC4 from a larger population of sensory neurons. 
HDAC4Nav1.8 Naive! HDAC4Adv Contra!
p! Average FC cKO! p! Average FC cKO!
 Scn11a! 0.04! 0.77!  Cacna2d1! 0.01! 1.55!
 Trpa1! 0.04! 0.84!  Opmr1! 0.01! 1.75!
 Scn10a! 0.05! 0.76!  P2rx3! 0.02! 1.30!
 Ptgs2! 0.05! 0.51!  Trpa1! 0.02! 0.69!
 Sgk1! 0.08! 0.69!  Vip! 0.04! 2.84!
 Cacna2d1! 0.13! 1.32!  Ntrk1! 0.06! 1.15!
 Tacr1! 0.15! 1.67!  Vgf! 0.07! 1.48!
 Gabbr1! 0.16! 0.89!  Gad2! 0.07! 1.32!
 Ngf! 0.20! 0.44!  Kcns1! 0.07! 1.25!



































































3.4.5.2 Effect of HDAC4 deletion on sensory neuron transcription after injury 
In contrast, comparison of gene expression after injury revealed three genes that 
were consistently differentially regulated in both strains of HDAC4 cKOs: Calca, 
Ntrk1, and Trpv1 (Figure 21) (n=16, p<0.01, Welchʼs t-test). All genes were 
downregulated in HDAC4 cKOs compared to controls (average fold change =0.46, 
0.54, 0.60, respectively).  It must be noted that only Calca passed false discovery 
testing.  
 
Figure 21 - HDAC4 cKO have altered transcriptional responses to injury 
A transcription ʻmeta-analysisʼ indicated that Ntrk1, Calca and Trpv1 were consistently 
downregulated in both strains of HDAC4 cKOs compared to similarly affected littermates after 
injury. NB Only Calca passed false discovery criteria. A – Heat map generated from dCT 
expression values. Each square comes from an individual sample, with HDAC4fl/fl samples on 
the left and HDAC4 cKO samples on the right. Genes are clustered hierarchically, with green 
representing higher expression, and red representing lower expression. Interestingly, Trpv1 
and Calca are very closely clustered, which is consistent with the known dependence of 
CGRP release on TRPV1 activity (Meng et al., 2009; Nakanishi et al., 2010). B – Fold change 
values from the individual experiments. Larger fold changes were observed in studies 1 and 






























































































3.5.1 Nav1.8 Cre and Advillin CreERT2 successfully recombine floxed 
HDAC4 
Targeted deletion is a powerful tool to investigate gene function in vivo, leading to 
great advances in our understanding of biological systems. HDAC4 function has 
been linked to sensory processing: humans with mutations to HDAC4 exhibit signs of 
self-harm and have increased pain thresholds (Williams et al., 2010), and mice that 
lack the deacetylase domain of HDAC4 are less sensitive to noxious thermal stimuli 
(Rajan et al., 2009). Characterization of HDAC4 function in adults requires a 
conditional knockout strategy, as global knockout is lethal in the early post-natal 
stage (Vega et al., 2004). Nav1.8 and Advillin are sensory neuron specific genes; Cre 
driven from their promoters allows for selective deletion of floxed alleles at different 
stages and in different sensory neuron populations (Lau et al., 2011; Nassar et al., 
2004). These Cre lines have been validated for use in pain studies, as they have 
been shown not to interfere with normal sensory processing.  
Crossing these Cre lines with the floxed Hdac4 line resulted in recombination of 
Hdac4, such that mRNA and protein expression was significantly reduced. As 
expected, some message and protein did remain in the DRG in both strains of mice.  
The remaining message in the HDAC4Nav1.8 cKO is likely to arise from the Nav1.8-
negative cells of the DRG: Aβ and Aδ neurons and non-neuronal cells such as 
satellite glia. The remaining message and protein in the HDAC4Adv line could derive 
from non-neuronal cells, or may be due to incomplete tamoxifen-mediated Cre 
release. In the original paper that describes the Advillin CreERT2 line, a 90% 
recombination rate is reported using a flox-stop LacZ reporter line (Lau et al., 2011). 
The recombination efficiency cannot be directly translated because excision of floxed 
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regions is highly dependent on chromatin compaction, which is region specific. 
However, it indicates that the remaining message and protein could come from 
neurons that have not been exposed to tamoxifen. Staining for HDAC4 in sensory 
neurons after tamoxifen administration would illuminate this. One limitation has been 
finding reliable HDAC4 antibodies for immunohistochemistry. Although we have been 
able to validate antibodies for western blotting, these bind nonspecifically in frozen 
tissue sections under all conditions tested (data not shown). HDAC4-specific 
antibodies, or the use of epitope or GFP tagged mutants are required to address this.  
3.5.2 HDAC4 is not required for sensory neuron development  
HDAC4 is known to negatively regulate RUNX2 (Vega et al., 2004) and RUNX3 (Jin 
et al., 2004). Both RUNX1 and RUNX3 are required for sensory neuron differentiation 
(Chen et al., 2006; Kramer, 2006; Lopes et al., 2012; Lou et al., 2013; Marmigere et 
al., 2006; Nakamura et al., 2008; Samad et al., 2010).  Due to the homology of 
RUNX1 with RUNX2 and RUNX3 we hypothesized that HDAC4 knockout from the 
Nav1.8 population would phenocopy Tau-driven RUNX1 over-expressing animals, 
that have a characteristic pattern of altered sensory neuron development (Samad et 
al., 2010), including loss of TrkA positive neurons and reduced expression of CGRP. 
Immunohistochemical analysis of sensory neuron populations in adult DRG did not 
support this hypothesis, as HDAC4Nav1.8 cKO animals had similar proportions of cells 
expressing markers for the three main neuronal subtypes, TrkA staining and cell size 
distribution. From this data we concluded that HDAC4 is not likely to repress RUNX1 
in sensory neurons, possibly due to its subcellular localization in development. 
HDAC4 is normally cytoplasmic in neurons, but undergoes phosphorylation and 
activity-dependent shuttling to the nucleus (Sando Iii et al., 2012), where it would be 
able to interact with transcription factors like RUNX1.  It is possible that at the stage 
in development when RUNX1 is active, HDAC4 is maintained in the cytoplasm. This 
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could be discerned using cellular fractionation and western blotting for RUNX1 and 
HDAC4, or through immunohistochemical analysis. HDAC4-specific antibodies, or 
the use of epitope or GFP-tagged HDAC4 mutants are required to investigate the 
subcellular localization of HDAC4 under different conditions and in development.  
3.5.3 HDAC4 may be required for Cacna2d1 and Trpa1 expression in 
uninjured sensory neurons 
HDAC4 has been shown to regulate the transcription of a number of genes 
associated with synaptic plasticity (Li et al., 2012; Sando Iii et al., 2012) and to 
interact with multiple transcription factors, such as CREB and MEF that are important 
for regulating neuronal function.  We hypothesized that loss of HDAC4 would have 
consequences for the regulation of sensory neuron transcription.  
Using a medium-throughput RT-qPCR screening method, four genes were found to 
be differentially regulated in experimentally naïve HDAC4Nav1.8 cKO DRG: Ptgs2, 
Trpa1, Scn10a and Scn11a.  All of these genes were less expressed in cKOs.  In the 
HDAC4Adv cKO animals, a few differences in gene expression were seen 
contralateral to nerve injury (considered in this case to reflect baseline transcriptional 
differences between genotypes). These included Trpa1, which was downregulated, 
as well as Oprm1, P2rx3, Vip and Cacna2d1, that were upregulated in cKOs. Further 
work to validate these changes with independent RT-qPCRs and Western blotting 
are required.  
In contrast to the transcriptional differences observed with PCR array cards, 
microarray analysis of naïve adult HDAC4Nav1.8 cKO and HDAC4fl/fl DRG yielded no 
significant differences between genotypes. This is in line with experiments from 
HDAC4CamKIIa cKO, which lack HDAC4 in cortex, and which also do not exhibit altered 
transcription when compared to littermate controls (Kim et al., 2012). This is further 
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evidence that HDAC4 is not required for neuronal development, and does not alter 
baseline transcriptional programmes that lead to long-term changes in gene 
expression. However, technical limitations having to do with the analysis of 
microarray data (normalization) may also mask some of the transcriptional 
differences that do truly exist. 
Microarray analysis relies on algorithms that normalize expression values across a 
chip, under the assumption that in most experiments, most genes will not be affected. 
However, the limitation of this assumption means that any intervention that causes 
global changes to gene expression, for example the use of a histone deacetylase 
inhibitor which will non-selectively increase gene expression across the entire 
genome, will be masked by the normalization process (Lovén et al., 2012). To get 
around this issue, it is necessary to either include samples with known RNA amounts 
as a kind of “standard” to correct against, or to use Next generation sequencing 
methods, or any other kind of direct quantification (such as the NanoString 
technology). These may reveal transcriptional differences that had previously been 
unrecognized using the LIMMA or SAM algorithms. 
3.5.4 HDAC4 regulates transcriptional responses after injury 
A key mechanism that underlies HDAC4 function is nucleo-cytoplasmic shuttling. 
This occurs in an activity-dependent manner. It is conceivable that injury could result 
in shuttling of HDAC4, allowing it to alter gene expression associated with synaptic 
plasticity or neuronal growth. Alternatively, it may interact with other factors in the 
cytoplasm that are required for altered transcription. Direct evidence of HDAC4 
shuttling in the DRG is still lacking, and is a question that is important to resolve. 
Transcriptional regulation in the absence of HDAC4 provides some clues as to the 
role of HDAC4 after injury.  
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Across four different injury models, at different time points and in two HDAC4 
knockout strains, there were consistent differences in gene expression between 
conditional knockouts and littermate controls. By analyzing all of this data together, 
as one dataset, the power of the analysis is increased, and it is possible to track 
down common HDAC4 target genes. In this manner I identified Calca, Trpv1, and 
Ntrk1 as putative HDAC4 targets. These three transcripts were found to be less 
expressed in conditional knockouts than in littermate controls, which is curious 
considering that HDAC4 is a negative transcriptional regulator. This may suggest that 
HDAC4 does not directly alter the transcription of these genes. Indeed, published 
HDAC4 ChIP-Seq data from the cerebellum does not show enrichment for HDAC4 
near these genes, although this may be due to cell-type specificity (Li et al., 2012). 
Interestingly, a recent study has shown that knockout of HDAC4 in cardiomyocytes 
results in altered chromatin dynamics, with knockout hearts exhibiting greater 
amounts of histone H3 lysine 9 (H3K9) di- and tri-methylation on the promoter region 
of a gene associated with stress-induced cardiac failure (Hohl et al., 2013). These 
marks are correlated to transcriptional repression (Kouzarides, 2007). Whether the 
ʻparadoxicalʼ downregulation of Ntrk1, Calca and Trpv1 is associated with changes to 
these marks remains to be seen. Other possibilities for the mechanism underlying 
this transcriptional change are discussed in Appendix 1: Bioinformatics analysis of 
HDAC4 expression and function. 
All of these genes are required for appropriate responses to inflammatory and heat 
stimuli, and are regulated by NGF (Ji et al., 2002; Lindsay and Harmar, 1989; 
McMahon, 1996). For example, NGF binding to TrkA sensitizes TRPV1 channels via 
the action of multiple intracellular signaling cascades (Bonnington and McNaughton, 
2003; Chuang et al., 2001), and can increase protein expression in a p38-MAPK 
dependent manner (Ji et al., 2002). The increased expression and activity of TRPV1 
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leads to thermal hypersensitivity (Galoyan et al., 2003). In turn, NGF and TRPV1 
signaling have also been shown to induce Calca mRNA expression (Lindsay and 
Harmar, 1989; Nakanishi et al., 2010). CGRP is an important signaling molecule at 
both the central and peripheral terminals of sensory neurons, and its expression 
levels have been shown to predict thermal hypersensitivity (Mogil, 2005). As all of 
these transcripts are reduced in HDAC4 cKOs, this may indicate that cKO animals 
would be less responsive to inflammatory mediators, and show reduced thermal 
hyperalgesia in models of inflammatory pain. This was investigated, and will be 
discussed in Chapter 5. 
HDAC4 has been shown to interact with many different transcription factors, and is 
also capable of directly binding DNA. Further work to determine the mechanisms by 







4  HDAC4 and Regeneration 
4.1 Introduction 
In science, sometimes the most interesting findings are accidental. In the previous 
chapter, I reported that HDAC4 cKOs have lower relative mRNA expression of Ntrk1, 
the gene that encodes the high-affinity NGF receptor, TrkA. This finding was of 
interest to us as NGF signaling via TrkA is required for sensory neuron development, 
and in adults NGF is an important peripheral pain mediator (Pezet and McMahon, 
2006). Ntrk1 downregulation was initially observed three hours after culturing 
dissociated neurons in a high concentration of NGF (50 ng/mL).  There were three 
hypotheses postulated to account for this: 1 – Ntrk1 is constitutively expressed at 
lower levels in conditional knockouts, 2 – Ntrk1 becomes downregulated as a result 
of nerve injury, 3 – Ntrk1 becomes downregulated as a result of reduced NGF 
signaling. To test the first, I checked the level of Ntrk1 in freshly dissected tissue; to 
test the second, I first performed an axotomy and then looked for Ntrk1 expression 
levels; to test the third, I tried to validate an NGF application procedure, using Bdnf 
and Hdac9 mRNA expression as a functional read-out, as they are known NGF 
targets (Guo et al., 2011; Michael et al., 1997).  
As I was going through these experiments, I used the injury-induced transcription 
factor, Atf3 as a positive control following axotomy. Interestingly, in cKO animals, 
Atf3 showed a much lower expression level in this injury paradigm (Figure 22). When 
I compared this to data I had from HDAC4Nav1.8 cKOs after partial sciatic nerve 
ligation, I discovered that Atf3 was also less upregulated in this injury model. 
Intrigued, we began a series of experiments to explore the potential link between 
HDAC4 and ATF3.  
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Figure 22 – After peripheral nerve injury, Atf3 is less upregulated in HDAC4Nav1.8 cKO 
DRG samples compared to littermate controls  
A – RT-qPCR data from DRG 24 hours after sciatic nerve transection (axotomy). Atf3 is 
upregulated after injury, however HDAC4 cKO induce Atf3 to a lesser extent (wt FC=91.4, 
cKO FC=31.4, n=2). B – Atf3 mRNA is upregulated after partial sciatic nerve ligation injury in 
both HDAC4 cKO and littermate controls (p<0.01, n=4), but HDAC4 cKOs show less 
upregulation (wt FC=8.5, cKO FC=4.1) C – Ipsilateral expression only, Hdac4 shown as 
positive control. Atf3 is less expressed in HDAC cKO (FC=0.34). D – Ipsilateral side only, 
PSL. Atf3 is less expressed in HDAC4 cKO (FC=0.48, p=0.05, n=4) 
 
ATF3 is a member of ATF/CREB subfamily of the basic region-leucine zipper (bZIP) 
family of transcription factors. Its expression is increased by multiple cell stress 
paradigms, a process that has been shown to rely on many different signaling 
pathways including JNK, p38, PKC and NFKB and the transcription factors Egr1, 
ATF2 and Fos/Jun (for review see (Hai et al., 2010)).  In the DRG, ATF3 has been 
used as a marker of injury since 2000, when Tsujino et al. described its rapid 
induction in the nucleus following nerve injury (Tsujino et al., 2000). More recent work 
has indicated that supplementing growth factors can reduce ATF3 induction in a 
population-specific manner, suggesting that it is downstream of growth factor 
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receptor signaling pathways as well (Averill et al., 2004; Wang et al., 2003). This is 
supported by previous work showing robust ATF3 upregulation in growth factor 
deprived PC12 cells (Mayumi-Matsuda et al., 1999). Considering its interesting 
expression pattern, the function of ATF3 in the DRG is still less well-characterized 
than perhaps it deserves to be. One story that has emerged has implicated ATF3 in 
promoting nerve regeneration after injury. Delivery of ATF3 has been shown to 
enhance neurite outgrowth in vitro (Pearson et al., 2003; Seijffers et al., 2006) and 
increase the rate of regeneration in vivo (Seijffers et al., 2007).  
HDAC4 nuclear accumulation has previously been linked to altered Atf3 mRNA 
expression (Schlumm et al., 2013). Could HDAC4 be responsible for coordinating the 
expression of ATF3 in sensory neurons and play a role in peripheral nerve 
regeneration?  
4.2 Aims 
The aims of this chapter are to explore the observed transcriptional dysregulation of 
Atf3 using the two sensory neuron-specific HDAC4 knockout lines established in 
Chapter 3 to determine whether HDAC4 is required for sensory neuron regeneration.  
4.3 Methods 
All experiments were performed as described in Chapter 2.  
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4.4 Results  
4.4.1 Pilot data indicate that HDAC4 may be involved in functional 
recovery following peripheral nerve injury, via an ATF3-
dependent transcriptional mechanism 
Data from our pilot experiments demonstrated reduced expression of Atf3 in 
HDAC4Nav1.8 cKO DRGs following peripheral nerve injury. ATF3 has previously been 
reported to regulate the expression of regeneration-associated genes including the 
heat-shock protein 27 (Hsp27), the small proline-rich protein 1a (Sprr1a) and cJun 
(Seijffers et al., 2007), and it was hypothesized that in the HDAC4Nav1.8 cKOs we may 
expect to see reduced expression of these genes compared to littermate controls. To 
test this hypothesis, I designed RT-qPCR primers for the three gene products and 
compared their expression in the DRG twenty-four hours after sciatic nerve 
transection injury (Figure 23). Once again, Atf3 was less robustly induced in 
HDAC4Nav1.8 conditional knockouts after this injury (wt FC=62.9, cKO FC=19.8, 
p=0.005 ipsi vs ipsi, n=3, Welchʼs t-test). In addition, the three injury-associated 
transcripts were upregulated, and Sprr1a expression achieved statistical significance 
in the ipsilateral DRG in both HDAC4 cKOs and littermate controls compared to the 
contralateral control samples (p<0.01, n=4, Welchʼs t-test).  Although there was no 
statistically significant difference in gene expression between genotypes, a trend 
toward decreased induction in the conditional knockouts was observed for both 




Figure 23 - Regeneration-associated genes are induced after sciatic nerve transection 
RT-qPCR analysis of mRNA expression 24 hours after sciatic nerve transection. A – Atf3 
expression is upregulated more in wt littermates than in HDAC4 cKO (p=0.005, n=3) B – 
Sprr1a is significantly upregulated after injury (FC=327.7, =253.3, p<0.01 wt ipsi vs wt contra, 
n=4). A slight trend toward lower expression of Sprr1a is observed in HDAC4 cKO, however 
this is not statistically significant. C – Hsp27 is induced after injury, with a slight trend toward 
lower expression in HDAC4 cKOs (FC=2.7, =2.1, p=0.07 wt ipsi vs wt contra, n=4) D – cJun 
is upregulated to a similar extent in both HDAC4 cKOs and littermate controls  
Following from this data, we performed a pilot behavioural experiment and assessed 
motor and sensory recovery after sciatic nerve crush, using the sciatic functional 
index and pinprick tests, respectively. In the sciatic functional index test, paw 
placement while walking is compared between affected and unaffected paws. At 
baseline, the difference between the paws should be close to 0. After injury on the 
left side, the score becomes negative. This recovers over time. The pinprick test is a 
binary test of sensation. Under light restraint, the affected paw is poked with a pin in 





































































The response is scored as yes (2 points), no (0 points) or inconsistent (1 point). After 
injury, animals do not respond on the affected side, but continue to respond on the 
unaffected side. This recovers over time, with animals first beginning to respond to 
more proximal stimulation and later responding to stimulation of the distal areas of 
the digits. Using these tests we observed no statistically significant difference 
between genotypes, however a trend toward delayed sensory recovery was 
observed at day 14 (Figure 24).  
 
Figure 24 – A trend toward delayed sensory recovery was observed in HDAC4Nav1.8 
cKOs after sciatic nerve crush 
The sciatic functional index and pinprick tests were used to assess motor and sensory 
recovery, respectively, after sciatic nerve crush. Red represents HDAC4Nav1.8 cKO and grey 
lines represent HDAC4fl/fl controls A – Impairment in paw and digit placement was observed 
immediately following crush injury, which recovered nearly to baseline levels after two weeks. 
No difference was observed between genotypes. B – Pinprick responses were marked out of 
a maximum of 8 points. RM ANOVA revealed no statistically significant difference between 
















































4.4.2 HDAC4 does not affect neurite outgrowth in vitro, or regeneration 
of epidermal nerve fibres after peripheral nerve injury 
Unlike neurons of the central nervous system, peripheral sensory neurons have a 
high regenerative capacity, and readily grow neurites in vitro. This can be enhanced 
by the addition of growth factors, such as NGF. To determine whether HDAC4 is 
involved in mediating neurite outgrowth, a semi-automated image-analysis system 
was used to measure neurite length after twenty-four hours in culture. Cells from 
wildtype C57Bl/6 animals were incubated in different concentrations of NGF, and 
allowed to grow for twenty-four hours before being fixed and stained with beta-3-
tubulin, a pan-neuronal marker. Eight images of each well were taken using the 
InCell Analyser, then this was processed using a semi-automated software program 
that allows the user to set parameters to select particular features within an image 
field. In this case, the cell body was identified separately from the neurites, which 
gave a quantification of both the number of neurons and the length of neurites in 
each well. For each condition, a measure of neurite length/neuron was assessed. 
Using these parameters, the program was capable of detecting an increasing neurite 
growth response with increasing NGF concentrations, that peaked at 10 ng/mL 
(Figure 25), however the effect sizes were small, with the maximum response only 
two-fold higher than the baseline. Following this, the same experiment was 
performed using cultures from HDAC4 cKO and wildtype controls. No difference in 
neurite outgrowth was observed between groups at any individual dose, however a 
comparison of the dose response curve indicated that HDAC4 cKOs responded 
much less to NGF (slope: wt = 45.3; cKO = 9.5). Contrary to our hypothesis, a trend 
toward increased neurite outgrowth was observed in HDAC4 cKOs at all but the 
highest dose of NGF.   
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Figure 25 - Neurite outgrowth is not impaired in HDAC4Nav1.8 cKOs 
A – Bars represent average neurite length/neuron from three independent experiments, 
normalized to 0 ng/mL NGF control. Increasing concentrations of NGF increase the average 
neurite length, with a maximal response at 10 ng/mL. B – Using the same assay, a less 
robust NGF dose response was observed, and there was a high degree of variability between 
cultures. Though there appears to be a trend toward longer neurites in the HDACNav1.8 cKO 
cultures across a range of doses, none of these were statistically significant (n=3). 
 
I wondered whether the selective nature of the knockout may limit the capacity to 
visualize the differences in outgrowth. For example, it is possible that outgrowth from 
large sensory neurons, which are not Nav1.8 positive, would obscure differences. We 
attempted to stain for CGRP and peripherin to get around this problem, but the high 
variability of staining meant that we could not use these to quantify outgrowth (data 


















































Instead, I used a different measure of nerve regeneration - the density of innervation 
in the skin of the affected paw after sciatic crush injury.  The advantage of this 
method is that it is specific for nociceptive Aδ and C-fibres, which are primarily 
Nav1.8 positive. In this model, the sciatic nerve undergoes Wallerian degeneration 
distal to the crush injury, and epidermal nerve fibres are completely lost. As the nerve 
regenerates over time, the epidermis is re-innervated. PGP9.5 is a pan-neuronal 
marker and as expected, at twenty-one days after injury there was a significant loss 
of PGP9.5 staining on the affected side. This was not different between genotypes 
(Figure 26). 
 
Figure 26 – HDAC4Nav1.8 cKOs have similar epidermal innervation after sciatic nerve 
crush when compared to littermate controls 
PGP9.5 was used to mark nerve fibres (green), and DAPI nuclear staining (blue) was used to 
visualize the epidermal border. Crossing fibres are indicated by arrows. All staining was 
performed 21 days after nerve injury. Scale bar represents 50 µM. A – HDAC4fl/fl contralateral 
to injury. B – HDAC4fl/fl ipsilateral to injury. C - HDAC4Nav1.8 cKO contralateral to injury. D - 
HDAC4Nav1.8 cKO  ipsilateral to injury. E – Quantification of epidermal innervation is expressed 
as fibres/mm. A marked reduction in fibre density was observed ipsilateral to injury, however 
no difference was observed between groups (n=3-5) 
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Instead, I used a different measure of nerve regeneration - the density of innervation 
in the skin of the affected paw after sciatic crush injury.  The advantage of this 
method is that it is specific for nociceptive Aδ and C-fibres, which are primarily 
Nav1.8 positive. In this model, the sciatic nerve undergoes Wallerian degeneration 
distal to the crush injury, and epidermal nerve fibres are completely lost. As the nerve 
regenerates over time, the epidermis is re-innervated. PGPG9.5 is a pan-neuronal 
marker and as expected, at twenty-one days after injury there was a significant loss 
of PGP9.5 staining on the affected side. This was not different between genotypes 
(Figure 25). 
 
Figure 25 - No difference in epidermal innervation following sciatic nerve crush 
PGP9.5 was used to mark nerve fibres (green), and DAPI nuclear staining (blue) was used to 
visualize the epidermal border. Crossing fibres are indicated by arrows. All staining was 
performed 21 days after nerve injury. Scale bar represents 50 µM A – HDAC4Nav1.8 cKO 
contralateral to injury. B – HDAC4fl/fl contralateral to injury. C - HDAC4Nav1.8 cKO ipsilateral to 
injury. D - HDAC4fl/fl ipsilateral to injury. E – Quantification of epidermal innervation is 
expressed as fibres/mm. A marked reduction in fibre density was observed ipsilateral to 




















Although more optimal experiments could be performed to have a definitive 
conclusion, from this evidence it appeared unlikely that HDAC4 has a significant role 
in mediating neurite outgrowth in vitro and for epidermal re-innervation in vivo.  
 
4.4.3 HDAC4 cKOs have similar ATF3 protein expression after sciatic 
nerve transection 
Atf3 mRNA expression was consistently dysregulated in a number of different 
experiments in HDAC4 cKOs (Figure 23). RNA levels are not always associated with 
protein expression, and the method of relative quantification used to assess mRNA 
expression means that variability in the reference sample can have implications for 
the interpretation of differences (Marguerat et al., 2012). To validate the RT-qPCR 
finding, immunohistochemistry for ATF3 protein was used.  
Twenty-four hours after sciatic nerve transection, a similar proportion of DRG profiles 
were ATF3 positive in HDAC4 cKOs when compared to littermate controls (Figure 27 
wt 83%, cKO 85%, n=3, p=0.3, Welchʼs t-test). Immunofluorescence intensity can be 
used as a surrogate for protein expression in sections that are the same thickness, 
stained at the same time and with images taken at the same exposure. Comparison 
of the immunofluorescence intensity distribution between cKOs and wildtype animals 
revealed no obvious difference in ATF3 intensity between groups (Figure 27).  
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Figure 27 - ATF3 protein expression is not different between HDAC4Nav1.8 cKOs and 
littermates 24 hours after nerve injury 
A – L4 DRG sections stained for ATF3 24 hours after sciatic nerve transection. 10x overview 
image of HDAC4fl/fl on the top, HDAC4Nav1.8 cKO below; scale bar represents 100 µM. No 
obvious difference in staining can be seen by eye. B – The proportion of ATF3 
immunoreactive neuronal profiles is the same in both groups (n=3). C – Chart shows % of 
neurons with different levels of ATF3 staining intensity. Both groups show similar intensity 
distributions, suggesting similar expression levels of ATF3.   
This data indicated that it was unlikely that ATF3 protein expression was different in 
HDAC4Nav1.8 cKOs, despite the observed difference in mRNA expression.  
4.4.4 Atf3 mRNA is not differentially regulated in HDAC4Adv cKO after 
sciatic nerve transection 
To continue to explore the evidence for the role of HDAC4 in regulating Atf3 
expression, RNA was extracted from L3 and L4 lumbar DRGs twenty-four hours after 
sciatic nerve transection from tamoxifen-treated HDAC4Adv cKOs and tamoxifen-
treated littermate controls. In contrast to the results obtained from HDAC4Nav1.8 cKOs, 



































Figure 28 - Atf3 is not differentially expressed in HDAC4Adv cKOs after sciatic nerve 
injury 
RT-qPCR analysis indicated that HDAC4Adv cKO express similar levels of Atf3 mRNA as 
littermate controls after sciatic nerve transection (n=4) 
 
4.4.5 HDAC4 is not required for sensory recovery after peripheral nerve 
injury  
Because we had failed to see differences in ATF3 protein expression, neurite 
outgrowth and epidermal re-innervation, it was deemed prudent to repeat the 
behavioural experiment. No difference in sensory recovery was observed in this 
second cohort (Figure 29).  
 
Figure 29 - No difference in sensory recovery was observed in a second behavioural 
experiment 
Scores are out of a maximum of 8 points. In contrast to the first behavioural study, no 



















Peripheral nerve regeneration is a complex tissue remodeling process that requires 
the coordination of both intrinsic and extrinsic signals (Chen et al., 2007). ATF3 is a 
transcription factor that is induced by nerve injury, and has previously been shown to 
promote regeneration and enhance the expression of growth-associated genes 
(Seijffers et al., 2006; Seijffers et al., 2007). The chance observation that Atf3 mRNA 
expression was reduced in HDAC4Nav1.8 cKOs after injury led us to investigate 
whether HDAC4 could play a role in peripheral nerve regeneration. Further 
experimental evidence failed to support the initial findings.  
One of the key problems with RT-qPCR data analysis is that it is always relative to a 
reference sample. Other fields of research have long recognized that this poses a 
challenge for interpretation of results (Lovell et al., 2011), and recently this has been 
brought to the fore in the biological sciences (Lovén et al., 2012; Marguerat et al., 
2012). In the case of Atf3, the perceived difference in expression could easily lie in 
simple arithmetic: dividing a large number over a small number can yield extremely 
different results. It is well-recognized that Atf3 is induced after injury. By comparing 
the expression after injury to that before injury, we are essentially doing just that, and 
this can be misleading. The ability to look at the absolute expression of transcripts is 
becoming increasingly easy and more affordable, with the reducing costs of next-
generation sequencing and medium-throughput technologies like the nCounter 
method. The adoption of these technologies over the more commonplace RT-qPCR 
will help to reduce some of the spurious correlations produced by relative 
quantification.  
Regardless of the technique used to measure transcriptional differences, it is 
important to validate transcriptional effects with measurements of protein abundance, 
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as mRNA expression is not always correlated to protein expression (Gygi et al., 
1999; Marguerat et al., 2012). Using immunohistochemistry, we determined that 
ATF3 staining was the same in both HDAC4Nav1.8 cKOs and wildtype controls at 24 
hours after sciatic nerve transection, suggesting that protein expression was equal. 
The use of a more quantitative technique, such as Western blotting, would provide 
further evidence for this.  As discussed above, technical problems with relative 
quantification may account for the disparity between the mRNA and protein 
expression. Another possibility is that differences in post-transcriptional mechanisms 
such as mRNA decay or translation are involved. 
Given that we did not see a difference in ATF3 protein expression, our inability to 
discern a difference in neurite outgrowth or skin re-innervation following injury are 
less surprising, but fairly significant technical limitations may also account for these 
results. The sensitivity of the in vitro neurite outgrowth assay could be improved by 
further technical optimization, for example by playing with plating density, serum and 
growth factor concentrations, and time in culture, which are all important factors in 
determining neurite outgrowth.  However, the inability to differentiate between A- and 
C-fibre sprouting remains problematic, and the optimization of a C-fibre marker for 
immunocytochemical analysis is required. Ideally HDAC4Nav1.8 cKOs and littermates 
would express GFP under the control of the Nav1.8 promoter. With this tool, one 
could directly compare only the Nav1.8-positive fibres from both groups.  
One way I attempted to work around this problem was to investigate intra-epidermal 
fibre density after peripheral nerve injury, as only C- and Aδ-fibre nociceptors exist as 
free-nerve endings in the epidermis (McMahon, 2013). The inability to see a 
difference between genotypes may result from the time-point tested (twenty-one days 
after surgery), which may have been insufficient to allow for sufficient re-innervation. 
Indeed, it is possible that the fibres that were there may have been uninjured in the 
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first place, and this would therefore be more of a test of the lesion itself rather than 
the re-growth. Other groups have used neurogenic inflammation as a measure of re-
innervation (Bester et al., 1998). This is something that we considered but did not 
pursue due to timing limitations. 
Another possibility would be the use of pan-DRG knockout animals. We 
hypothesized that HDAC4 knockout would have a consistent effect on Atf3 mRNA 
expression, and that the HDAC4Adv cKOs would also demonstrate reduced induction 
of Atf3 after injury. In this case, these animals could be used to investigate the role of 
HDAC4 in mediating neurite outgrowth without the need to optimize C-fibre specific 
markers. However, the transcriptional difference was not observed, and therefore the 
rationale to pursue neurite outgrowth and behavioural experiments was lacking. One 
interesting thing to note is that ATF3 has been shown to be regulated by estrogen-
receptor signaling (Liu et al., 2007). The assessment of Atf3 mRNA expression in the 
HDAC4Adv cKOs and littermate controls was done only seven days after the animals 
received high doses of tamoxifen, an estrogen-receptor agonist. This is a potential 
confound to the direct interpretation of the results, which is that knockout of HDAC4 
from adult sensory neurons does not affect Atf3 expression. Analysis of Atf3 
expression at a later time may help to clear up this issue. 
Behavioural data from our pilot study were consistent with the apparent reduction in 
Atf3 mRNA that we measured, and suggested that sensory recovery could be 
delayed in HDAC4Nav1.8 cKOs. However, we failed to replicate these findings in a 
second cohort. Every effort was made to ensure that animals in both groups received 
equal treatment, with surgeries performed as identically as possible, and all 
behavioural tests done blind to genotype. A power calculation using the 
experimentally determined means and population standard deviations at day 
fourteen, and the sample size of the different groups indicated that we had sufficient 
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power to detect this in both experiments (β = 0.9). Behavioural testing and 
interpretation is far from straightforward, and there are many variables in a test 
environment that may give rise to artefactual results (Crabbe et al., 1999). Whether 
the initial finding was true or a result of differences in animal husbandry or even slight 
variations in surgical procedures cannot be ruled out, nor can the lack of phenotype 
in the second group serve as a representative picture of what occurred. The 
conclusion that HDAC4 is unlikely to play a role in peripheral nerve regeneration has 
arisen from analysing evidence accumulated from multiple techniques. Further 
modification and optimization of outgrowth assays could be done, but in the absence 
of ATF3 protein differences and the inability to reproduce the behavioural findings, 




5  HDAC4 and Nociception 
5.1 Introduction 
The impact of chronic pain is staggering. Affecting approximately one in five adults, 
chronic pain is associated with a significantly reduced quality of life, as well as a 
higher risk of depression and other mental health disorders (Breivik et al., 2006; 
Gureje O, 1998). The economic costs of chronic pain reflect this: for example in the 
UK, back pain alone is responsible for an estimated £5 billion of public funds each 
year (The British Pain Society, www.britishpainsociety.org/media_faq.htm). Critically, 
current therapies to treat pain often fall short of patient expectations. In a recent 
survey, 40% of sufferers reported inadequate pain control (Breivik et al., 2006).  The 
need for improved treatment options is clear.   
When we think about pain, it is often broken down into three different types: 
nociceptive or “good pain”, which arises from direct activation of nociceptors, like 
stepping on a piece of glass; inflammatory pain, which arises as a consequence to 
local inflammation and inflammatory mediators, and which can be treated by the use 
of steroids or non-steroidal anti-inflammatory drugs; and neuropathic pain, which is 
defined as “pain caused by a lesion or disease of the somatosensory nervous 
system” (McMahon, 2013). All of these different types of pain involve common 
anatomical substrates: primary nociceptors of the DRG, spinal dorsal horn 
interneurons and descending modulatory inputs from the brainstem and higher 
cortical centers.  
Nociception is evolutionarily ancient and is critical for organisms to survive. For this 
reason, it is appropriate to model in lower species such as rodents. Tests of acute 
nociception, such as the hot plate test, have good face-, etiology- and construct-
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validity and can be translated to human nociception, for example by comparing to 
heat pain threshold measurements from quantitative sensory testing (QST). Reflex 
withdrawal assays, such as the Hargreaves test and the Von Frey test, which 
measure thermal and mechanical withdrawal thresholds, respectively, can readily be 
employed in rodents to assess hypersensitivity associated with models of chronic 
pain, for example after the injection of an adjuvant which results in long-term 
inflammation, or after nerve injury.  These measurements have been shown to be 
able to predict clinical efficacy of drugs for neuropathic pain (Kontinen and Meert, 
2002) and are valuable tools which have led to the discovery of many novel 
therapeutic targets, for example the anti-NGF therapeutic, tanezumab (Lane et al., 
2010; McMahon et al., 1995).  
Over the past few years, the high attrition rate of novel analgesics has led to some 
backlash against some of the commonly used models of nociception in rodents, and 
emphasis has been placed on the development of new models that better mirror the 
clinical situation (Rice, 2008), as well as multifactorial behavioural analyses, rather 
than relying on reflex withdrawal alone (Mogil, 2009; Mogil and Crager, 2004). The 
stavudine (d4T) model belongs to this new category of neuropathic pain models. D4T 
is a thymidine analogue used to treat HIV, and painful peripheral neuropathy is a 
common side-effect in patients (Browne et al., 1993; Smyth et al., 2007; Winston et 
al., 2005). Intravenous injection of d4T has been shown to produce a long-lasting 
mechanical hypersensitivity in rodents (Huang et al., 2013; Renn et al., 2011) and 
can recapitulate other changes that are observed in patients, such as increased 
anxiety-like behaviours, as well as length-dependent changes to peripheral 
innervation (Huang et al., 2013). The molecular mechanisms underlying this remain 
unclear, with some groups citing a role for mitochondrial dysfunction, or BDNF 
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signaling (Cui et al., 1997; Renn et al., 2011; Robinson et al., 2007). This model has 
good face- and etiology-validity and is relatively under-explored.  
Work to uncover the molecular mechanisms that contribute to chronic pain states 
may have great clinical relevance. Over the past few decades, it has become clear 
that widespread transcriptional dysregulation occurs throughout the pain neuraxis 
(LaCroix-Fralish et al., 2011), a process that is thought to contribute to the hyper-
sensitized state of the system.  Whether these changes may invoke epigenetic marks 
that allow for their persistence is a question that is only beginning to be answered 
(Denk and McMahon, 2012).  
There is growing evidence to suggest that interfering with histone deacetylase activity 
can attenuate pain-related behaviour in a number of pre-clinical inflammatory pain 
models (Bai et al., 2010; Chiechio et al., 2009; Zhang et al., 2011).  As HDAC 
inhibitors (HDACi) have been shown to have anti-inflammatory properties in other 
models (Shakespear et al., 2011) this is perhaps unsurprising. The first group to 
show efficacy of HDACi treatment in pain used repeated dosing with the HDACi MS-
275 or SAHA and demonstrated that HDACi could reduce the nociceptive phenotype 
in the second phase of the formalin test.  This was associated with increased 
acetylation of the NF-Kappa B subunit p65/RelA as well as increased expression of 
one of its target genes, mGlu2, in the spinal dorsal horn and DRG. The anti-
nociceptive effect of MS-275 was blocked with a mGlu2/3 receptor antagonist 
(Chiechio et al., 2009).  Another group, Bai et al., have shown that intrathecal pre-
treatment of the HDAC inhibitors SAHA, TSA, LAQ824, VPA and 4-PB could be anti-
nociceptive in the acute stages of a different inflammatory pain model, the Complete 
Freundʼs Adjuvant (CFA) model, though whether the effects are mediated at the 
chromatin level or by enhanced acetylation of non-histone proteins is not clear (Bai et 
al., 2010).   
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More recently, Zhang et al. determined that repeated TSA injection into the nucleus 
raphe magnus (NRM) was able to attenuate CFA-induced hypersensitivity. The effect 
was attributed to the drugʼs ability to increase acetylation at the hypoacetylated Gad2 
promoter, enhancing GAD65 expression and GABA inhibition, and thus altering 
descending pain modulation (Zhang et al., 2011). Intriguingly, this group also 
demonstrated hypoacetylation of Gad2 in a model of neuropathic pain, indicating that 
this may be a common event in chronic pain states. It will be interesting to see 
whether HDAC inhibitor treatment in the NRM will be as effective in this, and other 
models of chronic pain. A paper from Tran et al reports analgesic efficacy of 
intracerebroventricular administration of the same HDAC inhibitor, TSA, in a stress-
induced visceral pain model (Tran et al., 2012), and our group has recently shown 
that intrathecal HDAC inhibitor administration can partially prevent mechanical 
hypersensitivity associated with neuropathic pain (Denk et al., 2013). Whether this is 
mediated through the same GABAergic mechanism is not known, but this early 
evidence for the therapeutic potential of HDAC inhibitors warrants further 
investigation.  
The most commonly used HDAC inhibitors are relatively “dirty” compounds, targeting 
multiple HDACs (Bradner et al., 2010). Investigating the role of individual HDACs 
using genetic tools may shed light on the mechanisms by which HDAC inhibitors 
work to alleviate pain, putting the groundwork in place to drive the development of 
novel inhibitors with improved specificity.  
HDAC4 is a transcriptional co-repressor, known to bind to and modulate the activity 
of multiple transcription factors (Chauchereau et al., 2004; Miska et al., 1999; Ren et 
al., 2009; Stronach et al., 2011). In the adult nervous system, HDAC4 is primarily 
cytoplasmic (Darcy et al., 2010) but shows activity and NMDA-dependent shuttling in 
and out of the nucleus (Chawla et al., 2003; Sando Iii et al., 2012; Zhao et al., 2001). 
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In cortical neurons, nuclear localization of HDAC4 has been shown to regulate the 
transcription of genes associated with synaptic plasticity, including Snap25 (Sando Iii 
et al., 2012). A recent ʻmeta-analysisʼ of pain-related transcriptional changes found 
that Snap25, Vamp1 and Sv2b, genes associated with synaptic vesicle release and 
synaptic plasticity, were downregulated in multiple experiments (LaCroix-Fralish et 
al., 2011). Furthermore, our data suggest that HDAC4 is required for the expression 
of Cacna2d1 and Trpa1 in intact DRGs, as well as Ntrk1, Calca and Trpv1 in injured 
ganglia. The dysregulation of these genes may have implications for the sensory 
behaviour of HDAC4 conditional knockouts.  
Direct evidence for HDAC4ʼs involvement in sensation comes from mutant mice in 
which the deacetylase domain of HDAC4 is deleted globally, as these animals 
displayed increased latency to respond to the hot plate test (Rajan et al., 2009). Our 
data indicate that this is unlikely to be due to developmental defects in the sensory 
nervous system, as Nav1.8 cKOs display normal DRG cell size distribution and 
expression of subtype markers. Furthermore, HDAC4 has been linked to 
neuroprotection. Although the literature on this is somewhat contradictory, HDAC4 
knockdown has been shown to be neuroprotective in neurons that are undergoing 
various types of cell stress, such as toxicity and oxidative stress (Bolger and Yao 
2005, Yang 2011). Although sensory neuron death is not commonly seen in pain 
states, toxic agents such as d4T and chemotherapeutic drugs can produce painful 
neuropathies in patients. Could knockout of HDAC4 be protective in these models? 
5.2 Aims 
The aims of this chapter are to use the two sensory neuron-specific HDAC4 knockout 
lines established in Chapter 3 to determine whether HDAC4 is required for 
nociceptive behaviours in models of acute and chronic pain.  
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5.3 Methods 
All experiments were performed as described in Chapter 2.  
5.4 Results  
5.4.1 Baseline sensory behaviour and acute nociception are unaffected 
by HDAC4 deletion 
In Chapter 3 I described the effect of HDAC4 deletion on sensory neuron 
transcription. In the HDAC4Nav1.8 cKO strain, the genes Ptgs2, Scn10a, Trpa1 and 
Scn11a were downregulated and in the HDAC4Adv cKO strain there was 
downregulation of Trpa1 and upregulation of Vip, Cacna2d1, Oprm1 and P2rx3. Only 
Trpa1 and Cacna2d1 were in the top ten dysregulated genes in both strains, which 
provides good evidence that these are true HDAC4 target genes. These genes have 
been implicated in sensory processing, and it is conceivable that the transcriptional 
differences observed may give rise to altered sensory behaviour: for example, the 
downregulation of Trpa1 may imply a reduced sensitivity to TRPA1 ligands such as 
mustard oil; the upregulation of Cacna2d1 may induce hyperexcitability by increasing 
synaptic calcium levels, leading to the prolonged release of peptides and glutamate 
from primary afferent terminals onto spinal dorsal horn interneurons. Behavioural 
testing was used to assess whether these transcriptional differences may have 
functional consequences. 
Experimental bias in behavioural testing can greatly influence perceived outcomes 
(Rice, 2008). Blinding and randomization are required to enable unbiased 
assessment of behaviour. HDAC4Nav1.8 cKO were indistinguishable from HDAC4fl/fl 
(aka wildtype (wt)) littermate controls by eye and grew to similar size and mass. This 
meant that blinding to genotype was completely effective. All comparisons were 
made between similarly affected littermates.   
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To begin to address the question of whether peripheral expression of HDAC4 is 
required for nociception, it was first necessary to ensure that the knockout had 
normal motor responses, as this can be a confound to interpreting withdrawal 
reflexes. The rotarod test is a measure of learned sensory-motor integration. To 
perform well, animals need to be able to coordinate their movements. HDAC4Nav1.8 
cKO were indistinguishable from littermates on this test (mean latency (s) wt = 213.2, 
cKO = 211.8; n =1 2; p > 0.05, Welchʼs t-test) (Figure 30). 
 
Figure 30 - HDAC4 expression in Nav1.8 positive neurons is not required for baseline 
mechano- or thermo-sensation or acute nociception 
A - The rotarod test is used as a measure of motor function. Animals are placed on a rotating 
bar that accelerates from 2-38 RPM and latency to fall is recorded. (n=12, p>0.05) B – 
Mechanical sensitivity was measured by the Von Frey test, no difference was observed 
between groups (n=30, p>0.05) C – In the Hargreaves test, animals are placed on a glass 
surface and latency to withdraw from a radiant heat source is recorded (latencies = 10.9, 
12.5; p = 0.056 n = 20, Welchʼs t-test). D – To determine the hot plate response threshold, 
mice habituate for 5 minutes at 40°C, then the temperature is increased until the animal 
responds. (n=17/18, p>0.05)  E – The Paw Pressure test (Randall Selitto test) is a measure of 
mechanical nociception. The force to elicit a withdrawal response is recorded (n=10, p>0.05) 
F - The tail flick response is used to test spinal reflex-mediated nociception.  Under light 
restraint, 1 cm of the tail is immersed in a hot water bath and time to withdraw is recorded. 
(n=12, p>0.05) G – The hot plate test is used to determine thermal nociceptive responses. 



































































































































The Von Frey test was used to assess mechanosensation; no difference was 
observed between genotypes (mean threshold (g): wt = 0.60, cKO = 0.57; n = 30; p > 
0.05). Threshold responses to thermal stimuli were assessed in two ways, using the 
Hargreaves test and using a variation of the hot plate test, in which animals are 
allowed to move freely on the hot plate while the temperature ramps at a constant 
rate of 2.5°C/minute. Because of the slow rate at which the temperature increases, 
this version of the hot plate test is thought to rely more on C-fibre than A-fibre 
function and has been shown to be sensitive to lower doses of analgesics than the 
traditional method (Hunskaar et al., 1986; Tjolsen et al., 1991). On both tests, there 
was a slight trend toward a greater latency to respond in the cKO group but this was 
not statistically significant (Hargreaves mean latency: wt = 10.9; cKO =12.6; n = 20; p 
= 0.056; hot plate threshold (ºC): wt = 45.6, cKO = 46.0; n = 17/18; p > 0.05).  
The Randall-Sellitto test (Paw Pressure test) was used to determine threshold to 
respond to a noxious mechanical stimulus. No difference was observed between 
groups (mean response threshold (g): wt = 104.3, cKO = 105; n = 10; p > 0.05). The 
tail flick test and the hot plate tests were used to determine noxious thermosensitivity. 
A slight trend toward increased latency to respond to the hot plate was observed in 
cKOs but this was not statistically significant (mean 52.5ºC latency (s) wt = 9.1, cKO 
= 10.8; n = 10; p> 0.05; mean 55ºC latency (s) wt = 6.3, cKO = 7.4; n = 10; p > 0.05). 
No difference was observed in the tail flick test (mean 49ºC latency (s) wt = 6.6, cKO 
= 6.6; n = 12; mean 52ºC latency (s) wt = 1.9, cKO = 2.0; n = 12).  
A similar battery of tests was performed on the HDAC4Adv cKOs and littermate 
controls. Due to time constraints the rotarod test was omitted. In keeping with the 
results from the HDAC4Nav1.8 cKOs, HDAC4Adv cKOs were indistinguishable from 
littermate controls, and had no significant difference in adult body mass or general 
locomotor activity in the cage (Figure 3, personal observation).  No differences 
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between genotypes were seen using the Von Frey test, or an adapted version of the 
Hargreaves test in which the animals are lightly restrained and a single paw is placed 
over a radiant heat source until the paw is withdrawn. The tail flick test similarly did 
not reveal any differences in thermosensation between genotypes. These results 
indicate that HDAC4 is not required for baseline sensory perception or acute 
nociception.  
 
Figure 31 - HDAC4 cKO in adult sensory neurons does not affect acute nociception or 
sensory perception 
A – HDAC4Adv cKOs and littermates had no obvious morphological differences, and body 
weight was approximately equal in adult animals (n=7-10). B – Mechanical withdrawal 
thresholds were not different between groups (n=7-10). C & D – No difference in thermal 
withdrawal latency was observed on either the Hargreaves test or the Tail Flick test (n=7-10) 
 
One strange result was observed in the Randall-Selitto test. This test was performed 
by a very experienced animal technician, and in his hands both the HDAC4Adv cKOs 
and littermates were unresponsive and nearly all of them went to the cut-off value of 
150 g (thresholds = 149, 148 g; n=7-10) (Figure 32). This was repeated in a second 




















































































pressure or cold stimulation at 10ºC (n=9-11). Other animals from the colony that had 
not been treated with tamoxifen were tested and found to have responses in the 
normal range on these tests (withdrawal thresholds of 105.6 g and 12.8 s, n=4). 
Although preliminary, these experiments suggest that tamoxifen may be analgesic for 
noxious mechanical and cold sensing.  
 
Figure 32 - Noxious mechanical and cold sensing are impaired after tamoxifen 
treatment 
A – In the first behavioural cohort, almost all tamoxifen treated animals went to the cut-off 
value of 150 g (n=7-10) B – A second cohort of animals showed the same impairment (n=9-
11). Interestingly, other animals from the colony that had not been treated with tamoxifen 
responded within the normal range (p<0.01, n=4). C – Cold sensing was also impaired in 
tamoxifen treated animals compared to untreated controls (p<0.01).  
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5.4.2 Mechanical hypersensitivity after nerve injury does not require 
HDAC4 expression from the Nav1.8 population of sensory 
neurons 
Transcriptional differences in the DRG were observed in both HDAC4Nav1.8 cKO and 
HDAC4Adv cKO across a number of injury models, including the partial sciatic nerve 
ligation (PSL) model and sciatic nerve transection (SNT) model. By comparing these 
two studies directly, it emerged that two peptides that regulate behavioural sensitivity 
were differentially regulated in both models and in both strains of HDAC4 cKOs: Sst, 
the gene that encodes somatostatin and Calca that encodes CGRP. Interestingly, Sst 
was upregulated in both models (HDAC4Nav1.8 FC = 2.64; HDAC4Adv FC = 3.08 both 
compared to WT ipsilateral controls), and Calca was downregulated (HDAC4Nav1.8 FC 
= 0.79; HDAC4Adv FC = 0.75 compared to WT ipsilateral controls) (Figure 33). These 
changes would be consistent with reduced behavioural sensitivity, as SST 
administration in the spinal cord is analgesic (Chrubasik et al., 1984) and CGRP 
expression levels have been shown to associate tightly with responses to noxious 
thermal stimuli, with lower expression levels linked to reduced sensitivity (Mogil, 
2005).   
Table 9 - Top ranked gene expression changes after nerve injury, by unadjusted p-
value. FC are calculated against HDAC4fl/fl ipsilateral controls. 
 
HDAC4Nav1.8 PSL! HDAC4Adv SNT!
p! FC! p! FC!
Sst! 0.00! 2.64! Scn10a! 0.01! 0.70!
Trpv1! 0.03! 0.74! Calca! 0.01! 0.75!
Gfap! 0.03! 0.36! Cacna2d1! 0.02! 1.39!
Ntrk1! 0.04! 0.81! Trpa1! 0.02! 0.71!
Atf3! 0.05! 0.48! Gad2! 0.02! 1.51!
Ccl2! 0.05! 0.69! Vip! 0.03! 1.47!
Npy! 0.05! 0.33! Ngf! 0.03! 1.42!
Calca! 0.09! 0.79! Sst! 0.07! 3.08!
Gabra5! 0.10! 0.82! Scn9a! 0.08! 0.89!




Figure 33 - Sst and Calca are differentially expressed in both strains of HDAC4 cKO 
after nerve injury 
Charts were generated from PCR array card data and represent fold changes compared to 
similarly affected wildtype controls (either after PSL or SNT). Stats and fold changes as listed 
in Table 9. 
The partial sciatic nerve ligation (PSL) model is a well-characterized model of 
neuropathic pain that is sensitive to drugs that show clinical efficacy such as 
gabapentin (Tanabe et al., 2005). The model consists of tying a suture around 
approximately one-third of the sciatic nerve, which results in long-lasting 
hypersensitivity to mechanical stimuli and is associated with transcriptional 
dysregulation (Kusuda et al., 2011). To test whether the transcriptional changes 
observed in HDAC4 cKOs may have consequences for nerve injury evoked 
hypersensitivity, the PSL model was induced in HDAC4Nav1.8 cKOs. Although results 
from the control group were somewhat variable, PSL resulted in mechanical and 
thermal hypersensitivity to a similar extent in both HDAC4Nav1.8 cKOs and littermates 
(Figure 34). A repeated measures ANOVA of Von Frey data confirmed significant 
main effects of both day (F(4,48=11.65, p<0.0001, n=8) and paw (F(1,70)=36.30, 

































































n=8).  A comparison of day x paw x genotype was not statistically significant, 
although a main effect of genotype was observed (F(1,14)=8.22, p=0.012, n=8) likely 
due to the surprisingly high withdrawal thresholds in the wildtype group on days 7 
and 14.  Similarly, thermal hypersensitivity was observed in both groups with a 
significant main effect of day (F(4,48)=11.65, p<0.0001, n=7) and a significant 
interaction of day x paw (F(4,48)=3.19, p=0.021, n=7), but no significant effect of 
genotype. This indicates that despite altered transcriptional regulation, HDAC4 does 
not contribute to behavioural sensitization in this model of neuropathic pain.  
 
Figure 34 - HDAC4Nav1.8 cKOs develop mechanical and thermal hypersensitivity after 
partial sciatic nerve ligation 
Behavioural hypersensitivity after PSL was tested using the Von Frey and Hargreaves tests. 
A & B – HDAC4Nav1.8 cKO (A) and HDACfl/fl (B) show significant mechanical hypersensitivity 
after PSL; *** = main effect of paw (3-way RM ANOVA, F(1,70)=36.3, p<0.0001, n=8). A 
significant main effect of genotype was observed (F(1,14)=8.22, p=0.012) likely due to the 
surprisingly high PWTs in the wt group on days 7 and 14. C – Thermal hypersensitivity was 
not different between groups. D – Both groups developed mild but statistically significant 











































































5.4.3 HDAC4 is dispensable for the development of mechanical 
hypersensitivity in the d4T model 
Stavudine, also known as d4T, is a thymidine analogue used to treat patients with 
HIV in the developing world. Its use has been associated with the development of 
painful peripheral neuropathy in patients (Browne et al., 1993; Smyth et al., 2007; 
Winston et al., 2005). Animal models recently been developed to unravel the 
mechanisms underlying this (Huang et al., 2013; Renn et al., 2011), and evidence 
from our lab indicates that prophylactic treatment with HDAC inhibitors can lessen 
the hypersensitivity associated with d4T treatment (Denk et al., 2013). D4T-
associated neuropathy was initiated in mice via a single tail vein injection of the drug, 
and behaviour was assessed using the Von Frey test. Bilateral mechanical 
hypersensitivity was observed at day three and persisted throughout the testing 
period (Figure 35), but no difference in mechanical hypersensitivity was observed 
between genotypes. A repeated measures ANOVA of Von Frey data confirmed a 
significant main effect of day (F(5,85)=10.46, p<0.0001, n=9-10), but no effect of 
genotype. D4T neuropathy has been shown to result in C-fibre loss from the 
epidermis (Huang et al., 2013). Twenty-eight days after D4T treatment, IENFD was 
assessed in cKOs and wildtype littermates, but no difference in epidermal innervation 
was observed (Figure 35). This indicates that HDAC4 is not required for D4T-
associated neuropathy or mechanical hypersensitivity. 
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Figure 35 - D4T results in mechanical hypersensitivity that does not require peripheral 
expression of HDAC4 
A – A single intravenous injection of 10 mg/kg d4T resulted in long-lasting mechanical 
hypersensitivity in HDAC4fl/fl and HDAC4Nav1.8 cKO animals (RM ANOVA main effect of day, 
F(5,85)=10.46, p<0.0001, n=9-10), but this was not different between groups. B – Area under 
the curve (AUC) analysis of withdrawal threshold data showed no significant difference 
between genotypes. C Skin sections stained for PGP9.5. Arrows indicate nerve fibres. Scale 
bar represents 50 μM. D - For each animal, intraepidermal nerve fibre density was calculated 
as the average number of fibres/average length of three sections. No significant difference 
was found between genotypes (n=3, Welchʼs t-test). 
 
5.4.4 Loss of HDAC4 alters responses to inflammation 
Some of the largest gene expression changes that we observed in HDAC4 cKOs 
came from experiments with an inflammatory component. For example, when 
dissociated sensory neurons from HDAC4Nav1.8 cKOs were cultured with a high level 
of NGF, rapid downregulation of Ntrk1, Calca, Trpv1 and Vgf was observed. 
Similarly, after Complete Freundʼs adjuvant injection into the hindpaw, HDAC4Adv 
cKOs also had profoundly reduced expression of the majority these genes. 
Interestingly, analysis of the top dysregulated genes in the two inflammatory 
conditions revealed many other consistently differentially regulated transcripts, 
including the gene encoding the voltage-gated sodium channel, Nav1.8 (Scn9a), the 
ATP-gated purinoreceptor 3 gene (P2rx3), GTP cyclohydrolase 1 (Gch1), Atf3, and 
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Figure 34 - D4T results in mechanical hypersensitivity that does not require peripheral 
expression of HDAC4 
A – A single intravenous injection of 10 T resulted in long-lasting mechanical 
hyp rsens ivity in HDAC4fl/fl and HDAC4Nav1.8 cKO animals (n=9-10, p<0.001 RM ANOVA 
overall effect of day B – Both two-way RM ANOVA and area under the curve analysis of 
withdrawal threshold data showed no significant difference between genotypes. C Skin 
sections stained for PGP9.5. Arrows indicate nerve fibres. Scale bar represents 50 μM. D - 
For each animal, intraepidermal nerve fibre density was calculated as the average number of 
fibres/average length of three sections. No significant difference was found between 
genotypes (n=3, Welchʼs t-test). 
 
5.4.4 Loss of HDAC4 alters responses to inflammation 
Some of the largest gene expression changes that we observed in HDAC4 cKOs 
came from experiments with an inflammatory component. For example, when 
dissociated sensory neurons from HDAC4Nav1.8 cKOs were cultured with a high level 
of NGF, rapid downregulation of Ntrk1, Calca, Trpv1 and Vgf was observed. 
Similarly, after Complete Freundʼs adjuvant injection into the hindpaw, HDAC4Adv 
cKOs also had profoundly reduced expression of the majority these genes. 
Interestingly, analysis of the top dysregulated genes in the two inflammatory 
conditions revealed many other consistently differentially regulated transcripts, 







































































































the voltage-gated potassium channel subunit Kcns1 (Figure 36). With the exception 
of the differential regulation of the voltage-gated channels, the majority of these 
changes would predict reduced nociception. This suggested that HDAC4 may have a 
role in mediating peripheral sensitization.  
 
Figure 36 - HDAC4 cKO have differential gene expression after inflammatory 
stimulation 
Genes that were differentially expressed between wildtype and HDAC4 cKO after 
inflammatory stimulation are listed by unadjusted p-value (Welchʼs t-test, n=4). FC=fold 
change compared to similarly affected wildtype controls. Genes on both lists appear in bold. 
With the exception of Reg3b, all of the expression changes were consistent between the two 
experiments. Reg3b is not well expressed in the DRG, so the inconsistency between the 
experiments may be due to detection limits.  
To begin to address this, we used calcium imaging to determine whether capsaicin 
responses may be reduced in HDAC4Nav1.8 cKO sensory neurons after incubation 
with 50 ng/mL NGF overnight. Interestingly, fewer HDAC4Nav1.8 cKO cells responded 
to capsaicin, although maximal responses were similar between genotypes (Figure 
37). This suggests that the reduced Trpv1 expression may be caused by selective 
HDAC4Nav1.8 NGF! HDAC4Adv CFA!
p! FC! p! FC!
Ntrk1! 0.00! 0.37! Ntrk1! 0.00! 0.32!
P2rx3! 0.01! 0.41! Trpv1! 0.00! 0.44!
Gch1! 0.01! 0.37! Trpa1! 0.00! 0.39!
Trpv1! 0.01! 0.41! Calca! 0.00! 0.22!
Ngf! 0.01! 2.04! Gch1! 0.00! 0.40!
Calca! 0.02! 0.35! Pdyn! 0.00! 2.51!
Kcns1! 0.02! 0.36! Kcns1! 0.00! 0.49!
Scn9a! 0.02! 1.78! P2rx3! 0.00! 0.43!
Atf3! 0.02! 0.72! P2rx4! 0.00! 0.57!
Sst! 0.02! 8.04! Hcn2! 0.00! 0.60!
Reg3b! 0.03! 31.11! Ctss! 0.01! 0.36!
Vip! 0.03! 17.24! Oprm1! 0.01! 1.54!
Gad2! 0.05! 4.76! Scn3a! 0.02! 0.30!








loss in a population of cells, rather than downregulation in all TRPV1 positive 
neurons. Immuocytochemical analysis of TRPV1 would help to verify this hypothesis.   
 
Figure 37 - Fewer HDAC4Nav1.8 cKO DRG neurons respond to capsaicin 
Representative fluorescence traces from calcium imaging experiments. C=100 nM capsaicin, 
K=50 mM KCl. A – HDAC4fl/fl neurons 18-24 hours after culturing with 50 ng/mL NGF B – 
HDAC4Nav1.8 cKO neurons. Similar capsaicin and KCl responses were seen in both groups, 
however fewer HDAC4 cKO neurons respond to capsaicin. C – Mean peak capsaicin 
response is plotted as a percentage of the maximal response to KCl. No difference was 
observed between groups (n=5-6 coverslips). D – Cells were considered capsaicin 
responsive if their capsaicin peak was >20% of the KCl peak response. Significantly fewer 
HDAC4Nav1.8 neurons responded to capsaicin treatment (n=5-6 coverslips, p=0.0001 Fisherʼs 
exact test, p=0.02 Welchʼs t-test) 
 
To address whether this might also affect behavioural outcomes, the carrageenan 
model was used to model acute inflammation in HDAC4Nav1.8 cKOs and littermates. 
Lambda-carrageenan was injected into the paw, and latency to respond to radiant 
heat was measured at various time points over a twenty-four hour period. In contrast 
to the marked differences in capsaicin sensitivity in vitro, no differences were 
observed on this test (RM ANOVA main effect of genotype, F(1,10)=2.06, p=0.18, n=6) 
(Figure 38).  
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36). This suggests that the reduced Trpv1 expression may be caused by selective 
loss in a population of cells, rather than downregulation in all TRPV1 positive 
neurons. Im tochemical analysis of TRPV1 would he p to verify this hypothesis.   
 
Figure 36 - F  DAC4 cKO DRG neurons respond to capsaicin
Representativ  fl rescence traces from cal ium imaging experiments. C=100 nM capsaicin, 
K=50 mM KCl. A – HDAC4fl/fl neurons 18-24 hours after culturing with 50 ng/mL NGF B – 
HDAC4Nav1.8 cKO neurons. Similar capsaicin and KCl responses were seen in both groups, 
however fewer HDAC4 cKO neurons respond to capsaicin. C – Mean peak capsaicin 
response is plotted as a percentage of the maximal response to KCl. No difference was 
observed between groups (n=5-6 coverslips). D – Cells were considered capsaicin 
responsive if their capsaicin peak was >20% of the KCl peak response. Significantly fewer 
HDAC4Nav1.8 neurons re ponded to capsaicin treatment (n=5-6, p=0.0001 Fisherʼs exact test, 
p=0.02 Welchʼs t-test)
 
To address whether this might also affect behavioural outcomes, the carrageenan 
model was used to model acute inflammation in HDAC4Nav1.8 cKOs and littermates. 
Lambda-carrageenan was injected into the paw, and latency to respond to radiant 








































































































Figure 38 - HDAC4 is not required for thermal hypersensitivity in the carrageenan 
model of acute inflammatory pain 
Withdrawal from a radiant heat source following intraplantar carrageenan injection does not 
require peripheral expression of HDAC4 (RM ANOVA main effect of genotype, F(1,10)=2.06, 
p=0.18, n=6). 
 
Because the onset of the behavioural changes occur rapidly, it is possible that this 
primarily reflects direct sensitization of nociceptors through post-translational 
modification. I hypothesized that a more long-term model may be more sensitive to 
transcriptional dysregulation and may reveal differences between the genotypes. The 
Complete Freundʼs Adjuvant (CFA) model is used to model arthritis pain. Injection of 
CFA into the plantar surface of the hindpaw leads to prolonged edema and 
hypersensitivity that recovers over a matter of weeks, and is associated with altered 
transcription in the DRG (Chang et al., 2010). Behavioural responses require the 
Nav1.8 population of sensory neurons, as ablation of these neurons with diphtheria 
toxin leads to a marked absence of CFA-induced hypersensitivity (Abrahamsen et al., 
2008).  Comparison of CFA responses in HDAC4Nav1.8 cKOs and littermates revealed 
a modest and statistically significant reduction in thermal hypersensitivity in the cKOs 

















Figure 39 - HDAC4 is required for thermal hypersensitivity after CFA 
A – Average thermal withdrawal thresholds from HDAC4Nav1.8  cKO are represented in red and 
HDAC4fl/fl littermates are in grey. Thermal hypersensitivity after CFA injection is significantly 
attenuated in HDAC4Nav1.8 cKO animals (RM ANOVA main effect of genotype, F(1,8) =16.18, 
p=0.004, n=5). B – Area under the curve (AUC) analysis of data in A. C – Similar to the 
results from HDAC4Nav1.8 cKO, knockout of HDAC4 from adult sensory ganglia results in 
significantly attenuated thermal hypersensitivity after CFA (RM ANOVA main effect of 
genotype, F(1,15)=5.56, p=0.03, n=6-12). D – AUC analysis of data in C 
 
Similarly, CFA injection in HDAC4Adv cKOs was also associated with attenuated 
thermal hypersensitivity (RM ANOVA, main effect of genotype F(1,15)=5.56, p=0.032, 
n=6 cKOs, =12 littermates).  
Interestingly, both HDAC4 cKO strains exhibited a similar degree of mechanical 
hypersensitivity when compared to littermate controls (Figure 40). A repeated 






















































































p=0.04 RM ANOVA 
p=0.03 RM ANOVA 
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confirmed significant effects of both day (F(5,45)=8.09, p<0.0001, n=5-6) and paw 
(F(1,9)=45.61, p<0.0001, n=5-6) as well as a significant interaction of day x paw 
(F(5,45)=3.23, p=0.014, n=5-6), but no effect of genotype was found. Similarly, 
repeated measures ANOVA analysis of Von Frey data from HDAC4Adv cKOs and 
littermates confirmed significant effects of both day (F(5,80)=8.79, p<0.0001, n=6-12) 
and paw (F(1,16)=147.09, p<0.0001, n=6-12) as well as a significant interaction of day 
x paw (F(5,80)=5.46, p<0.0001, n=6-12). No effect of genotype was observed. This 
provides evidence that HDAC4 may be involved specifically in mediating thermal 
sensitization following inflammation.  
 
Figure 40 - HDAC4 is not required for mechanical hypersensitivity after CFA 
Mechanical hypersensitivity was measured by the Von Frey test. A – Both HDAC4Nav1.8 cKOs 
and littermates developed mechanical hypersensitivity after CFA injection (RM ANOVA 
significant effect of day (F(5,45)=8.09, p<0.0001); paw (F(1,9)=45.61, p<0.0001); significant 
interaction of day x paw (F(5,45)=3.23, p=0.014, n=5-6). B – HDAC4Adv cKOs and littermates 
developed mechanical hypersensitivity after CFA injection, which was not different between 
groups (RM ANOVA significant effect of day (F(5,80)=8.79, p<0.0001); paw (F(1,16)=147.09, 
p<0.0001); significant interaction of day x paw (F(5,80)=5.46, p<0.0001, n=6-12). 
Following these behavioural results, I looked at the regulation of other HDAC4 target 
genes to see whether they may also be differentially regulated after injury and in the 
HDAC4 cKO.  Interestingly, wildtype animals showed downregulation of two known 
HDAC4 targets, Hdac9 and Snap25 after CFA injection (FC=0.74, =0.68, p=0.03, 
n=4, Welchʼs t-test between wt contra and wt ipsi). These genes were not 
























































contra vs cKO ipsi) (Figure 41). No significant difference was observed in the 
expression of the HDAC4 target gene calcium/calmodulin kinase 2a (Camk2a) 
(FC=0.83, =0.66, n=4, p>0.05). Interestingly, validation of the previously 
characterized Trpv1 expression changes revealed that Trpv1 was not differentially 
regulated after injury in wildtype animals, however it was significantly downregulated 
in HDAC4Adv cKOs (FC=0.95, =0.20, p<0.01 between wt ipsi and cKO ipsi).  A similar 
trend was observed with the HDAC4 target gene, Vglut1 (FC=0.74, =0.46, p>0.05 
between wt ipsi and cKO ipsi, p=0.006 cKO contra vs cKO ipsi). Whether these 
changes may underlie the behavioural phenotype observed remains to be confirmed.  
 
Figure 41 - Known HDAC4 targets are transcriptionally dysregulated after CFA 
RT-qPCR analysis of previously described HDAC4 target genes. Significant differential 
regulation was observed for Hdac9, Snap25a and Trpv1 in HDAC4Adv cKO after CFA 
compared to HDAC4fl/fl littermates, but Camk2a, Sst and Vglut1 were not significantly 







































5.4.5 Peripheral expression of HDAC4 is not required for most pain 
modalities  
Histone deacetylase inhibitors are analgesic in a number of pre-clinical pain models, 
however the endogenous function of histone deacetylases in nociceptive pathways is 
far from clear (Denk and McMahon, 2012). Mutation of the deacetylase domain of 
HDAC4 affects thermosensation in the absence of obvious physiological defects 
(Rajan et al., 2009). Furthermore, knockdown of HDAC4 in vitro results in striking 
neurodegeneration and enhanced sensitivity to toxic insults (Li et al., 2012). Because 
of this we hypothesized that knockout of HDAC4 in sensory neurons, both in a 
subpopulation during development, and in all sensory neurons in adulthood, would 
alter sensitivity to noxious and innocuous stimuli. Interestingly, the phenotype of the 
conditional mutants was remarkably selective, indicating that HDAC4 is largely not 
required for innocuous sensation or nociception, with the exception of thermal 
hypersensitivity in a model of chronic inflammatory pain.  
This suggests that the defect in thermosensation observed in HDAC4 deacetylase 
domain mutants does not depend on peripheral expression of HDAC4. Instead, this 
phenotype may arise as a consequence of defects in other areas of the nociceptive 
pathways, for example the interneurons of the spinal dorsal horn or the descending 
modulatory neurons of the midbrain. Conditional deletion of HDAC4 from these 
populations may provide evidence for this.  
One of the hypotheses that I investigated was that HDAC4 could be neuroprotective 
in a model of toxic neuropathy, the d4T model.  This was supported by evidence in 
the literature indicating that knockdown of HDAC4 could reduce sensitivity to 
oxidative and excitotoxic stress (Bolger and Yao, 2005; Yang et al., 2011). I failed to 
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see any difference in the mechanical hypersensitivity and skin innervation in 
HDAC4Nav1.8 cKOs in this model, indicating that HDAC4 does not play a role in 
mediating the toxic effects of d4T and may not be important for oxidative stress 
signaling in vivo. Indeed, evidence for HDAC4 in mediating neuronal cell death has 
been conflicting. Although some studies claim HDAC4 knockdown is protective 
(Bolger and Yao, 2005; Yang et al., 2011), others indicate that knockdown causes 
neuronal cell death (Chen and Cepko, 2009; Li et al., 2012; Majdzadeh et al., 2008; 
Sando Iii et al., 2012). Neither of these claims have been substantiated by conditional 
knockout studies. In the past year, two studies have been published in which HDAC4 
was knocked out of three different neuronal populations, none of which showed 
alterations to neuronal survival or gross brain morphology (Kim et al., 2012; Price et 
al., 2012). The absence of overt sensory behaviour differences after conditional 
ablation of HDAC4 in adult sensory neurons implies that developmental 
compensation cannot account for the lack of phenotype. Gross dissection, RNA and 
protein extraction also indicated that HDAC4Adv cKOs were unlikely to have fewer 
neurons as DRGs were of a similar size and yielded similar amounts of RNA and 
protein (data not shown). Immunohistochemical analysis, for example staining for 
pro-apoptotic proteins such as caspases, alongside DRG cell counts would give a 
definitive answer to this question. 
One surprising finding was that animals treated with tamoxifen were insensitive to 
cold and noxious mechanical stimulation, although heat and innocuous sensation 
were intact. This effect was independent of genotype, and a small group of animals 
that were not tamoxifen treated showed normal responses on these tests. Previous 
studies have indicated that tamoxifen treatment does not alter pain behaviour (Lau et 
al., 2011). However, sex-differences in pain behaviour are well-documented (Berkley, 
1997), and estradiol and tamoxifen administration in ovariectomized rats has been 
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shown to reduce responses in the formalin test (Kuba et al., 2006). It is important to 
note that though the experimenter was blind to genotype, he was aware of the 
treatment status of all animals. The inclusion of a vehicle treatment group, and 
testing the same animals before and after treatment would clarify the role of 
tamoxifen in modulating noxious mechano- and cold sensation.  
5.4.6 Loss of HDAC4 is associated with altered transcriptional 
regulation in inflammatory states, and reduced sensitivity to 
capsaicin in vitro 
I previously reported that Ntrk1, Calca and Trpv1 are consistently downregulated in 
both strains of HDAC4 cKOs after injury. Interestingly, the largest expression 
changes were seen in models with an inflammatory component, namely incubation 
with high levels of NGF and intraplantar CFA. Both Calca and Trpv1 expression have 
been shown to be downstream of NGF signaling through the TrkA receptor (Amaya 
et al., 2004; Donnerer et al., 1992), and CGRP can also be influenced directly by 
TRPV1 activity (Nakanishi et al., 2010). Thus, altered intracellular signaling after 
TrkA activation may underlie the transcriptional change. Another possibility could be 
that HDAC4 interacts directly with the receptors, which is necessary for downstream 
activation of target genes. As discussed in Chapter 3, further work to explore the 
mechanism of this transcriptional change is required.  
I hypothesized that Trpv1 downregulation would affect responses to the TRPV1 
ligand, capsaicin. Capsaicin binding to TRPV1 causes cation influx, which can be 
monitored using a calcium sensitive fluorescent dye. Interestingly, in knockout 
sensory neurons the response sizes were similar, but fewer neurons responded to 
capsaicin stimulation. This suggests that the reduced mRNA expression reflects the 
loss of TRPV1 from a subpopulation of neurons, rather than overall reduction of 
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message, which may be expected to produce smaller calcium responses in the same 
number of neurons. It will be necessary to validate this finding with 
immunocytochemistry. Another explanation for this finding could be loss of TRPV1 
neurons due to cell death. Although no obvious difference in cell numbers or 
morphology was observed in DRG cultures, it will be important to investigate this as a 
potential mechanism because of the reported link between HDAC4 and neuronal 
survival in the literature.  
Interestingly, a comparison of changes between the two inflammatory models 
indicated that there are more genes that are differentially expressed in both strains of 
HDAC4 cKOs. These included P2rx3, Scn9a, Kcns1, Gch1 and Atf3. With the 
exception of Atf3, all of these genes have been shown to be important for pain 
processing, which is why they appear on the PCR array card. For example, single-
nucleotide polymorphisms in the Gch1 gene can predict pain sensitivity in some 
human populations, and inhibition of its activity has been shown to be analgesic in 
animal pain models (Latremoliere and Costigan, 2011). It will be interesting to 
determine whether these transcriptional changes give rise to functional differences in 
HDAC4 cKO sensory neurons, for example by testing the sensitivity of HDAC4 cKO 
neurons to P2xr3-selective ligands using calcium imaging. Further work to validate 
these targets is required. 
5.4.7 Thermal hypersensitivity is attenuated in HDAC4 cKOs in a model 
of chronic inflammatory pain, but not after nerve injury or acute 
inflammation 
Thermal hypersensitivity was attenuated in HDAC4 cKOs after intraplantar CFA 
injection, but not after carrageenan injection or in the partial sciatic nerve ligation 
(PSL) model of neuropathic pain. In the case of carrageenan, this may be due to the 
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requirement of de novo transcription for phenotypic differences. Carrageenan 
injection leads to an almost immediate decrease in withdrawal latencies, and 
responses are monitored in a short time frame after injection, from two to twenty-four 
hours. Transcriptional changes may occur on the order of hours, but protein turnover 
takes much longer, on the order of days, particularly if proteins need to be trafficked 
from distant cell bodies to nociceptor terminals (Djouhri et al., 2001). It is likely, 
therefore, that the nociceptor sensitization in this model is due to post-translational 
modification of receptors by inflammatory mediators, rather than transcriptional 
alterations. This would be consistent with the idea that transcriptional alterations 
resulting from HDAC4 loss are implicated in the conditional knockout phenotype. 
It is somewhat surprising that no difference in thermal hypersensitivity was observed 
after PSL, particularly as expression changes, including reduced Calca expression 
and increased Sst expression in cKOs, would predict this (Chrubasik et al., 1984; 
Mogil, 2005). The small window afforded to observe differences (decreased latency 
of approximately two seconds compared to the contralateral paw) may have limited 
our capacity to detect behavioural differences in this model. The use of a model that 
exhibits a greater degree of thermal hypersensitivity, for example the chronic 
constriction injury, may reveal an additional role for HDAC4 in mediating thermal 
hypersensitivity after nerve injury.   
It is important to note that it has been reported that the Nav1.8 population of sensory 
neurons is dispensable for hypersensitivity in the partial sciatic nerve ligation model 
(Abrahamsen et al., 2008). In this study, Abrahamsen et al drove diphtheria toxin 
expression from the Nav1.8 promoter to selectively ablate this population of neurons. 
However, it is now known that the expression of Nav1.8 is much more wide-spread 
than was originally reported in this paper, which calls into question whether the 
diphtheria targeting in these animals was efficient (Shields et al., 2012). Additionally, 
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other studies employing the Nav1.8-Cre line have shown differences in neuropathic 
pain behaviour using the PSL model (Emery et al., 2011; Samad et al., 2010). 
Further investigation of the mechanism through which HDAC4 contributes to thermal 
hypersensitivity, and possibly the use of other neuropathic pain models may help to 
clarify this.  
The primary phenotypic change we observed in HDAC4 cKOs was reduced thermal 
hypersensitivity following CFA injection. This was seen in animals with HDAC4 
deletion in a subset of primary neurons from embryonic stages, as well as in animals 
with targeted ablation in adulthood. This indicates that the difference is not likely to 
be due to a developmental process. Thermal hypersensitivity after inflammation has 
been shown to depend on TRPV1 activation, and indeed I demonstrated that HDAC4 
cKOs express much lower levels of Trpv1 mRNA, which may underlie the 
behavioural change. It is important to note, however, that a number of other pain-
related transcripts were differentially expressed in HDAC4 cKOs after inflammation, 
some of which were not changed in the neuropathic pain models. Whether these 
genes may play a more important role than Trpv1 in mediating this phenotype 
remains to be seen. Interestingly, previously described HDAC4 targets, Snap25 and 
Hdac9, were downregulated in wildtype animals after CFA, and HDAC4Adv cKOs 
were spared from these changes. Snap25 is required for neurotransmitter release, 
and is transcriptionally dysregulated in multiple tissues and pain models (LaCroix-
Fralish et al., 2011) and Hdac9 has been shown to be differentially regulated by NGF 
(Guo et al., 2011). It will be interesting to determine whether these genes may also 
be involved in peripheral sensitization.  
Inflammation causes the release of many different inflammatory mediators that rely 
on intracellular signaling cascades to produce altered transcriptional regulation and 
peripheral sensitization. HDAC4 activity and subcellular localization is dependent on 
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many of the same signaling cascades, for example it can be trafficked from the 
nucleus in a calcium/calmodulin kinase-dependent manner. One of the main 
questions that remains regards the localization of HDAC4 in the sensory neurons of 
the DRG both before and after injury. Investigation of the subcellular localization 
could be done with immunohistochemistry, however given the lack of specific 
antibodies this remains a challenge. Instead, I have been attempting to optimize a 
subcellular fractionation protocol for Western blotting to look for the relative 
enrichment of HDAC4 in the cytoplasm or nucleus after CFA. Pilot data indicates that 
it may, indeed, be trafficked into the cytoplasm after injury, however further validation 
of this is required.  
Alternatively, investigation of GFP-tagged HDAC4 in cell lines that are responsive to 
inflammatory mediators, for example PC12 cells, may provide a good model system 
to investigate HDAC4 shuttling. If this cell line can recapitulate some of the 
transcriptional differences observed after CFA, it may also be of use to investigate 
the mechanism of HDAC4 action through the introduction of mutated and/or tagged 
forms of HDAC4, and the use of luciferase constructs.  
Finally, it may be interesting to try novel HDACi, for example MC1568 that targets the 
MEF2 binding site of class IIa HDACs and causes enforced repression of MEF2 
activity (Nebbioso et al., 2009). Use of this drug would allow us to determine whether 
this domain of HDAC4 contributes to the cKO phenotype. Other pharmacological 
approaches, for example inhibition of ERK/MAPK to look for upstream signals 
regulating HDAC4 function, or inhibition of histone demethylation may also help to 
further elucidate the mechanism of HDAC4, potentially providing novel therapeutic 
approaches to modulate thermal hypersensitivity. 
 
136 
6 General Discussion 
The role of histone deacetylases and other chromatin modifying proteins is a vast 
and largely unexplored area of sensory neuron biology. Evidence that HDACs are 
involved in pain and regeneration are accumulating (Geranton, 2011; Rivieccio et al., 
2009). In this thesis I aimed to explore the function of HDAC4 using a conditional 
knockout approach. In the first data chapter, I reported the validation of two novel 
strains of HDAC4 knockouts with selective ablation of the enzyme in a subpopulation 
of sensory neurons during embryonic development and in all sensory neurons in 
adulthood. With these animals I established that HDAC4 was required for 
transcriptional regulation in response to injury and at rest.  
In the second data chapter I investigated whether HDAC4 could play a role in 
peripheral nerve regeneration. I found that, despite regulating Atf3 mRNA 
expression, it was not likely to be required for appropriate re-innervation. 
In the final data chapter I determined that sensory neuron expression of HDAC4 was 
not required for innocuous or acutely noxious sensation, or for the development of 
mechanical hypersensitivity in a number of pain models. Interestingly, HDAC4 was 
required for full expression of thermal hypersensitivity in a model of chronic 
inflammatory pain. This was associated with reduced sensitivity to capsaicin in vitro 
and many transcriptional changes, including robust downregulation of the gene 
encoding the heat- and capsaicin-sensitive channel, TRPV1.  
Many questions remain and many of these results require further validation. 
Throughout my project I used RT-qPCR array cards as a medium-throughput 
screening tool to determine whether HDAC4 loss may have implications for the 
transcriptional regulation of genes that we know are involved in innocuous and 
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noxious cutaneous sensation. This was a very productive experimental route, 
yielding many interesting results within each study.  However, at times these results 
failed to hold up to closer scrutiny. For example, Atf3 mRNA expression was found to 
be differentially regulated in conditional knockouts after nerve injury but protein 
expression appeared to be largely normal. There are many reasons that may account 
for this, which were discussed in more detail in Chapter 4; the take-home message is 
that transcriptional data cannot be used as a direct proxy for protein expression. In 
order to confidently determine the role of HDAC4 in sensory neurons, validation at 
the protein and functional levels are required.  
That said, despite the negative data surrounding the Atf3 and regeneration story 
there remain some interesting observations and questions. Although ATF3 protein 
expression did not appear to be different using immunohistochemistry, Western 
blotting would provide more robust evidence for this. In addition, the lack of 
observable differences on outgrowth measures could be due to technical limitations: 
the inability to differentiate small from large fibres in the culture study; and looking at 
an inappropriate time point for skin re-innervation. Further optimization of histological 
outcomes may help to answer whether HDAC4 does have an effect on neurite 
outgrowth. I attempted to inject a tracer distal to the crush site in order to trace 
neurons that had re-grown but this proved to be non-specific: almost every neuron 
picked up the tracer even when it was injected farther than the nerves could have 
been expected to regenerate. Direct imaging of C-fibre markers within the crushed 
nerve and through the lesion would provide the best evidence and could be achieved 
with some experimental optimization. 
Another intriguing finding came from my attempt to repeat the sciatic nerve crush 
study in a cohort of HDAC4Adv cKOs.  I was required to terminate the study after one 
week because three out of five conditional knockouts autotomized. None of the seven 
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controls autotomized. This could be due to chance but it remains an odd observation 
and potentially interesting to explore further.  
I have started to accumulate data on the role of HDAC4 in mediating responses to 
inflammation, and there is a hint that it may be due to altered regulation of TRPV1. 
Further experiments to elucidate the molecular mechanisms underlying this are 
required. Trpv1 mRNA is highly downregulated in HDAC4 cKOs, which is curious 
because HDAC4 is thought to negatively regulate transcription, and thus, in its 
absence, one may expect enhanced transcription of target genes. This may imply 
that HDAC4 is required for the regulation of a negative transcription factor, such as 
REST or members of the NFKB subfamily. On the other hand, a cytoplasmic 
mechanism cannot be ruled out. It is possible that cytoplasmic HDAC4 is required to 
promote sumoylation or deacetylation of TRPV1 or other mediators that regulate its 
expression. In this case the loss of HDAC4 could alter the activity of these proteins. 
The first step to begin to address this will be to determine the subcellular localization 
of HDAC4 in inflammatory pain models. Dissociated DRG cultures treated with high 
levels of NGF mimicked many of the transcriptional changes observed after 
intraplantar CFA injection and were associated with reduced capsaicin sensitivity. 
This model system may provide a good starting point for uncovering the molecular 
mechanisms of HDAC4. Experiments to separate protein lysates into cytoplasmic 
and nuclear fractions have begun to be optimized and results look promising. Once 
this has been established, work to determine the expression and activity of putative 
nuclear or cytoplasmic targets can be investigated in more detail.  
One interesting avenue that I did not discuss in my thesis was our attempt to deliver 
Cre intrathecally using adeno-associated viral vectors in order to target spinal cord 
neurons. Although this strategy was not successful in our first attempts, further 
optimization of this method, for example the use of higher titre vectors or a different 
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administration protocol, may provide new insights into the role of HDAC4 in other 
areas of the nervous system. This would also be a translatable strategy for other 
floxed mouse lines, streamlining some of the breeding time required for most 
experiments with transgenic animals. 
Indeed, one of the key issues I encountered over the course of my project was the 
length of time required to prepare for animal experiments. The use of complementary 
strategies, for example pharmacological tools that interfere with HDAC4-MEF2 
activity or other model systems to discern the function of HDAC4 e.g. cell lines that 
are easily transfected with tagged forms of the protein, may have sped up some of 
the progress. However, because my project was largely led by the behavioural 
phenotyping of conditional mutants, mechanistic studies were initiated only 
subsequent to validation of in vivo function. This is a high-risk, high-gain approach, 
although it is ʻsafeʼ in that the results are compelling and fairly definitive. Future 
studies to determine the role of novel targets would benefit from the use of higher-
throughput screening methods. 
HDAC inhibitors and other drugs that target chromatin modifying and transcriptional 
regulatory proteins are already being used clinically to treat cancer. Work to 
characterize the function of these molecules in diverse systems will provide a rational 
basis for the broader application of these therapies. 
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Appendix 1: Bioinformatics analysis of HDAC4 expression 
and function 
6.1 Introduction 
With the adoption of high-throughput technologies an increasing amount of data and 
resources have been made available online. Gene expression data, known and 
predicted protein-protein and protein-DNA interactions, motif finding algorithms – all 
of these can be accessed from the comfort of your own home (for example, while you 
are writing your thesis).  
This chapter has its origins in curiosity about HDAC4 expression in the dorsal root 
ganglion, but the further I delved into the abyss of online bioinformatics tools, the 
more addicted I became to taking advantage of the mounds of data that have been 
produced to identify novel, conserved downstream targets. The power of this analysis 
comes from the use of genome-wide expression data, which allows for a completely 
unbiased approach to target identification, generating data-driven hypotheses that 
can be investigated experimentally.  
 
6.2 Aims 
The aims of this chapter are to describe HDAC4 expression in the dorsal root 
ganglion and spinal cord, and to explore its putative function using published data 
and online bioinformatics tools. 
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6.3 Results  
6.3.1 Characterising Hdac mRNA expression in the DRG and spinal 
cord 
From the earliest characterization of the class IIa HDACs (HDAC4, -5, -7 and -9), 
their expression has been shown to be tissue-specific, enriched in the brain, skeletal 
muscle and heart (Grozinger et al., 1999) and HDAC4 has been shown to have 
important roles in all of these tissues (Miska et al., 2001; Sando Iii et al., 2012; Vega 
et al., 2004). Darcy et al characterized the expression of HDAC4 in the brain, and 
showed that it was widely expressed across multiple areas and neuronal subtypes 
(Darcy et al., 2010). This suggests that HDAC4 is likely to be expressed in other 
neurons, such as spinal cord interneurons and primary sensory neurons of the dorsal 
root ganglia. To date, there has been no specific characterization of the HDAC 
expression profile in sensory neurons of the dorsal root ganglia or the spinal cord. To 
examine this, I made specific RT-qPCR primers for each of the HDACs and looked 
for their expression in naïve adult DRG and spinal cord. In addition, I obtained data 
from a next generation sequencing experiment that was performed by a post-doctoral 
fellow in our lab (Dr. Ana Antunes-Martins) to compare the expression profiles in 
mouse and rat tissue (Figure 1).  
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Figure 42 - HDAC mRNA expression profiles in mouse and rat DRG and spinal cord 
Mouse expression data (A and C) comes from RT-qPCR experiments using HDAC specific 
primers. Abundance is relative to a housekeeping gene, Ywhaz. Rat expression data (B and 
D) are normalized read counts from next-generation sequencing (NGS) performed by Dr. Ana 
Antunes-Martins. Black lines represent median expression values (A=0.022, B=393, C=0.04, 
D=567). Interestingly, Hdac4 expression is above the median value in both mouse (A) and rat 
(B) DRG, but not in spinal cord (C and D). Similar HDAC expression profiles are obtained in 
the DRG in both species, with HDAC2, -3, -4 and -11 showing the highest expression, though 
there is divergent expression of HDAC5. The spinal cord has a very different profile from the 
DRG in both species, with strong expression of HDAC3 and -11 in both mouse and rat, but 
some divergent patterns. These may represent true differences between the species, or may 
be attributed to the different techniques used to obtain data. 
 
Interestingly, in adult mouse DRG, Hdac4 was the most highly expressed class IIa 
HDAC, suggesting a primary role of HDAC4 in mediating class IIa HDAC activities in 
this tissue. It was also expressed above the median value for all HDACs in the rat, 
however, Hdac5 was more expressed, which may represent a species difference in 
HDAC expression or may reflect differences in the techniques used to obtain data. 
For example, because of the high homology of HDAC4 and HDAC5 and because the 
rat genome is considerably less well-characterized than the mouse genome, it is 































































































































































































































Hdac5. RT-qPCR and protein analysis would help to determine whether this is the 
case.  
In the spinal cord, Hdac4 was expressed below the median in both species. 
Surprisingly, the class IV HDAC, HDAC11, was highly expressed in both tissues in 
both species. Very little is known about this HDAC, and its strong expression in these 
tissues may indicate a role in neuronal function. 
6.3.2 Localising Hdac4 expression using the Allen Brain Atlas 
The Allen Brain Atlas (www.alleninstitute.org) is an online resource that integrates 
gene expression and neuroanatomical data using RNA probe based in situ 
hybridization. Images of mouse spinal cord at post-natal day four (P4) are often 
accompanied by DRG sections, and allow for anatomical mapping of genes of 
interest within both structures (http://mousespinal.brain-map.org). Having established 
the expression of Hdac4 mRNA in the mouse DRG, I sought to determine whether it 
might show subpopulation-specific expression, using the menthol-sensitive Trpm8 as 
a positive control (Figure 43). 
144 
 
Figure 43 - Hdac4 mRNA is expressed in all DRG sensory neurons at P4 
Images from the Allen Brain Atlas. Top row, Hdac4, bottom row Trpm8. C and D are 
magnified views of the boxes in A and B. A – Hdac4 has weak expression throughout the 
neuropil of the spinal cord, and is moderately expressed in the DRG. B – Trpm8 shows 
strong, DRG specific expression, and no discernable expression in the spinal cord. C – No 
neuronal subtype-specificity is observed for Hdac4 in the DRG. D – Sparse localization of 
Trpm8 indicates subtype-specific expression  
Hdac4 mRNA showed diffuse expression in both the DRG and neuropil of the spinal 
cord. In contrast, Trpm8 was strongly localized to what appeared to be individual 
neurons of the DRG and could not be detected in the spinal cord. This is in line with 
the RT-qPCR and NGS data, indicating that HDAC4 is expressed in these tissues. 
(Mean Trpm8 read count in spinal cord = 8.8 +- 3.5; in L4 DRG = 2503.4 +- 217.7; 
Mean Hdac4 read count in spinal cord = 474.2 +- 51; in L4 DRG = 649.7 +- 13.5). In 
addition, this evidence suggests that HDAC4 is not preferentially expressed in 







6.3.3 Using published chromatin immunoprecipitation and next 
generation sequencing data (ChIP-Seq) to investigate HDAC4 
function 
Chromatin immunoprecipitation in combination with next-generation sequencing 
(ChIP-Seq) allows for genome-wide characterization of transcription factor binding. 
To date, one group has published ChIP-Seq data of HDAC4 binding sites in the 
cerebellum (Li et al., 2012). In this paper, the authors compared HDAC4 occupancy 
between wildtype and ataxia telangiectasia knockout mice (Atm-/-) in which HDAC4 
accumulates in the nucleus. To determine whether HDAC4 may be involved in 
mediating transcription through direct binding of genes known to be important for 
sensory neuron function, we performed a conservative bioinformatics analysis of this 
data, using tools on the Galaxy server (https://usegalaxy.org/). First, SoLID FASTQ 
files were uploaded to Galaxy from the European Nucleotide Archive 
(http://www.ebi.ac.uk/ena/) then converted to Sanger FASTQ files using the FASTQ 
Groomer tool (Blankenberg et al., 2010). Reads were mapped to the mm9 build of 
the mouse genome (Waterston et al., 2002) using the Bowtie tool (Langmead et al., 
2009) which has recently been evaluated against other short-read mapping 
algorithms and consistently performed extremely well (Hatem et al., 2013). Following 
alignment, files were re-formatted into both BAM and BED formats for further 
analysis using SAM tools (Li et al., 2009). Peak calling was performed on BED files 
using the MACS peak calling algorithm, with wildtype input chromatin as the 
background control (Zhang et al., 2008). Finally, the Intersect tool was used to 
determine overlapping peaks between wildtype and Atm-/- samples. This yielded 
1299 overlapping regions (Figure 44). Using the profile annotations tool, 294 of these 
regions were found to map to known UCSC genes. GPAT was used to annotate this 
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list  (http://bips.u-strasbg.fr/GPAT/) (Krebs et al., 2008) and 212 genes were 
identified (Chromosome 10 results in Table 10, full list in Appendix 3: GPAT output 
file from ChIP-Seq analysis). Surprisingly, this list contained two genes that are 
essential for analgesia: the mu-opioid receptor, Oprm1 and Cacna2d1 that encodes 
the voltage-gated calcium channel subunit α2δ. Interestingly, Cacna2d1 is 
upregulated in both strains of HDAC4 cKOs (FC=1.32, 1.55, Chapter 3), suggesting 
that HDAC4 may directly bind Cacna2d1 in the DRG to regulate its expression. 
Oprm1 was also upregulated in HDAC4Adv cKOs (FC=1.75). This evidence suggests 
that HDAC4 may recognize similar targets in the brain and in the dorsal root 
ganglion. Although these transcriptional differences were not associated with overt 
behavioural differences at baseline, this suggests that HDAC4 cKOs would be more 
sensitive to gabapentinoids and morphine analgesia, indicating that modulation of 
HDAC4 could provide novel mechanisms of pain management.  
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Figure 44 - Bioinformatics analysis of published HDAC4 ChIP-Seq data, partial chromosome 16 alignment 
Figure from IGB viewer. Data from Li et al 2012. Peaks were discovered with the MACS algorithm, using 10% input chromatin as a control. The WT Peaks 
line shows the aligned HDAC4 peaks from wildtype cerebellum, in blue. ATM-/- Peaks are from ATM knockout cerebellum, shown in yellow on grey 
background. Many more peaks are found in the ATM knockout as HDAC4 accumulates in the nucleus. Intersect represents peaks that overlap between both 














Table 10 - Sample of GPAT output - Overlapping Peaks on Chromosome 10 
feature_ID chromosome min_pos max_pos gene_ID gene_name strand start_position TSS_distance 
MACS_peak_859 chr10 3527715 3527773 NM_001039652 Oprm1 - 3557940 30196 
MACS_peak_870 chr10 4860285 4860320 NM_153399 Syne1 + 4795848 64454 
MACS_peak_949 chr10 20179615 20179737 NM_013875 Pde7b - 20444874 265198 
MACS_peak_952 chr10 21977836 21977908 NM_009018 Raet1c + 21893707 84165 
MACS_peak_953 chr10 21977933 21978018 NM_009018 Raet1c + 21893707 84268 
MACS_peak_1005 chr10 31516009 31516040 NM_001013411 Nkain2 - 32609721 1093697 
MACS_peak_1062 chr10 42242152 42242186 NM_017472 Snx3 + 42221859 20310 
MACS_peak_1113 chr10 50686748 50686787 NM_011376 Sim1 + 50615456 71311 
MACS_peak_1124 chr10 51864278 51864336 NM_011282 Ros1 - 51915050 50743 
MACS_peak_1224 chr10 72841935 72841971 no_match         
MACS_peak_1289 chr10 94334776 94334830 NM_018797 Plxnc1 - 94407212 72409 
MACS_peak_1365 chr10 107614275 107614309 NM_027892 Ppp1r12a + 107599455 14837 
MACS_peak_1369 chr10 107998262 107998296 NM_009306 Syt1 - 108448031 449752 
MACS_peak_1402 chr10 114174430 114174494 NM_146241 Trhde - 114238426 63964 
MACS_peak_1403 chr10 114546341 114546392 NM_173391 Tph2 - 114622078 75712 
MACS_peak_1429 chr10 123113356 123113391 NR_045514 Fam19a2 + 122701131 412242 
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6.3.4 Bioinformatics analysis of HDAC4 targets using publicly available 
microarray and ChIP-Seq data reveals three conserved HDAC4 
target genes 
To continue to explore the role of HDAC4 I looked for published microarray data from 
experiments in which HDAC4 had been overexpressed or knocked down on the GEO 
website. Two datasets were used for further analysis: one from overexpression of 
full-length HDAC4 in cardiomyocytes (Kehat et al., 2011) and a dataset from cultured 
embryonic cortical neurons that overexpressed a constitutively nuclear form of 
HDAC4 (Sando Iii et al., 2012). Using the GEO2R tool, I looked for differential 
regulation between controls and HDAC4 over-expressing samples. A list of 
differential genes was discovered for each study, and these three lists were input to a 
Venn Diagram making tool, genevenn.sourceforge.net. Three genes were found in all 
three lists: Cacna2d1, palmdelphin (Palmd), a lipid-raft associated protein involved in 
cell-shape control, and the adenylyl cyclase-associated protein 2 (Cap2) (Figure 45). 
Interestingly, all three genes show similar expression profiles to HDAC4, with 
overexpression in the brain, heart and skeletal muscle (Lattin et al., 2008; Wu et al., 
2009) (Figure 46).  CAP2 and CACNA2D1, like HDAC4, have both been linked to 
cardiac and skeletal muscle defects (Effendi et al., 2013; Fuller-Bicer et al., 2009; 
Peche et al., 2013), although the interaction of these proteins has never been tested 
experimentally. This evidence would suggest that HDAC4 may coordinate the 
appropriate expression of these genes through direct DNA binding.  
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Figure 45 – Venn Diagram from genevenn.sourceforge.net 
Gene lists were generated from published microarray and annotated ChIP-Seq data 
(Figure 3). OE = over-expression. The dataset in red came from over-expression of 
full-length HDAC4 in cardiomyocytes (Kehat et al., 2011), green from over-
expression of a constitutively nuclear form of HDAC4 in cultured cortical neurons. 
The three overlapping genes were Cacna2d1, known to be involved in pain signaling 





Figure 45 – Venn Diagram from genevenn.sourceforge.net 
Gene lists were generated from published microarray and annotated ChIP-Seq data 
(Figure 3). OE = over-expression. The dataset in red came from over-expression of 
full-length HDAC4 in cardiomyocytes (Kehat et al., 2011), green from over-
expression of a constitutively nuclear form of HDAC4 in cultured cortical neurons. 
The three overlapping genes were Cacna2d1, known to be involved in pain signaling 





Figure 46 - HDAC4 and putative targets show similar tissue expression profiles, figure adapted from BioGPS.org 
Tissue types are represented by individual bars, with tissues from similar origins represented in the same colour. The length of the bars 
indicates expression level.  
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Figur  46 - HDAC4 and putative targets show similar tissue expression profiles, figur  adapted from BioGPS.org 
Tissue types are repr s nted by individual bars, with tissues from similar origins represented in the same colour. The length of the bars 










6.3.5 Pathway analysis of putative HDAC4 targets confirms known 
functions of the protein  
Pathway analysis programs make predictions about protein function by taking 
advantage of published data for example, yeast-two-hybrid protein-protein interaction 
studies, microarrays in various disease models, and literature searching for 
commonly co-published keywords.  
To try to dig out new functions of HDAC4, I input the three gene lists into Ingenuity 
Pathway Analysis (Figure 47). Although this did not provide much new insight into the 
function of HDAC4, it did confirm current understanding of its function, for example 
highlighting enrichment for gene ontology (GO) terms such as development, 
morphology and cell-to-cell signaling, all of which have been shown to be affected by 
HDAC4 overexpression and knockout studies (Miska et al., 2001; Sando Iii et al., 
2012; Vega et al., 2004), and gave me confidence that the gene lists that I generated 




Figure 47 - Example of results from Ingenuity Pathway Analysis 
Individual gene ontology terms are listed above, and adjusted p-values for each of 
the three datasets are charted. The expression gene lists are represented in darker 
blue, and the ChIP list is in light blue. The threshold p-value is in black. Gene lists 
show enrichment for GO annotations including development, cell assembly and cell 
signaling, which is in line with known HDAC4 functions from knockout and 
overexpression studies. 
 
6.3.6 Network analysis of both experimentally validated and predicted 
HDAC4 targets identifies HDAC4 and NGF as upstream regulators 
and NF-Kappa B proteins as possible intermediaries 
Ingenuity pathway analysis can also be used to identify whether genes of interest can 
be linked together in functional networks. Analysis of the three HDAC4 targets 
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identified from bioinformatics analysis (Cap2, Palmd and Cacna2d1) as well as the 
genes that were commonly dysregulated in the HDAC4 cKOs (Trpa1, Ntrk1, Trpv1 
and Calca) yielded a highly interconnected network associated with the GO terms 
Organismal Injury and Abnormalities, Neurological Disease, Cell Death and Survival. 
The top upstream regulators predicted were NGF (4/8 genes, p=3.9e-7) and HDAC4 
(3/8 genes, p=5.84e-6).  Interestingly, the NF-Kappa B (NFKB) complex was highly 
interconnected with the target genes, and had a central position in the network, 
indicating that it may be involved in mediating some of the expression differences 
observed (Figure 48). 
 
Figure 48 - Ingenuity Pathway Analysis Network 
Target genes are in bold. Shapes are indicative of protein function. Solid lines represent direct 
interactions, dashed lines represent indirect interactions. Interestingly, the NF-Kappa B 
complex is quite central to the network, and interacts with most of the target genes. Whether 
HDAC4 exerts its transcriptional regulatory function in sensory neurons through interaction 




The use of bioinformatics tools is straightforward, cheap and allows for rapid 
hypothesis generation. Further work to investigate the targets identified in this 
manner may provide novel insights into the role of HDAC4. 
6.4.1 Expression data shows Hdac4 mRNA in DRG and spinal cord 
To my knowledge, there has been no direct characterization of HDAC isoform 
expression in the DRG and spinal cord, although a number of studies have 
investigated the analgesic potential of HDAC inhibitors. I used RT-qPCR and NGS 
sequencing data to look at the relative expression of these molecules, and 
discovered that in the mouse, HDAC4 is the most highly expressed class IIa HDAC in 
the DRG, which suggests that it may subserve most of the class IIa functions in this 
tissue. Interestingly, the relatively understudied class IV HDAC, HDAC11, is the most 
highly expressed HDAC in the rat DRG and spinal cord, and is very highly expressed 
in the mouse as well. Further investigation into the role of this HDAC may be 
warranted.  
The Allen Brain Atlas is an excellent tool to determine mRNA localization in the 
developing and adult mouse spinal cord and brain. As an added bonus, P4 spinal 
cord sections often are flanked by DRGs, and can be investigated for sensory neuron 
expression of genes of interest. Using the Allen Brain Atlas, I determined that HDAC4 
mRNA was expressed widely in the DRG though at a moderate level, compared to 
TRPM8, the menthol and cold-sensitive TRP channel that is known to have subtype 
specific expression. Confirmation of these findings at the protein level and in adult 
animals is required, however the lack of suitable antibodies for 
immunohistochemistry remains problematic.  
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6.4.2 “Conserved” HDAC4 targets include Cacna2d1, an important pain 
gene 
The majority of published microarray data is now available through the GEO website, 
which has an incredibly easy-to-use analysis tool, GEO2R. Using these tools, along 
with a number of software tools in the Galaxy suite, I generated three lists of putative 
HDAC4 targets based on overexpression studies and an HDAC4 ChIP-Seq study.  
Three genes overlapped between these datasets, Cacna2d1, Palmd and Cap2.  
Interestingly, all of them showed very similar tissue-specific expression patterns, 
providing further evidence for their coordinated expression, and suggests that 
HDAC4 may be involved in regulating the expression of these genes in all of these 
tissues. 
Cacna2d1 is a voltage-gated calcium channel subunit that has repeatedly been 
linked to pain, and is the target of one of the most common drug classes for 
neuropathic pain, the gabapentinoids (Dickenson and Ghandehari, 2007). 
Interestingly, we observed upregulation of Cacna2d1 in both strains of HDAC4 cKOs, 
although this was not associated with altered baseline sensory behaviour (Chapter 
5). It would be interesting to determine whether this may alter the excitability of 
sensory neurons, or the sensitivity of the animals to gabapentinoids. Validation of this 
finding at the protein level would be required before undertaking this course of work. 
CAP2 and PALMD are relatively underexplored proteins, although it was very 
surprising to discover that CAP2 mutations are associated with very similar 
pathologies as HDAC4 mutations. To date, no one has explored the possible link 
between these proteins. HDAC4 regulation of Cap2 mRNA expression through direct 
association with chromatin represents a novel potential mechanism that could 
underlie cardiomyopathies and skeletal muscle defects.  
157 
This analysis was very conservative, reducing the amount of false positives as much 
as possible through the use of overlapping gene lists. However, it must be noted that 
9788 HDAC4-positive peaks were discovered in the wildtype cerebellum using the 
MACS algorithm, which may represent true HDAC4 binding sites that simply are not 
shared with the ATM knockout.  
Furthermore, our analysis was restricted to binding sites within annotated gene 
regions, but there may be true HDAC4 binding sites that do not lie within genes. 
Indeed, other studies that look for transcription binding sites can look as far as 100 
kb away from transcription start sites for cis-regulatory regions (Bruce et al., 2009). 
Further investigation of these data may reveal other HDAC4 target genes.  
6.4.3 Network analysis confirms known functions of HDAC4 in tissue 
development, morphology and cell-to-cell signaling, and suggests 
a role for NF-Kappa B interactions in mediating transcriptional 
effects 
Pathway analysis and network generating tools are useful for making predictions 
about protein function and interactions. I used Ingenuity Pathway Analysis to search 
for novel functions of HDAC4 using the gene lists I generated from published 
microarray and ChIP-Seq studies. This provided a sanity check at the end of these 
investigations, confirming enrichment for genes in these lists for functions that are 
known to be associated with HDAC4 such as tissue and cellular morphology and 
development (Vega et al., 2004; Villavicencio-Lorini et al., 2013; Williams et al., 
2010) as well as neuronal function and cell-to-cell signaling (Sando Iii et al., 2012). 
Interestingly, analysis with a refined list of genes identified HDAC4 as an upstream 
regulator, and suggested that the NFKB complex may be involved in mediating some 
of these changes as it was highly interconnected with many HDAC4 targets. HDAC4 
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siRNA has previously been reported to reduce NFKB transcriptional activity (Usui et 
al., 2012), and a number of papers have shown that NFKB proteins can modulate 
behavioural hypersensitivity (Sun et al., 2006; Wei et al., 2007; Zang et al., 2010). 
Co-immunoprecipitation of HDAC4 with NFKB proteins, and measuring NFKB activity 
in both the wildtype and conditional knockout would provide evidence for this 
interaction.  
This naïve bioinformatic analysis proves the utility of these freely available tools, and 
has provided good supporting evidence for the role of HDAC4 in mediating Cacna2d1 
transcription through direct chromatin association and repression, a result we could 
not have derived from our simple transcriptional expression study. It will be 
interesting to investigate this with ChIP-qPCR. Furthermore, this analysis has 
identified NF-Kappa B proteins as putative HDAC4 targets which may underlie the 
reduced transcription observed in HDAC4 cKOs after injury. Work to validate this 
may help to elucidate the mechanism through which HDAC4 modulates sensory 
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Appendix 2: Bioinformatics analysis parameters 
Table 11 - Bowtie Alignment Parameters 
Input Parameter Value 
Will you select a reference genome from your history or use a built-in index? indexed 
Select a reference genome /galaxy/data/mm9/bowtie_index/mm9 
Is this library mate-paired? single 
FASTQ file 27: FASTQ Groomer on data 7 
Bowtie settings to use full 
Skip the first n reads (-s) 0 
Only align the first n reads (-u) -1 
Trim n bases from high-quality (left) end of each read before alignment (-5) 0 
Trim n bases from low-quality (right) end of each read before alignment (-3) 5 
Maximum number of mismatches permitted in the seed (-n) 0 
Maximum permitted total of quality values at mismatched read positions (-e) 70 
Seed length (-l) 28 
Whether or not to round to the nearest 10 and saturating at 30 (--nomaqround) Round to nearest 10 
Number of mismatches for SOAP-like alignment policy (-v) -1 
Whether or not to try as hard as possible to find valid alignments when they exist (-y) Do not try hard 
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Report up to n valid alignments per read (-k) 1 
Whether or not to report all valid alignments per read (-a) Do not report all valid alignments 
Suppress all alignments for a read if more than n reportable alignments exist (-m) -1 
Write all reads with a number of valid alignments exceeding the limit set with the -m 
option to a file (--max) 
False 
Write all reads that could not be aligned to a file (--un) False 
Whether or not to make Bowtie guarantee that reported singleton alignments are 'best' 
in terms of stratum and in terms of the quality values at the mismatched positions (--
best) 
doBest 
Maximum number of backtracks permitted when aligning a read (--maxbts) 800 
Whether or not to report only those alignments that fall in the best stratum if many 
valid alignments exist and are reportable (--strata) 
Do not use strata option 
Override the offrate of the index to n (-o) -1 
Seed for pseudo-random number generator (--seed) -1 
Suppress the header in the output SAM file False 
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Table 12 - MACS peak-finding parameters 
Experiment Name MACS in Galaxy 
Paired End Sequencing single_end 
ChIP-Seq Tag File 
30: SAM-to-BAM on data 26: 
converted BAM 
ChIP-Seq Control File 
42: SAM-to-BAM on data 40: 
converted BAM 
Effective genome size 2700000000.0 
Tag size 25 
Band width 300 
Pvalue cutoff for peak detection 1e-05 
Select the regions with MFOLD high-confidence enrichment ratio against 
background to build model 
32 
Parse xls files into into distinct interval files False 
Save shifted raw tag count at every bp into a wiggle file no_wig 
Use fixed background lambda as local lambda for every peak region False 
3 levels of regions around the peak region to calculate the maximum lambda as 
local lambda 
1000,5000,10000 
Build Model create_model 
Diagnosis report no_diag 
Perform the new peak detection method (futurefdr) False 
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Appendix 3: GPAT output file from ChIP-Seq analysis 
feature_ID chromosome min_pos max_pos gene_ID gene_name strand start_position TSS_distance 
MACS_peak_41 chr1 10592022 10592094 NM_177834 Cpa6 - 10710024 117966 
MACS_peak_114 chr1 22562733 22562819 NM_183018 Rims1 - 22812563 249787 
MACS_peak_119 chr1 24618337 24623028 no_match         
MACS_peak_244 chr1 53298693 53298724 NM_153556 Pms1 - 53353840 55132 
MACS_peak_296 chr1 66451937 66451980 NM_008632 Mtap2 + 66221902 230056 
MACS_peak_300 chr1 67366481 67366517 no_match         
MACS_peak_311 chr1 70605410 70605476 NM_025728 Spag16 + 69998188 607255 
MACS_peak_314 chr1 71125910 71125974 NM_007525 Bard1 - 71149546 23604 
MACS_peak_319 chr1 72742935 72742972 NM_176980 Ankar - 72747138 4185 
MACS_peak_320 chr1 72743061 72743095 NM_176980 Ankar - 72747138 4060 
MACS_peak_324 chr1 73900119 73900166 NR_045311 6030407O03Rik - 73911040 10898 
MACS_peak_337 chr1 78511600 78511643 NM_026713 Mogat1 + 78507634 3987 
MACS_peak_358 chr1 82744083 82744119 NM_029409 Mff + 82721492 22609 
MACS_peak_389 chr1 93116722 93116761 NM_016894 Ramp1 + 93076398 40343 
MACS_peak_609 chr1 133333857 133333914 NM_001081011 Srgap2 - 133423938 90053 
185 
MACS_peak_621 chr1 138115036 138115070 NM_028872 5730559C18Rik - 138130857 15804 
MACS_peak_742 chr1 162958354 162958390 NM_173424 Zbtb37 - 162964390 6018 
MACS_peak_778 chr1 172504407 172504445 NM_001109985 Nos1ap - 172519980 15554 
MACS_peak_811 chr1 182866962 182866997 NM_010094 Lefty1 + 182865169 1810 
MACS_peak_830 chr1 190802224 190802300 NM_172650 Kctd3 - 190831719 29457 
MACS_peak_842 chr1 195054003 195054111 NM_001044751 Hsd11b1 - 195068554 14497 
MACS_peak_859 chr10 3527715 3527773 NM_001039652 Oprm1 - 3557940 30196 
MACS_peak_870 chr10 4860285 4860320 NM_153399 Syne1 + 4795848 64454 
MACS_peak_949 chr10 20179615 20179737 NM_013875 Pde7b - 20444874 265198 
MACS_peak_952 chr10 21977836 21977908 NM_009018 Raet1c + 21893707 84165 
MACS_peak_953 chr10 21977933 21978018 NM_009018 Raet1c + 21893707 84268 
MACS_peak_1005 chr10 31516009 31516040 NM_001013411 Nkain2 - 32609721 1093697 
MACS_peak_1062 chr10 42242152 42242186 NM_017472 Snx3 + 42221859 20310 
MACS_peak_1113 chr10 50686748 50686787 NM_011376 Sim1 + 50615456 71311 
MACS_peak_1124 chr10 51864278 51864336 NM_011282 Ros1 - 51915050 50743 
MACS_peak_1224 chr10 72841935 72841971 no_match         
MACS_peak_1287 chr10 92363657 92363691 no_match         
MACS_peak_1289 chr10 94334776 94334830 NM_018797 Plxnc1 - 94407212 72409 
MACS_peak_1365 chr10 107614275 107614309 NM_027892 Ppp1r12a + 107599455 14837 
186 
MACS_peak_1369 chr10 107998262 107998296 NM_009306 Syt1 - 108448031 449752 
MACS_peak_1402 chr10 114174430 114174494 NM_146241 Trhde - 114238426 63964 
MACS_peak_1403 chr10 114546341 114546392 NM_173391 Tph2 - 114622078 75712 
MACS_peak_1429 chr10 123113356 123113391 NR_045514 Fam19a2 + 122701131 412242 
MACS_peak_1471 chr11 3547495 3547533 NR_002322 Tug1 - 3547536 22 
MACS_peak_1475 chr11 5127047 5127079 NM_032396 Kremen1 - 5161613 34550 
MACS_peak_1489 chr11 9252974 9253008 NM_178259 Abca13 + 9091944 161047 
MACS_peak_1596 chr11 34440916 34440951 NM_033374 Dock2 - 34597325 156392 
MACS_peak_1609 chr11 39125133 39125187 no_match         
MACS_peak_1613 chr11 40551695 40551732 NM_026023 Nudcd2 + 40547143 4570 
MACS_peak_1652 chr11 51269256 51269290 NM_153393 Col23a1 + 51103421 165852 
MACS_peak_1673 chr11 57116144 57116235 NM_001252403 Gria1 + 56826547 289642 
MACS_peak_1719 chr11 70794600 70794639 NM_007573 C1qbp - 70796528 1909 
MACS_peak_1785 chr11 90400104 90400242 NM_011505 Stxbp4 - 90499422 99249 
MACS_peak_1786 chr11 90400305 90400381 NM_011505 Stxbp4 - 90499422 99079 
MACS_peak_1787 chr11 90400408 90400451 NM_011505 Stxbp4 - 90499422 98993 
MACS_peak_1807 chr11 94443982 94444020 NM_153807 Acsf2 - 94463100 19099 
MACS_peak_1826 chr11 100668946 100668979 NM_011489 Stat5b - 100683884 14922 
MACS_peak_1841 chr11 103044907 103044948 NM_019679 Fmnl1 + 103032451 12476 
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MACS_peak_1842 chr11 104393573 104393611 NM_145436 Cdc27 - 104411934 18342 
MACS_peak_1848 chr11 105267800 105267837 NM_172568 Mar-10 - 105318049 50231 
MACS_peak_1885 chr11 114560471 114560517 NM_053273 Ttyh2 + 114536781 23713 
MACS_peak_1893 chr11 119327933 119327965 no_match         
MACS_peak_1937 chr12 7933008 7933052 no_match         
MACS_peak_1979 chr12 16754618 16754711 NM_001252071 Greb1 - 16764045 9381 
MACS_peak_1989 chr12 20923166 20923204 no_match         
MACS_peak_2076 chr12 42241697 42241756 NM_053122 Immp2l + 41750676 491050 
MACS_peak_2090 chr12 46034622 46034665 NM_144552 Stxbp6 - 46175470 140827 
MACS_peak_2186 chr12 68160152 68160209 NM_207010 Mdga2 - 68323536 163356 
MACS_peak_2188 chr12 68160332 68160532 NM_207010 Mdga2 - 68323536 163104 
MACS_peak_2190 chr12 68160850 68160937 NM_207010 Mdga2 - 68323536 162643 
MACS_peak_2227 chr12 82217935 82218007 NM_022316 Smoc1 + 82127794 90177 
MACS_peak_2303 chr12 103576125 103576163 NM_001161365 Rin3 + 103521850 54294 
MACS_peak_2340 chr12 115059591 115059622 no_match         
MACS_peak_2347 chr12 116472701 116472735 no_match         
MACS_peak_2410 chr13 12410921 12410962 NM_033268 Actn2 - 12432999 22058 
MACS_peak_2424 chr13 15091904 15091945 no_match         
MACS_peak_2543 chr13 46017910 46017945 NM_009124 Atxn1 - 46060360 42433 
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MACS_peak_2544 chr13 46042013 46042045 NM_009124 Atxn1 - 46060360 18331 
MACS_peak_2545 chr13 46622579 46622615 NM_026056 Cap2 + 46597271 25326 
MACS_peak_2547 chr13 47009683 47009715 NM_010617 Kif13a - 47025087 15388 
MACS_peak_2551 chr13 49012998 49013037 NM_001033268 Fam120a - 49063197 50180 
MACS_peak_2566 chr13 53365271 53365354 NM_013846 Ror2 - 53381478 16166 
MACS_peak_2579 chr13 60777947 60778038 NM_134062 Dapk1 + 60703571 74421 
MACS_peak_2588 chr13 62583854 62583884 no_match         
MACS_peak_2595 chr13 63142897 63142932 NM_028079 2010111I01Rik + 63116293 26621 
MACS_peak_2664 chr13 77444222 77444276 NM_001145676 2210408I21Rik + 77274796 169453 
MACS_peak_2668 chr13 77578162 77578320 NM_001145676 2210408I21Rik + 77274796 303445 
MACS_peak_2674 chr13 78139588 78139623 NM_001163420 Fam172a + 77847950 291655 
MACS_peak_2675 chr13 78159832 78159943 NM_001163420 Fam172a + 77847950 311937 
MACS_peak_2676 chr13 78217440 78217475 NM_001163420 Fam172a + 77847950 369507 
MACS_peak_2762 chr13 97921248 97921282 NM_177266 Gfm2 + 97907891 13374 
MACS_peak_2817 chr13 113643535 113643568 NM_008903 Ppap2a + 113591130 52421 
MACS_peak_2837 chr13 120151364 120151394 NM_008710 Nnt - 120197818 46439 
MACS_peak_2839 chr13 120276600 120276641 NR_027974 3110070M22Rik - 120277191 571 
MACS_peak_2888 chr14 11727973 11728027 NM_010210 Fhit - 11994546 266546 
MACS_peak_2890 chr14 11825648 11825724 NM_010210 Fhit - 11994546 168860 
189 
MACS_peak_2892 chr14 13370194 13370258 NM_012061 Cadps - 13655593 285367 
MACS_peak_2968 chr14 35154586 35154620 NM_008133 Glud1 + 35123912 30691 
MACS_peak_3067 chr14 53420088 53420152 no_match         
MACS_peak_3088 chr14 58051162 58051222 NM_009376 Ift88 + 58042907 8285 
MACS_peak_3139 chr14 77836070 77836123 NM_001253759 Enox1 + 77556569 279527 
MACS_peak_3335 chr14 115612244 115612279 NM_175500 Gpc5 + 115491436 120825 
MACS_peak_3368 chr14 123850814 123850897 NM_177393 Nalcn - 124026366 175511 
MACS_peak_3508 chr15 31434664 31434694 NM_172606 37315 - 31460792 26113 
MACS_peak_3536 chr15 37183389 37183424 NM_026496 Grhl2 + 37162790 20616 
MACS_peak_3563 chr15 44304155 44304226 NM_138674 Pkhd1l1 + 44289098 15092 
MACS_peak_3583 chr15 47905751 47905788 NM_001081391 Csmd3 - 48623535 717766 
MACS_peak_3638 chr15 59288130 59288167 NM_001164604 Nsmce2 + 59205752 82396 
MACS_peak_3656 chr15 63890297 63890378 NM_144846 Fam49b - 63892010 1673 
MACS_peak_3740 chr15 85372595 85372669 NM_001163634 Wnt7b - 85408500 35868 
MACS_peak_3781 chr15 100243296 100243331 NM_008732 Slc11a2 - 100253486 10173 
MACS_peak_3827 chr16 10975160 10975272 NM_019980 Litaf - 10993214 17998 
MACS_peak_3850 chr16 18511270 18511303 NM_023120 Gnb1l + 18498963 12323 
MACS_peak_3851 chr16 19117281 19117317 no_match         
MACS_peak_3871 chr16 22560593 22560632 NM_138650 Dgkg - 22657304 96692 
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MACS_peak_3903 chr16 32236284 32236316 NM_173439 Fbxo45 - 32247111 10811 
MACS_peak_3935 chr16 41705086 41705124 NM_175548 Lsamp + 41533454 171651 
MACS_peak_3994 chr16 56755742 56755775 NM_172825 Gpr128 - 56795971 40213 
MACS_peak_4129 chr16 88239233 88239265 NM_146072 Grik1 - 88290503 51254 
MACS_peak_4177 chr17 12195749 12195783 NM_016694 Park2 + 11033249 1162517 
MACS_peak_4183 chr17 13743882 13744007 NR_045437 2700054A10Rik - 13746960 3016 
MACS_peak_4186 chr17 13744420 13744533 NR_045437 2700054A10Rik - 13746960 2484 
MACS_peak_4187 chr17 13744590 13744862 NR_045437 2700054A10Rik - 13746960 2234 
MACS_peak_4188 chr17 13744975 13745591 NR_045437 2700054A10Rik - 13746960 1677 
MACS_peak_4189 chr17 13745604 13746081 NR_045437 2700054A10Rik - 13746960 1118 
MACS_peak_4250 chr17 26114174 26114205 no_match         
MACS_peak_4253 chr17 27064710 27064740 NM_053173 Kifc5b + 27054035 10690 
MACS_peak_4260 chr17 29413077 29413116 NM_030561 BC004004 + 29405732 7364 
MACS_peak_4265 chr17 30309378 30309416 NM_148926 Zfand3 + 30142031 167366 
MACS_peak_4278 chr17 34706666 34706699 NM_010929 Notch4 + 34701239 5443 
MACS_peak_4284 chr17 36028987 36029027 NM_026987 Dhx16 + 36016722 12285 
MACS_peak_4328 chr17 42939260 42939317 NM_009847 Cd2ap - 43013373 74085 
MACS_peak_4332 chr17 43457759 43457822 NM_133776 Gpr110 + 43407295 50495 
MACS_peak_4372 chr17 51890542 51890577 NM_001163630 Satb1 - 51951379 60820 
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MACS_peak_4469 chr17 68090697 68090735 NM_008480 Lama1 + 68046604 44112 
MACS_peak_4470 chr17 68090802 68090842 NM_008480 Lama1 + 68046604 44218 
MACS_peak_4494 chr17 71896979 71897016 no_match         
MACS_peak_4497 chr17 72427434 72427475 NM_007439 Alk - 72953647 526193 
MACS_peak_4499 chr17 73492973 73493010 NM_001177968 Lclat1 + 73457324 35667 
MACS_peak_4500 chr17 73515938 73515991 NM_001177968 Lclat1 + 73457324 58640 
MACS_peak_4501 chr17 73548076 73548113 NM_001177968 Lclat1 + 73457324 90770 
MACS_peak_4663 chr18 11995310 11995344 NR_045421 Gm6277 - 11997886 2559 
MACS_peak_4700 chr18 22531712 22531756 NM_001167777 Asxl3 + 22503589 28145 
MACS_peak_4702 chr18 22978430 22978461 NM_001161483 Nol4 - 23197164 218719 
MACS_peak_4703 chr18 22997222 22997257 NM_001161483 Nol4 - 23197164 199925 
MACS_peak_4705 chr18 23664013 23664054 NM_207650 Dtna + 23573915 90118 
MACS_peak_4707 chr18 25335360 25335405 NM_001033532 AW554918 + 25327520 7862 
MACS_peak_4781 chr18 43073577 43073650 NM_028392 Ppp2r2b - 43219125 145512 
MACS_peak_4782 chr18 43733449 43733489 NM_001163637 Jakmip2 - 43847427 113958 
MACS_peak_4882 chr18 65263659 65263715 NM_031881 Nedd4l + 65183180 80507 
MACS_peak_4884 chr18 65279469 65279644 NM_031881 Nedd4l + 65183180 96376 
MACS_peak_4943 chr18 78394983 78395032 NM_001110274 Slc14a2 - 78403179 8172 
MACS_peak_4944 chr18 78395088 78395149 NM_001110274 Slc14a2 - 78403179 8061 
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MACS_peak_4985 chr18 89200748 89200791 NM_175542 Rttn + 89141181 59588 
MACS_peak_4986 chr18 89645076 89645113 NM_001039173 Dok6 - 89938528 293434 
MACS_peak_5052 chr19 18752719 18752790 NM_026120 2410127L17Rik + 18745269 7485 
MACS_peak_5071 chr19 23431916 23431993 NM_174857 Mamdc2 - 23522812 90858 
MACS_peak_5097 chr19 30809409 30809448 NM_011160 Prkg1 - 31738860 929432 
MACS_peak_5099 chr19 32018778 32018811 NM_001081074 A1cf + 31943250 75544 
MACS_peak_5100 chr19 32018885 32018933 NM_001081074 A1cf + 31943250 75659 
MACS_peak_5124 chr19 36497198 36497233 NM_029508 Pcgf5 + 36453556 43659 
MACS_peak_5126 chr19 36777943 36777979 no_match         
MACS_peak_5164 chr19 50385115 50385194 NM_001252501 Sorcs1 - 50753136 367982 
MACS_peak_5216 chr2 5082897 5082932 NM_028804 Ccdc3 + 5058821 24093 
MACS_peak_5217 chr2 5455951 5455990 NM_177343 Camk1d - 5635710 179740 
MACS_peak_5305 chr2 22442807 22442990 NM_148413 Myo3a + 22149129 293769 
MACS_peak_5306 chr2 22443049 22446054 NM_148413 Myo3a + 22149129 295422 
MACS_peak_5374 chr2 41751717 41751790 NM_053011 Lrp1b - 42509118 757365 
MACS_peak_5383 chr2 43518346 43518383 NM_027552 Kynu + 43410848 107516 
MACS_peak_5401 chr2 49644585 49644622 NM_027990 Lypd6b + 49643205 1398 
MACS_peak_5478 chr2 62466752 62466794 NM_001164477 Ifih1 - 62484312 17539 
MACS_peak_5499 chr2 68436980 68437063 NM_177651 4933409G03Rik + 68420469 16552 
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MACS_peak_5666 chr2 105466045 105466081 NR_002867 Pax6os1 - 105510487 44424 
MACS_peak_5691 chr2 110133770 110133849 NM_130452 Bbox1 - 110145882 12073 
MACS_peak_5710 chr2 112983268 112983300 no_match         
MACS_peak_5731 chr2 120762337 120762412 NM_009461 Ubr1 - 120796451 34077 
MACS_peak_5734 chr2 121348240 121348274 NM_030234 Wdr76 + 121332458 15799 
MACS_peak_5740 chr2 122536223 122536261 no_match         
MACS_peak_6336 chr3 75754176 75754212 NM_175193 Golim4 - 75760753 6559 
MACS_peak_6376 chr3 87241592 87241635 NM_183222 Fcrl5 + 87239703 1910 
MACS_peak_6430 chr3 98971413 98971447 NM_027462 Wars2 + 98945012 26418 
MACS_peak_6440 chr3 99785195 99785251 NM_028892 Spag17 + 99689339 95884 
MACS_peak_6441 chr3 99785290 99785323 NM_028892 Spag17 + 99689339 95967 
MACS_peak_6464 chr3 104756200 104756243 NM_009520 Wnt2b - 104764627 8406 
MACS_peak_6532 chr3 116666552 116666596 NM_023245 Palmd - 116671870 5296 
MACS_peak_6535 chr3 117040253 117040289 NM_177664 D3Bwg0562e - 117063794 23523 
MACS_peak_6551 chr3 120925849 120925913 NM_178936 Tmem56 - 120966234 40353 
MACS_peak_6609 chr3 135125098 135125135 NM_025356 Ube2d3 + 135101722 23394 
MACS_peak_6707 chr3 158111997 158112033 NM_001081358 Lrrc7 - 158225185 113170 
MACS_peak_6739 chr4 5765020 5765061 no_match         
MACS_peak_6749 chr4 6778838 6778879 NM_145711 Tox - 6917870 139012 
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MACS_peak_6827 chr4 19572532 19572611 NM_177327 Wwp1 - 19636147 63576 
MACS_peak_6991 chr4 56866312 56866372 NM_018761 Ctnnal1 - 56878083 11741 
MACS_peak_7073 chr4 70039154 70039288 NM_145990 Cdk5rap2 - 70071401 32180 
MACS_peak_7232 chr4 97315407 97315441 NM_001122952 Nfia + 97248633 66791 
MACS_peak_7268 chr4 110966433 110966465 NM_030231 Agbl4 + 110070395 896054 
MACS_peak_7287 chr4 113667574 113667617 NM_001167878 Skint5 - 113672108 4513 
MACS_peak_7311 chr4 120174330 120174368 NM_013883 Scmh1 + 120077885 96464 
MACS_peak_7407 chr4 154252264 154252349 NM_013783 Mmel1 + 154243693 8613 
MACS_peak_7409 chr4 154891898 154891961 NM_001160017 Gnb1 + 154865469 26460 
MACS_peak_7450 chr5 9328616 9328691 NM_172706 9330182L06Rik + 9266192 62461 
MACS_peak_7495 chr5 15606949 15606986 NM_001110843 Cacna2d1 + 15440508 166459 
MACS_peak_7531 chr5 22105725 22105759 no_match         
MACS_peak_7563 chr5 31952587 31952622 NM_153196 Rbks - 31999983 47379 
MACS_peak_7569 chr5 34420761 34420804 NM_181857 Poln - 34512097 91315 
MACS_peak_7750 chr5 73131805 73131839 NM_001122754 Txk - 73144012 12190 
MACS_peak_7825 chr5 86480418 86480454 NM_007683 Cenpc1 - 86494608 14172 
MACS_peak_7888 chr5 103293219 103293252 NM_029270 Arhgap24 + 102910409 382826 
MACS_peak_7897 chr5 106010419 106010460 NM_133897 Lrrc8c + 105948489 61950 
MACS_peak_7924 chr5 113185591 113185626 NM_028901 Myo18b - 113325382 139774 
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MACS_peak_7926 chr5 113662469 113662534 NM_001033428 Tmem211 + 113655928 6573 
MACS_peak_7962 chr5 128014781 128014825 NM_175432 Tmem132c + 127722195 292608 
MACS_peak_7974 chr5 132568314 132568353 NM_177047 Auts2 - 133018213 449880 
MACS_peak_7994 chr5 136837356 136837398 NM_198602 Cux1 - 137043275 205898 
MACS_peak_8001 chr5 138482217 138482248 NM_001039889 Smok3b + 138478451 3781 
MACS_peak_8013 chr5 141818269 141818304 NM_177879 Sdk1 + 141717487 100799 
MACS_peak_8025 chr5 144263582 144263614 NM_144915 Daglb + 144225360 38238 
MACS_peak_8026 chr5 144404009 144404091 NM_011182 Cyth3 + 144383315 20735 
MACS_peak_8050 chr5 148423005 148423155 NM_010228 Flt1 - 148537564 114484 
MACS_peak_8072 chr6 4873768 4873876 NM_181595 Ppp1r9a + 4853319 20503 
MACS_peak_8073 chr6 4874140 4874176 NM_181595 Ppp1r9a + 4853319 20839 
MACS_peak_8074 chr6 4929320 4929372 NM_181595 Ppp1r9a + 4853319 76027 
MACS_peak_8194 chr6 27982346 27982382 NM_008174 Grm8 - 28084369 102005 
MACS_peak_8201 chr6 29698349 29698691 NM_176996 Smo + 29685496 13024 
MACS_peak_8202 chr6 29698765 29698948 NM_176996 Smo + 29685496 13360 
MACS_peak_8203 chr6 29698976 29699059 NM_176996 Smo + 29685496 13521 
MACS_peak_8214 chr6 33727952 33727987 NM_009148 Exoc4 + 33199149 528820 
MACS_peak_8224 chr6 37314886 37314918 NM_178661 Creb3l2 - 37392148 77246 
MACS_peak_8238 chr6 41074097 41074158 no_match         
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MACS_peak_8281 chr6 47605196 47605276 no_match         
MACS_peak_8285 chr6 47609466 47609612 no_match         
MACS_peak_8286 chr6 47613766 47613952 no_match         
MACS_peak_8287 chr6 47618143 47618261 no_match         
MACS_peak_8288 chr6 47622501 47622583 no_match         
MACS_peak_8295 chr6 47635427 47635545 no_match         
MACS_peak_8296 chr6 47636057 47636197 no_match         
MACS_peak_8298 chr6 47689999 47690223 no_match         
MACS_peak_8302 chr6 47698642 47698788 no_match         
MACS_peak_8384 chr6 62123479 62123549 NM_001164316 Fam190a + 61130318 993196 
MACS_peak_8418 chr6 67961891 67961960 no_match         
MACS_peak_8487 chr6 82711256 82711309 NM_013820 Hk2 - 82724448 13166 
MACS_peak_8489 chr6 83090519 83090558 NM_133641 Rtkn + 83087077 3461 
MACS_peak_8502 chr6 88211729 88211759 NM_023060 Eefsec - 88396533 184789 
MACS_peak_8531 chr6 100529278 100529325 NM_181590 Shq1 - 100621151 91850 
MACS_peak_8542 chr6 103599041 103599289 NM_007697 Chl1 + 103460869 138296 
MACS_peak_8554 chr6 105744443 105744474 NM_001109749 Cntn4 + 105627738 116720 
MACS_peak_8617 chr6 119940739 119940828 NM_001185021 Wnk1 - 119988673 47890 
MACS_peak_8709 chr6 142906337 142906397 NM_011374 St8sia1 - 142912972 6605 
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MACS_peak_8713 chr6 144174729 144174782 no_match         
MACS_peak_8829 chr7 19618910 19618972 NM_026605 Sympk + 19609725 9216 
MACS_peak_8902 chr7 35743189 35743244 NM_008820 Pepd + 35697425 45791 
MACS_peak_8913 chr7 38157254 38157286 no_match         
MACS_peak_9020 chr7 66021157 66021205 NM_009728 Atp10a + 65913571 107610 
MACS_peak_9087 chr7 71752092 71752130 NM_007461 Apba2 + 71646591 105520 
MACS_peak_9148 chr7 89050992 89051024 NM_013886 Hdgfrp3 - 89079345 28337 
MACS_peak_9157 chr7 90759371 90759406 NM_177695 Tmc3 + 90733440 25948 
MACS_peak_9209 chr7 101433469 101433504 no_match         
MACS_peak_9272 chr7 119818511 119818545 no_match         
MACS_peak_9415 chr8 17290635 17290684 NM_053171 Csmd1 - 17535385 244726 
MACS_peak_9437 chr8 24205944 24206174 NM_031158 Ank1 + 24168746 37313 
MACS_peak_9438 chr8 24206235 24206280 NM_031158 Ank1 + 24168746 37511 
MACS_peak_9451 chr8 28220148 28220183 NM_054044 Gpr124 + 28196312 23853 
MACS_peak_9496 chr8 40449077 40449129 NR_044988 Gm6213 + 40383333 65770 
MACS_peak_9572 chr8 58454287 58454347 NM_080438 Glra3 + 58419621 34696 
MACS_peak_9645 chr8 73543979 73544018 NR_045487 1700026F02Rik - 73550654 6656 
MACS_peak_9649 chr8 74932251 74932291 NM_007944 Eps15l1 - 74945373 13102 
MACS_peak_9705 chr8 90282778 90282818 NM_033327 Zfp423 - 90483494 200696 
198 
MACS_peak_9708 chr8 91111252 91111289 NM_001163660 Nkd1 + 91051531 59739 
MACS_peak_9805 chr8 119893178 119893218 NM_028941 Cmip + 119873069 20129 
MACS_peak_9806 chr8 120193924 120193972 NM_028725 Sdr42e1 - 120195415 1467 
MACS_peak_9826 chr8 126485381 126485458 NM_019552 Abcb10 - 126507022 21603 
MACS_peak_9853 chr9 3590942 3590978 NM_001033322 Gucy1a2 + 3532348 58612 
MACS_peak_9899 chr9 10186515 10186578 NM_001033359 Cntn5 - 10904726 718180 
MACS_peak_9922 chr9 15124219 15124268 NM_176976 5830418K08Rik - 15162232 37989 
MACS_peak_9924 chr9 15126016 15126055 NM_176976 5830418K08Rik - 15162232 36197 
MACS_peak_9973 chr9 24549530 24549669 NM_194263 Tbx20 - 24578747 29148 
MACS_peak_9993 chr9 31700236 31700319 NM_013800 Barx2 - 31720870 20593 
MACS_peak_10006 chr9 35444874 35444931 no_match         
MACS_peak_10007 chr9 35489188 35489246 no_match         
MACS_peak_10097 chr9 64584698 64584731 NM_017382 Rab11a - 64585563 849 
MACS_peak_10131 chr9 78559796 78559829 NM_153098 Cd109 + 78463352 96460 
MACS_peak_10138 chr9 79931764 79931833 NM_146003 Senp6 + 79914709 17089 
MACS_peak_10155 chr9 83452812 83452858 NM_172507 Sh3bgrl2 + 83441944 10891 
MACS_peak_10215 chr9 96753566 96753607 NM_153420 Acpl2 - 96789841 36255 
MACS_peak_10240 chr9 107750112 107750169 NM_029169 Rbm6 - 107775150 25010 
MACS_peak_10259 chr9 113779357 113779391 NM_029633 Clasp2 + 113721703 57671 
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MACS_peak_10285 chr9 123016478 123016532 NM_026917 Zdhhc3 - 123022323 5818 
MACS_peak_11142 chrX 34989842 34989880 NM_001085356 Rhox2f + 34985927 3934 
MACS_peak_11148 chrX 36165249 36165286 NM_183126 6030498E09Rik + 36125956 39311 
MACS_peak_11360 chrX 68640647 68640683 NM_016985 Mtmr1 + 68617934 22731 
MACS_peak_11463 chrX 84127738 84127768 NM_001160403 Il1rapl1 - 85360962 1233209 
MACS_peak_11521 chrX 93297952 93297983 NM_010833 Msn + 93291383 6584 
MACS_peak_11558 chrX 100917600 100917635 NM_009197 Slc16a2 - 101017327 99710 
MACS_peak_11570 chrX 103060192 103060222 NM_009530 Atrx - 103124711 64504 
MACS_peak_11745 chrX 126917888 126917942 NM_172493 Diap2 + 126284277 633638 
MACS_peak_11768 chrX 130684595 130684650 NM_183319 Xkrx - 130696467 11845 
MACS_peak_11921 chrX 163813503 163813544 NM_026662 Prps2 - 163820631 7108 
MACS_peak_11924 chrX 164425136 164425168 NM_001033330 Frmpd4 - 165015165 590013 
MACS_peak_11936 chrX 166427377 166427446 NM_183151 Mid1 + 166317553 109858 
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Appendix 4: Gene expression data 
All values are expressed as fold changes, and genes are listed alphabetically. wt=wildtype (HDAC4fl/fl); ko = HDAC4 cKO; sem = standard error of the mean.  
#VALUE! indicates the transcript was not detected. If #VALUE! appears across an entire row, it was not expressed in one or more of the control samples and 
a fold change could not be determined. These were excluded from analysis. P-values represent t-tests of FC values.  

















4  p  wt average 
wt 
sem ko average 
ko 
sem 
Adcyap 1.21 1.07 0.77 0.95 1.05 0.92 0.63 0.95  0.43  1.00 0.09 0.89 0.09 
Aif1 0.55 0.87 1.51 1.07 1.08 1.24 2.16 3.20  0.16  1.00 0.20 1.92 0.49 
Atf3 1.06 0.88 0.89 1.17 0.64 0.66 0.80 0.76  0.02  1.00 0.07 0.72 0.04 
Bdnf 0.58 0.52 1.31 1.58 0.17 0.91 1.76 2.73  0.55  1.00 0.26 1.39 0.55 
Cacna2d1 1.33 0.92 0.58 1.17 0.78 1.00 0.39 0.16  0.15  1.00 0.16 0.58 0.19 
Calca 0.99 0.61 1.34 1.06 0.28 0.45 0.45 0.21  0.02  1.00 0.15 0.35 0.06 
Ccl2 0.75 0.60 1.49 1.16 0.33 1.10 0.58 0.99  0.39  1.00 0.20 0.75 0.18 
Ccr2 1.91 0.98 0.47 0.65 7.65 25.46 2.50 3.71  0.20  1.00 0.32 9.83 5.33 
Ctss 0.49 0.01 1.02 2.48 0.11 0.13 0.22 0.32  0.23  1.00 0.53 0.19 0.05 
Egfr 0.95 1.47 0.85 0.73 1.12 0.17 0.30 0.44  0.12  1.00 0.16 0.51 0.21 
Gabbr1 1.18 1.02 0.82 0.97 0.90 0.90 1.11 0.98  0.76  1.00 0.07 0.97 0.05 
Gabra5 1.39 0.88 0.87 0.87 1.19 2.30 1.41 0.07  0.64  1.00 0.13 1.24 0.46 


















4  p  wt average 
wt 
sem ko average 
ko 
sem 
Gal 0.78 0.53 1.34 1.35 0.26 0.43 0.70 1.58  0.51  1.00 0.20 0.75 0.29 
Gapdh 1.24 1.27 0.75 0.74 1.61 1.38 1.50 0.91  0.15  1.00 0.15 1.35 0.16 
Gch1 1.18 0.90 0.86 1.06 0.46 0.27 0.68 0.06  0.01  1.00 0.07 0.37 0.13 
Gfap 1.46 0.62 1.45 0.47 1.48 1.04 0.19 0.28  0.55  1.00 0.26 0.74 0.31 
Hcn2 1.12 1.14 0.94 0.79 1.33 0.92 1.08 0.81  0.82  1.00 0.08 1.03 0.11 
Hprt 0.69 0.68 1.32 1.31 0.52 0.64 0.58 1.11  0.26  1.00 0.18 0.71 0.13 
Kcns1 0.98 0.96 1.03 1.03 0.66 0.50 0.24 0.02  0.02  1.00 0.02 0.36 0.14 
Ngf 1.03 1.24 1.07 0.67 1.51 1.80 2.37 2.49  0.01  1.00 0.12 2.04 0.23 
Ngfr 0.66 0.96 1.45 0.93 1.58 1.29 0.72 0.39  0.99  1.00 0.16 0.99 0.27 
Nos1 1.11 1.58 0.52 0.79 0.79 0.78 0.26 0.27  0.14  1.00 0.23 0.53 0.15 
Npy 3.52 0.17 0.04 0.27 0.77 0.33 0.49 4.44  0.71  1.00 0.84 1.51 0.98 
Ntrk1 1.17 0.89 1.07 0.87 0.52 0.35 0.38 0.22  0.00  1.00 0.07 0.37 0.06 
Ntrk2 1.27 1.45 0.55 0.72 1.77 1.81 1.55 0.54  0.30  1.00 0.22 1.42 0.30 
Ntrk3 1.33 1.27 0.71 0.69 1.93 1.44 1.67 0.36  0.41  1.00 0.17 1.35 0.34 
Oprm1 2.48 0.16 1.13 0.22 1.53 1.76 3.06 4.54  0.10  1.00 0.54 2.72 0.69 
P2rx3 1.27 1.10 0.71 0.92 0.59 0.48 0.34 0.24  0.01  1.00 0.12 0.41 0.08 


















4  p  wt average 
wt 
sem ko average 
ko 
sem 
Pdyn 0.96 0.79 1.26 1.00 1.56 0.21 0.37 0.54  0.37  1.00 0.10 0.67 0.30 
Ptgs2 1.20 0.77 1.13 0.90 0.88 0.67 1.49 0.77  0.83  1.00 0.10 0.95 0.18 
Reg3b 0.86 1.88 0.31 0.96 17.44 20.10 35.00 51.89  0.03  1.00 0.33 31.11 7.93 
Rest 1.24 1.40 0.68 0.68 0.23 1.00 0.25 0.78  0.16  1.00 0.19 0.56 0.19 
Scn10a 1.23 1.32 0.58 0.87 0.83 0.93 0.68 0.30  0.21  1.00 0.17 0.69 0.14 
Scn11a 1.22 1.40 0.55 0.82 1.31 1.47 1.13 1.30  0.22  1.00 0.19 1.30 0.07 
Scn3a 1.38 1.06 0.59 0.97 0.95 1.14 0.27 0.40  0.29  1.00 0.16 0.69 0.21 
Scn9a 1.14 1.21 0.62 1.03 1.75 1.94 2.16 1.26  0.02  1.00 0.13 1.78 0.19 
Sgk1 1.47 0.84 0.76 0.92 0.80 1.19 0.96 1.40  0.68  1.00 0.16 1.09 0.13 
Slco1a6 0.58 1.26 0.21 1.95 11.74 13.53 23.57 34.94  0.03  1.00 0.39 20.95 5.34 
Sst 0.55 1.89 0.84 0.72 8.17 10.31 10.56 3.13  0.02  1.00 0.30 8.04 1.72 
Tac1 1.07 0.84 0.87 1.21 0.74 1.05 1.31 1.54  0.45  1.00 0.09 1.16 0.17 
Tacr1 2.56 0.11 0.52 0.80 1.04 1.20 2.10 3.11  0.28  1.00 0.54 1.86 0.48 
Trpa1 0.97 1.13 0.78 1.12 0.91 0.89 0.85 0.50  0.14  1.00 0.08 0.79 0.10 
Trpv1 1.10 0.71 0.90 1.28 0.39 0.63 0.37 0.27  0.01  1.00 0.12 0.41 0.08 
Vgf 0.90 0.42 0.95 1.73 0.08 0.13 0.10 0.24  0.05  1.00 0.27 0.14 0.04 




Table 14 - HDAC4Nav1.8 naive gene expression (Study 2) 
ID 
  naive 
wt1 
  naive 
wt2 
  naive 
wt3 
  naive 
wt4 
  naive 
cko1 
  naive 
cko2 
  naive 
cko3 
  naive 
cko4 p  
wt 
averag
e wt sem 
ko 
averag
e ko sem 
Adcyap 0.79 0.97 1.12 1.13 0.88 0.87 1.46 1.02  0.73  1.00 0.08 1.06 0.14 
Aif1 0.53 1.08 0.86 1.53 1.25 0.80 1.59 1.68  0.30  1.00 0.21 1.33 0.20 
Atf3 1.37 1.27 0.97 0.40 1.42 0.67 0.34 0.36  0.40  1.00 0.22 0.70 0.25 
Bdnf 0.98 0.38 1.65 0.98 0.88 0.83 1.39 1.17  0.83  1.00 0.26 1.07 0.13 
Cacna2d
1 0.94 0.74 1.38 0.94 1.15 1.11 1.41 1.60  0.13  1.00 0.14 1.32 0.12 
Calca 0.90 0.92 1.30 0.89 0.68 0.68 1.27 0.79  0.43  1.00 0.10 0.85 0.14 
Ccl2 0.88 1.15 0.50 1.46 0.74 0.59 1.07 0.85  0.45  1.00 0.20 0.81 0.10 
Ccr2 1.00 0.83 0.91 1.26 1.05 1.08 1.45 0.95  0.39  1.00 0.09 1.13 0.11 
Ctss 1.43 1.00 0.95 0.61 0.92 0.97 1.45 0.61  0.96  1.00 0.17 0.99 0.18 
Egfr 0.77 1.04 0.78 1.40 0.71 0.94 1.20 0.97  0.82  1.00 0.15 0.96 0.10 
Gabbr1 0.85 1.12 1.02 1.01 0.85 0.84 0.90 0.98  0.16  1.00 0.06 0.89 0.03 






























  naive 
wt1 
  naive 
wt2 
  naive 
wt3 
  naive 
wt4 
  naive 
cko1 
  naive 
cko2 
  naive 
cko3 
  naive 
cko4 p  
wt 
averag
e wt sem 
ko 
averag
e ko sem 
Gal 0.97 0.69 1.05 1.29 0.61 0.53 1.94 0.92  0.99  1.00 0.13 1.00 0.33 
Gapdh 0.91 1.12 0.95 1.02 1.03 1.10 1.05 1.08  0.27  1.00 0.05 1.06 0.01 
Gch1 1.16 1.07 1.04 0.73 1.06 0.68 1.01 0.76  0.38  1.00 0.09 0.88 0.09 
Gfap 1.52 1.02 1.01 0.46 0.54 0.71 0.90 1.78  0.95  1.00 0.22 0.98 0.28 
Hcn2 0.91 1.12 1.08 0.89 0.98 0.94 1.02 1.20  0.67  1.00 0.06 1.04 0.06 
Hprt 1.13 0.85 1.06 0.96 0.95 0.87 0.93 0.89  0.24  1.00 0.06 0.91 0.02 
Kcns1 0.82 1.16 1.00 1.02 1.10 0.83 0.81 1.06  0.64  1.00 0.07 0.95 0.07 
Ngf 1.14 1.92 0.51 0.43 0.39 0.33 0.60 0.45  0.20  1.00 0.34 0.44 0.06 
Ngfr 0.75 1.36 0.92 0.97 0.64 0.79 0.81 1.00  0.26  1.00 0.13 0.81 0.07 
Nos1 0.78 1.25 1.05 0.92 0.64 0.85 1.35 0.64  0.53  1.00 0.10 0.87 0.17 
Npy 1.15 0.77 1.43 0.65 0.29 1.84 0.08 3.88  0.60  1.00 0.18 1.52 0.88 
Ntrk1 0.76 1.01 1.08 1.16 0.72 0.74 0.94 1.02  0.26  1.00 0.09 0.86 0.07 
Ntrk2 0.85 1.11 1.05 0.99 0.97 0.90 1.18 1.22  0.51  1.00 0.06 1.07 0.08 






























  naive 
wt1 
  naive 
wt2 
  naive 
wt3 
  naive 
wt4 
  naive 
cko1 
  naive 
cko2 
  naive 
cko3 
  naive 
cko4 p  
wt 
averag
e wt sem 
ko 
averag
e ko sem 
P2rx3 0.88 1.10 1.04 0.98 0.91 0.86 1.05 1.07  0.68  1.00 0.05 0.97 0.05 
P2rx4 1.00 1.06 1.12 0.81 0.85 0.72 0.99 1.02  0.31  1.00 0.07 0.89 0.07 
Pdyn 0.22 2.63 0.58 0.57 1.79 1.35 
#VALU
E! 1.60  
#VALU

































Rest 0.75 1.16 0.72 1.38 0.93 0.71 1.23 1.27  0.88  1.00 0.16 1.03 0.13 
Scn10a 0.79 1.12 1.12 0.97 0.72 0.76 0.72 0.85  0.05  1.00 0.08 0.76 0.03 
Scn11a 0.84 1.12 1.01 1.03 0.61 0.89 0.85 0.73  0.04  1.00 0.06 0.77 0.06 
Scn3a 0.83 0.77 1.17 1.23 1.58 0.67 1.48 2.26  0.23  1.00 0.12 1.50 0.33 
Scn9a 0.85 0.80 1.24 1.10 0.91 0.93 1.09 1.11  0.94  1.00 0.10 1.01 0.05 




























Sst 0.70 0.79 0.55 1.96 0.85 0.93 2.45 2.83  0.26  1.00 0.32 1.76 0.51 
Tac1 0.90 0.95 1.10 1.05 0.84 0.82 1.37 0.77  0.75  1.00 0.05 0.95 0.14 
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ID 
  naive 
wt1 
  naive 
wt2 
  naive 
wt3 
  naive 
wt4 
  naive 
cko1 
  naive 
cko2 
  naive 
cko3 
  naive 
cko4 p  
wt 
averag
e wt sem 
ko 
averag
e ko sem 
Tacr1 1.48 0.47 1.59 0.46 2.30 1.33 1.92 1.12  0.15  1.00 0.31 1.67 0.27 
Trpa1 0.95 1.03 1.09 0.92 0.79 0.81 0.98 0.77  0.04  1.00 0.04 0.84 0.05 
Trpv1 0.94 0.95 1.09 1.03 1.20 0.93 1.80 0.96  0.36  1.00 0.04 1.22 0.20 































Table 15 - HDAC4Nav1.8  D28 partial sciatic nerve ligation (Study 2). Expression values are normalized to wildtype naïve controls 






cko3 PSL cko4 p  
wt 
average wt sem 
ko 
average ko sem 
Adcyap 1.68 1.88 1.78 1.78 1.52 1.28 1.15 1.97  0.19  1.78 0.04 1.48 0.18 
Aif1 1.71 2.96 1.97 1.91 3.22 2.21 1.77 1.53  0.92  2.14 0.28 2.18 0.37 
Atf3 7.40 7.08 11.51 6.57 3.98 3.31 3.96 4.91  0.03  8.14 1.14 4.04 0.33 
Bdnf 1.48 1.55 1.70 1.71 1.33 1.08 2.02 2.43  0.76  1.61 0.06 1.71 0.31 
Cacna2d1 1.36 1.99 2.14 2.30 1.65 0.99 1.72 1.87  0.22  1.95 0.21 1.56 0.19 
Calca 0.80 1.09 1.02 1.10 0.69 0.74 0.92 0.89  0.08  1.00 0.07 0.81 0.06 
Ccl2 1.11 1.13 1.19 1.20 0.60 0.80 0.82 1.06  0.03  1.16 0.02 0.82 0.10 
Ccr2 2.49 1.67 1.10 0.61 1.66 1.63 1.07 1.25  0.88  1.47 0.40 1.40 0.15 
Ctss 2.81 2.40 3.60 1.64 2.39 2.24 1.68 1.51  0.22  2.61 0.41 1.95 0.21 
Egfr 1.90 1.34 1.52 0.81 1.47 1.43 0.77 1.18  0.55  1.39 0.23 1.21 0.16 
Gabbr1 0.70 1.04 0.82 1.01 0.95 0.90 0.88 0.83  0.99  0.89 0.08 0.89 0.02 
Gabra5 1.47 1.42 1.45 1.54 1.35 1.23 0.95 1.44  0.12  1.47 0.03 1.24 0.11 
Gad2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Gal 2.01 2.99 7.93 3.69 1.67 1.61 2.64 2.40  0.21  4.16 1.30 2.08 0.26 
Gapdh 0.82 1.09 0.78 1.11 1.09 1.20 0.82 0.91  0.66  0.95 0.09 1.01 0.08 
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cko3 PSL cko4 p  
wt 
average wt sem 
ko 
average ko sem 
Gch1 1.40 1.35 1.27 1.12 1.20 0.57 0.93 1.23  0.14  1.29 0.06 0.98 0.15 
Gfap 2.83 2.63 4.35 2.22 1.66 0.43 0.97 1.43  0.02  3.01 0.47 1.12 0.27 
Hcn2 0.85 0.98 0.81 0.93 1.12 0.98 1.06 0.66  0.62  0.89 0.04 0.95 0.10 
Hprt 1.14 1.09 1.19 0.89 1.05 1.01 1.18 1.00  0.87  1.08 0.07 1.06 0.04 
Kcns1 0.63 0.68 0.61 0.68 0.88 0.70 0.81 0.58  0.26  0.65 0.02 0.74 0.07 
Ngf 0.52 0.71 0.69 0.68 0.59 0.68 0.47 0.70  0.57  0.65 0.04 0.61 0.05 
Ngfr 0.93 0.99 0.77 1.22 1.24 1.12 1.04 1.05  0.26  0.98 0.09 1.11 0.05 
Nos1 0.86 1.33 1.14 1.14 1.38 1.30 1.44 0.93  0.37  1.12 0.10 1.26 0.11 
Npy 215.93 202.48 384.07 180.23 89.81 77.57 85.75 86.19  0.04  245.68 46.72 84.83 2.59 
Ntrk1 0.73 1.10 0.80 0.95 0.85 0.78 0.71 0.64  0.17  0.89 0.08 0.74 0.05 
Ntrk2 1.06 1.19 0.92 1.06 1.25 1.08 1.01 0.91  0.96  1.06 0.06 1.06 0.07 
Ntrk3 1.46 1.46 1.28 1.71 1.93 1.27 1.53 1.10  0.93  1.48 0.09 1.46 0.18 
Oprm1 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
P2rx3 0.53 1.11 0.79 1.01 1.03 0.96 0.95 0.85  0.55  0.86 0.13 0.95 0.04 
P2rx4 1.03 1.17 0.93 1.06 1.31 0.98 1.16 0.91  0.71  1.05 0.05 1.09 0.09 
Pdyn #VALUE! 2.50 0.48 #VALUE! #VALUE! 1.19 #VALUE! 0.20  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ptgs2 1.32 0.70 0.31 0.31 0.78 0.97 0.41 0.22  0.83  0.66 0.24 0.60 0.17 
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cko3 PSL cko4 p  
wt 
average wt sem 
ko 
average ko sem 
Reg3b #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Rest 1.68 1.30 1.41 1.05 1.03 1.14 1.00 1.01  0.09  1.36 0.13 1.04 0.03 
Scn10a 0.50 1.20 0.74 1.20 0.65 0.69 0.62 0.73  0.27  0.91 0.17 0.67 0.02 
Scn11a 0.42 1.15 0.63 1.12 0.74 0.84 0.80 0.65  0.71  0.83 0.18 0.76 0.04 
Scn3a 0.84 1.93 1.35 2.57 2.01 0.90 1.63 1.75  0.83  1.67 0.37 1.58 0.24 
Scn9a 0.78 1.02 0.95 1.26 1.32 0.67 1.29 1.11  0.62  1.00 0.10 1.10 0.15 
Sgk1 0.81 0.44 0.66 0.37 0.97 0.48 0.59 0.60  0.58  0.57 0.10 0.66 0.11 
Slco1a6 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Sst 0.27 0.73 0.71 0.76 1.41 2.01 1.80 1.43  0.00  0.62 0.12 1.66 0.15 
Tac1 0.84 1.36 0.97 1.19 1.19 1.18 1.14 1.08  0.67  1.09 0.11 1.15 0.02 
Tacr1 #VALUE! 0.78 0.53 1.16 0.46 0.67 0.36 0.81  #VALUE!  #VALUE! #VALUE! 0.58 0.10 
Trpa1 0.50 0.74 0.68 1.04 0.53 0.44 0.65 0.89  0.49  0.74 0.11 0.63 0.10 
Trpv1 0.95 1.51 1.23 1.38 0.94 1.04 0.90 0.96  0.08  1.27 0.12 0.96 0.03 
Vgf 1.24 1.64 2.07 1.76 2.19 1.19 1.88 2.44  0.47  1.68 0.17 1.93 0.27 




Table 16 - HDAC4Adv naive gene expression (Study 3) 
ID wt 1 wt 2 wt 3 wt 4 cKO 1 cKO 2 cKO 3 cKO 4  p  
wt 
average wt sem 
ko 
average ko sem 
Adcyap #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Aif1 1.38 0.52 1.13 0.97 1.62 0.65 1.75 1.85  0.22  1.00 0.18 1.47 0.28 
Atf3 0.46 0.87 0.48 2.19 0.78 0.58 1.57 4.44  0.44  1.00 0.41 1.84 0.89 
Bdnf 0.56 1.15 1.24 1.06 1.43 0.88 3.08 2.95  0.14  1.00 0.15 2.08 0.55 
Cacna2d1 1.15 1.15 1.04 0.66 1.60 1.50 1.67 1.43  0.01  1.00 0.12 1.55 0.05 
Calca 0.92 0.83 1.05 1.20 1.40 0.71 1.43 1.17  0.39  1.00 0.08 1.18 0.17 
Ccl2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ccr2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ctss 2.08 0.81 0.28 0.83 1.02 0.74 0.59 0.74  0.60  1.00 0.38 0.77 0.09 
Egfr 1.20 1.43 0.79 0.58 1.62 1.20 0.63 0.44  0.94  1.00 0.19 0.97 0.27 
Gabbr1 1.07 1.25 1.06 0.62 1.12 1.03 1.17 0.96  0.64  1.00 0.13 1.07 0.05 
Gabra5 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Gad2 0.89 1.10 0.99 1.03 1.43 0.96 1.45 1.45  0.07  1.00 0.04 1.32 0.12 
Gal 1.33 1.25 0.89 0.53 1.43 0.40 1.01 0.29  0.53  1.00 0.18 0.78 0.27 
Gapdh 1.12 1.04 0.93 0.92 1.24 1.18 1.09 0.99  0.14  1.00 0.05 1.12 0.05 
Gch1 1.07 1.12 0.88 0.93 1.39 1.21 0.86 1.08  0.33  1.00 0.05 1.14 0.11 
211 
ID wt 1 wt 2 wt 3 wt 4 cKO 1 cKO 2 cKO 3 cKO 4  p  
wt 
average wt sem 
ko 
average ko sem 
Gfap #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Hcn2 1.23 0.81 1.00 0.96 0.99 1.00 1.03 0.99  0.98  1.00 0.09 1.00 0.01 
Hprt 0.91 0.97 1.06 1.06 0.83 0.86 0.93 1.00  0.13  1.00 0.04 0.91 0.04 
Kcns1 1.07 1.06 1.03 0.84 1.53 1.13 1.22 1.12  0.07  1.00 0.05 1.25 0.10 
Ngf 0.68 0.79 1.31 1.23 1.03 0.80 0.83 0.98  0.62  1.00 0.16 0.91 0.06 
Ngfr 1.17 0.80 1.02 1.01 1.74 0.78 1.20 1.12  0.38  1.00 0.08 1.21 0.20 
Nos1 0.90 1.20 0.94 0.96 1.03 1.08 1.44 0.79  0.60  1.00 0.07 1.08 0.13 
Npy #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ntrk1 1.08 0.84 1.02 1.05 1.23 1.16 1.09 1.14  0.06  1.00 0.06 1.15 0.03 
Ntrk2 1.13 0.86 1.15 0.86 1.07 0.82 1.37 1.02  0.64  1.00 0.08 1.07 0.11 
Ntrk3 0.92 1.25 1.10 0.72 1.55 0.96 1.36 1.14  0.20  1.00 0.12 1.25 0.13 
Oprm1 1.13 1.18 0.94 0.75 1.96 1.34 2.07 1.62  0.01  1.00 0.10 1.75 0.17 
P2rx3 0.87 1.16 1.04 0.92 1.45 1.13 1.38 1.24  0.02  1.00 0.06 1.30 0.07 
P2rx4 1.02 1.16 0.92 0.89 2.02 0.88 1.01 0.75  0.62  1.00 0.06 1.16 0.29 
Pdyn 1.14 1.54 0.73 0.60 0.71 0.88 1.02 0.77  0.53  1.00 0.21 0.84 0.07 
Ptgs2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Reg3b 0.91 1.19 1.03 0.88 1.23 0.85 1.34 0.83  0.69  1.00 0.07 1.06 0.13 
212 
ID wt 1 wt 2 wt 3 wt 4 cKO 1 cKO 2 cKO 3 cKO 4  p  
wt 
average wt sem 
ko 
average ko sem 
Rest 0.86 1.04 1.15 0.95 2.10 0.74 1.31 1.37  0.27  1.00 0.06 1.38 0.28 
Scn10a 1.34 0.90 0.96 0.80 0.93 0.73 0.99 0.80  0.35  1.00 0.12 0.86 0.06 
Scn11a 1.04 0.91 1.18 0.86 0.64 0.62 1.21 0.91  0.37  1.00 0.07 0.85 0.14 
Scn3a 0.84 1.06 1.59 0.52 2.50 0.81 1.61 0.39  0.56  1.00 0.22 1.33 0.47 
Scn9a 1.12 1.21 1.13 0.54 1.45 1.17 1.60 1.02  0.18  1.00 0.16 1.31 0.13 
Sgk1 0.56 0.42 1.62 1.40 1.60 0.93 0.98 1.36  0.55  1.00 0.30 1.22 0.16 
Slco1a6 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Sst 0.87 1.31 0.87 0.95 0.36 0.47 0.89 2.68  0.86  1.00 0.11 1.10 0.54 
Tac1 1.31 1.17 0.71 0.82 0.96 0.74 1.17 0.87  0.72  1.00 0.14 0.94 0.09 
Tacr1 0.85 1.13 1.21 0.81 2.71 0.92 1.43 1.11  0.27  1.00 0.10 1.54 0.40 
Trpa1 1.07 1.08 1.08 0.77 0.77 0.59 0.83 0.58  0.02  1.00 0.08 0.69 0.06 
Trpv1 1.32 0.88 0.76 1.04 1.15 0.90 1.23 0.94  0.72  1.00 0.12 1.06 0.08 
Vgf 0.66 1.06 0.82 1.46 1.39 1.43 1.42 1.67  0.07  1.00 0.17 1.48 0.07 




Table 17 - HDAC4Adv 24 hours after sciatic nerve transection (Study 3). Values are normalized to wildtype naïve controls.  
ID   wt i 1   wt i 2   wt i 3   wt i 4   ko i 1   ko i 2   ko i 3   ko i 4  p  
wt 
average wt sem 
ko 
average ko sem 
Adcyap #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Aif1 2.57 3.17 1.57 2.29 4.89 1.82 3.53 4.26  0.17  2.40 0.33 3.63 0.66 
Atf3 18.18 18.70 31.61 50.15 22.15 23.44 51.51 73.87  0.41  29.66 7.50 42.74 12.39 
Bdnf 1.26 1.20 2.12 3.25 2.78 2.88 3.14 3.36  0.11  1.96 0.48 3.04 0.13 
Cacna2d1 1.63 1.60 1.19 1.93 2.26 1.98 2.35 2.25  0.02  1.59 0.15 2.21 0.08 
Calca 1.13 1.42 1.26 1.37 1.10 0.87 0.91 1.03  0.01  1.30 0.06 0.98 0.05 
Ccl2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ccr2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ctss 4.34 3.76 1.15 2.17 2.21 4.41 2.45 3.33  0.79  2.85 0.73 3.10 0.50 
Egfr 1.19 1.12 1.07 1.34 1.40 1.37 0.91 1.49  0.46  1.18 0.06 1.29 0.13 
Gabbr1 1.30 2.14 1.08 1.82 1.56 1.38 1.26 1.24  0.42  1.59 0.24 1.36 0.07 
Gabra5 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Gad2 3.23 3.90 3.67 5.79 5.59 6.11 6.15 7.16  0.02  4.15 0.56 6.25 0.33 
Gal 1.61 1.58 0.59 1.51 1.99 0.95 1.05 1.20  0.94  1.32 0.24 1.30 0.24 
Gapdh 1.09 1.15 1.01 1.24 1.23 1.25 0.98 1.00  0.93  1.12 0.05 1.11 0.07 
214 
ID   wt i 1   wt i 2   wt i 3   wt i 4   ko i 1   ko i 2   ko i 3   ko i 4  p  
wt 
average wt sem 
ko 
average ko sem 
Gch1 0.57 0.98 0.80 0.62 0.78 0.81 0.37 0.77  0.67  0.74 0.09 0.68 0.10 
Gfap #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Hcn2 0.89 0.72 0.95 0.71 0.91 0.68 0.92 0.92  0.66  0.82 0.06 0.86 0.06 
Hprt 0.92 0.88 0.98 0.83 0.84 0.82 1.01 1.00  0.86  0.91 0.03 0.92 0.05 
Kcns1 1.05 1.15 0.89 1.20 1.25 1.19 0.95 1.15  0.53  1.07 0.07 1.14 0.06 
Ngf 1.92 1.46 1.56 1.99 3.02 2.48 2.04 2.28  0.03  1.73 0.13 2.45 0.21 
Ngfr 1.00 0.95 1.06 0.85 0.99 0.78 0.97 0.95  0.54  0.97 0.04 0.93 0.05 
Nos1 1.02 1.35 0.78 0.92 1.34 0.63 1.26 0.80  0.96  1.02 0.12 1.01 0.17 
Npy #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ntrk1 1.02 1.27 0.88 0.99 1.02 1.06 0.69 1.08  0.55  1.04 0.08 0.96 0.09 
Ntrk2 0.88 0.84 0.88 0.87 1.03 0.82 1.11 0.98  0.15  0.87 0.01 0.98 0.06 
Ntrk3 0.92 1.04 1.02 1.17 1.03 0.76 0.99 1.02  0.35  1.04 0.05 0.95 0.06 
Oprm1 1.25 1.06 0.94 0.92 1.26 0.83 1.20 1.29  0.46  1.04 0.08 1.15 0.11 
P2rx3 1.17 1.42 0.96 1.47 1.20 1.07 1.18 1.30  0.63  1.25 0.12 1.19 0.05 
P2rx4 1.12 1.49 1.02 0.87 1.02 1.00 0.73 0.98  0.25  1.13 0.13 0.93 0.07 
Pdyn 0.76 1.32 0.73 0.72 0.60 0.70 0.67 0.84  0.31  0.88 0.14 0.70 0.05 
Ptgs2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
215 
ID   wt i 1   wt i 2   wt i 3   wt i 4   ko i 1   ko i 2   ko i 3   ko i 4  p  
wt 
average wt sem 
ko 
average ko sem 
Reg3b 1.67 1.24 0.79 0.85 0.94 1.59 1.02 1.35  0.74  1.14 0.20 1.23 0.15 
Rest 1.80 1.30 1.11 1.88 1.74 1.38 1.19 1.44  0.71  1.52 0.19 1.44 0.11 
Scn10a 0.83 1.06 0.84 0.87 0.71 0.67 0.62 0.51  0.01  0.90 0.05 0.63 0.04 
Scn11a 0.66 0.94 1.02 1.35 0.65 0.62 0.76 0.75  0.12  0.99 0.14 0.69 0.03 
Scn3a 1.96 1.36 0.93 1.75 1.35 0.93 1.92 0.71  0.47  1.50 0.23 1.23 0.27 
Scn9a 1.11 0.92 1.11 1.02 0.97 0.91 0.96 0.85  0.08  1.04 0.05 0.92 0.03 
Sgk1 0.74 0.42 1.12 1.23 0.88 1.06 0.58 1.51  0.64  0.88 0.18 1.01 0.20 
Slco1a6 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Sst 3.90 4.31 1.73 3.10 5.96 5.29 13.75 15.21  0.07  3.26 0.57 10.05 2.58 
Tac1 1.06 0.83 0.82 1.13 0.97 0.85 1.08 0.76  0.70  0.96 0.08 0.92 0.07 
Tacr1 1.61 1.25 0.83 1.07 1.76 0.82 1.06 1.22  0.92  1.19 0.16 1.22 0.20 
Trpa1 0.98 1.16 0.98 1.31 0.95 0.75 0.71 0.69  0.02  1.10 0.08 0.78 0.06 
Trpv1 1.29 0.92 1.29 0.99 1.30 1.12 1.08 0.90  0.87  1.12 0.10 1.10 0.08 
Vgf 3.94 2.86 2.37 2.52 4.44 4.52 2.68 3.54  0.17  2.92 0.35 3.79 0.43 




Table 18 - HDAC4Adv D15 CFA gene expression (Study 4) 
ID wt 1 wt 2 wt 3 wt 4 ko 1  ko 2 ko 3 ko 4  p  
wt 
average wt sem 
ko 
average ko sem 
Adcyap #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Aif1 1.18 1.09 0.97 0.75 3.00 0.68 1.09 1.47  0.35  1.00 0.09 1.56 0.51 
Atf3 0.68 0.98 1.14 1.20 0.69 0.33 0.32 0.80  0.03  1.00 0.12 0.54 0.12 
Bdnf 1.07 0.81 1.24 0.88 1.70 0.71 1.10 0.49  0.99  1.00 0.09 1.00 0.26 
Cacna2d1 0.81 0.99 1.29 0.91 0.94 1.09 0.91 0.95  0.84  1.00 0.10 0.98 0.04 
Calca 0.93 0.87 1.06 1.13 0.23 0.23 0.18 0.23  0.00  1.00 0.06 0.22 0.01 
Ccl2 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ccr2 0.80 1.20 1.17 0.83 1.95 #VALUE! #VALUE! #VALUE!  #VALUE!  1.00 0.11 #VALUE! #VALUE! 
Ctss 0.68 1.25 1.01 1.05 0.27 0.43 0.62 0.13  0.01  1.00 0.12 0.36 0.10 
Egfr 0.81 1.44 1.11 0.64 #VALUE! #VALUE! 0.16 0.12  #VALUE!  1.00 0.18 #VALUE! #VALUE! 
Gabbr1 1.03 0.87 1.15 0.96 1.18 1.61 1.70 1.17  0.05  1.00 0.06 1.42 0.14 
Gabra5 #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Gad2 0.83 0.98 1.14 1.04 0.54 0.67 0.61 1.00  0.06  1.00 0.06 0.71 0.10 
Gal 0.85 1.47 0.92 0.75 1.14 1.57 1.61 2.67  0.10  1.00 0.16 1.75 0.33 
Gapdh 0.96 0.91 1.07 1.05 0.86 0.72 1.00 0.80  0.08  1.00 0.04 0.85 0.06 
Gch1 1.17 0.81 1.05 0.97 0.46 0.41 0.19 0.54  0.00  1.00 0.08 0.40 0.07 
217 
ID wt 1 wt 2 wt 3 wt 4 ko 1  ko 2 ko 3 ko 4  p  
wt 
average wt sem 
ko 
average ko sem 
Gfap 0.41 0.94 1.10 1.56 #VALUE! #VALUE! 0.59 0.29  #VALUE!  1.00 0.24 #VALUE! #VALUE! 
Hcn2 1.19 0.89 0.99 0.93 0.53 0.48 0.66 0.74  0.00  1.00 0.07 0.60 0.06 
Hprt 1.03 1.07 0.94 0.96 1.16 1.34 1.02 1.22  0.06  1.00 0.03 1.18 0.07 
Kcns1 0.90 1.04 0.90 1.16 0.48 0.54 0.44 0.51  0.00  1.00 0.06 0.49 0.02 
Ngf 0.92 1.14 0.92 1.03 0.66 1.03 0.17 0.77  0.15  1.00 0.05 0.66 0.18 
Ngfr 0.77 0.82 1.46 0.95 1.65 1.23 1.27 1.23  0.13  1.00 0.16 1.34 0.10 
Nos1 0.97 0.74 0.98 1.32 0.75 0.33 0.31 0.67  0.03  1.00 0.12 0.51 0.11 
Npy #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!  #VALUE!  #VALUE! #VALUE! #VALUE! #VALUE! 
Ntrk1 0.95 0.93 1.07 1.06 0.32 0.32 0.25 0.40  0.00  1.00 0.04 0.32 0.03 
Ntrk2 1.23 0.85 0.99 0.93 2.66 1.63 2.29 1.43  0.03  1.00 0.08 2.00 0.29 
Ntrk3 0.98 0.99 1.06 0.97 1.01 0.77 0.95 0.92  0.19  1.00 0.02 0.91 0.05 
Oprm1 0.78 1.05 1.11 1.06 1.77 1.72 1.28 1.37  0.01  1.00 0.07 1.54 0.12 
P2rx3 0.85 0.89 1.04 1.22 0.49 0.41 0.34 0.48  0.00  1.00 0.08 0.43 0.04 
P2rx4 1.08 0.83 1.01 1.08 0.70 0.37 0.59 0.63  0.00  1.00 0.06 0.57 0.07 
Pdyn 0.79 1.24 0.85 1.12 2.27 2.95 2.76 2.07  0.00  1.00 0.11 2.51 0.21 
Ptgs2 0.70 1.85 0.99 0.46 #VALUE! 3.41 1.91 1.91  #VALUE!  1.00 0.30 #VALUE! #VALUE! 
Reg3b 0.84 1.24 1.00 0.92 0.73 0.14 0.44 0.76  0.04  1.00 0.09 0.52 0.15 
218 
ID wt 1 wt 2 wt 3 wt 4 ko 1  ko 2 ko 3 ko 4  p  
wt 
average wt sem 
ko 
average ko sem 
Rest 2.61 0.62 0.46 0.31 0.24 0.08 0.01 0.23  0.21  1.00 0.54 0.14 0.06 
Scn10a 0.96 0.86 1.19 0.99 1.09 0.76 0.68 0.68  0.15  1.00 0.07 0.80 0.10 
Scn11a 0.79 1.03 0.96 1.21 1.05 0.72 0.71 0.77  0.17  1.00 0.09 0.81 0.08 
Scn3a 0.94 1.35 1.12 0.59 0.74 0.32 0.06 0.10  0.02  1.00 0.16 0.30 0.16 
Scn9a 0.75 0.86 1.36 1.02 2.09 1.34 1.89 1.48  0.02  1.00 0.13 1.70 0.18 
Sgk1 0.98 1.31 0.91 0.80 0.87 1.00 0.60 0.88  0.29  1.00 0.11 0.84 0.08 
Slco1a6 0.65 0.68 1.65 1.02 2.61 3.89 2.22 1.66  0.03  1.00 0.23 2.60 0.47 
Sst 1.22 0.91 1.13 0.74 6.19 10.59 #VALUE! 3.14  #VALUE!  1.00 0.11 #VALUE! #VALUE! 
Tac1 0.72 0.98 1.25 1.04 0.85 0.73 0.73 0.98  0.22  1.00 0.11 0.82 0.06 
Tacr1 0.70 1.73 1.04 0.53 0.81 0.47 0.32 0.73  0.22  1.00 0.26 0.58 0.11 
Trpa1 0.87 1.10 1.08 0.94 0.31 0.50 0.28 0.46  0.00  1.00 0.06 0.39 0.06 
Trpv1 0.98 0.97 0.95 1.10 0.44 0.45 0.34 0.52  0.00  1.00 0.03 0.44 0.04 
Vgf 1.13 0.94 0.98 0.95 #VALUE! 0.12 0.15 0.25  #VALUE!  1.00 0.04 #VALUE! #VALUE! 
Vip 1.08 0.88 0.94 1.09 0.37 0.33 0.89 1.35  0.35  1.00 0.05 0.73 0.24 
  
 
 
 
